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Abstract 
Neurocognitive deficits and thought disorder in schizophrenia have 
generally been accepted as core features of the illness, yet their 
underlying relationship, response to treatment, and correlations with 
outcome remain unclear. Most of the studies to date have used 
cross-sectional designs and focussed on stable patients already on 
treatment. The purpose of this study was to assess changes in 
neurocognition and thought disorder in antipsychotic naïve or 
minimally treated first episode psychosis (FEP) patients, over the 
course of 12 months of treatment according to a standard algorithm 
with flupenthixol decanoate (FD) long acting injectable antipsychotic.  
 
This was a prospective, non-comparative, open-label, longitudinal 
study of 42 patients with FEP. There was an initial wash-out phase of 
up to 7 days after which treatment was initiated with oral flupenthixol, 
1 to 4 mg/day for 1 week prior to when the first long-acting FD was 
given. The starting dose of FD was 10mg every second week, with 
dose increases allowed at 6-week intervals. The Matrics Consensus 
Cognitive Battery (MCCB) and Rorschach Percerptual Thinking Index  
(PTI) were used as the primary co-measures for the assessment of 
neurocognition, thought disorder and perceptual disturbances 
respectively, at baseline prior to treatment, at month 6 and month 12.   
 
Stellenbosch University  https://scholar.sun.ac.za
3 
 
The main findings of this study were as follows: we confirmed the 
presence of significant neurocognitive impairment, thought disorder 
and perceptual disturbances prior to treatment, with improvement in 
neurocognitive performance and thought disorder from baseline to 6 
months, with form perception improving later between month 6 and 
month 12. Improvements in symptoms were associated with 
improvements in neurocognitive performance, thought disorder and 
perceptual disturbances but a degree of residual impairment was 
evident at month 12. This study confirmed the association between 
neurocognition and form perception per se as well as their relative 
stability in FEP after initial improvement with treatment. We found 
support for the correlation between the amount of improvement in 
neurocognition, thought and perceptual disorder with outcome. We 
found the Social and Occupational Functioning Scale  (SOFAS) to be 
a more robust measure of social and functional outcome with highest 
level of education (HLOE), substance abuse, reasoning-and-problem 
solving, form perception and Rorschach PTI emerging as predictors 
in a best subset regression analysis.   
 
The findings of this study suggest that neurocognitive impairments, 
thought disorder  and perceptual disturbances have both state and 
trait like features, that patients benefit from treatment with a low-dose 
FGA, and that residual neurocognitive and perceptual impairment 
after treatment may indicate persisting underlying cerebral pathology.    
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Abstrak 
Neurokognitiewe inkortinge en gedagteproses versteuring in 
skisofrenie word algemeen aanvaar as kern eienskappe van die 
siekte, tog is die onderliggende verhouding, die respons op 
behandeling, en die verwantskap met uitkoms onduidelik. Die meeste 
studies het 'n oorkruis-deursnee navorsingontwerp gebruik en 
gefokus op stabiele pasiёnte wat reeds op behandeling was. Die doel 
van hierdie studie was om die verandering in neurokognisie,  
gedagte vesteuring en perseptuele inkortinge te meet in eerste-
episode psigose  pasiёnte wat behandeling naïef was, of wat 
minimale behandeling gekry het, oor die verloop van 12 maande, met 
die toediening van 'n langwerkende, lae dosis flupenthixol inspuiting.  
 
Hierdie was 'n prospektiewe, nie-vergelykende, oop etiket, 
longitudinale studie van 42 eerste episode psigose pasiёnte almal op 
behandeling volgens 'n vaste protokol. Daar was 'n inisiёle uitwas 
periode van tot 7 dae waarna behandeling begin is op orale 
flupethixol, 1 tot 4 mg/dag vir 1 week voordat die eerste 
langwerkende flupenthixol inspuiting toegedien was. Die aanvangs- 
dosis was 10mg elke tweede week met verhogings in dosis elke 
sesde week daarna. Die "Matrics Consensus Cognitive Battery'' 
(MCCB) en Rorschach "Perceptual Thinking Index" (PTI) is gebruik 
as die primêre instrumente vir die meting van neurokognisie, gedagte 
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versteuring en perseptuele inkorting in noue samehang voor 
aanvang van behandeling, op maand 6 en op maand 12.   
  
Die hoof bevindinge van hierdie studie was as volg: Ons het die 
teenwoordigheid van beduidende neurokognitiewe, gedagte  
versteuring en perseptuele inkortinge bevestig voor behandeling, met 
verbetering in neurokognitiewe prestasie en gedagte versteuring  
tussen basislyn en maand 6,  en  verbetering in vorm persepsie wat 
later gevolg het tussen maand 6 en maand 12. Die verbetering in 
simptome was geassosieёr  met verbetering in neurokognitiewe 
prestasie, gedagte versteuring en perseptuele inkortinge maar teen 
maand 12 was 'n graad van residuele neurokognitiewe en 
perseptuele inkortinge aanwesig.  Hierdie studie het die verwantskap 
tussen neurokognisie en vorm persepsie bevestig, asook die 
relatiewe stabiliteit daarvan in  eerste episode psigose na 
aanvanklike verbetering op behandeling. Ons het bewyse gevind wat 
die korrelasie tussen neurokognisie, gedagte en perseptuele 
versteuring met uitkomste ondersteun. Ons het bevind dat die "Social 
and Occuapational Functioning Scale" (SOFAS) 'n meer robuuste 
meting van sosiale en funksionele uitkoms is, en dat hoogste 
opvoedkundige vlak, substans misbruik, redenering-en-probleem 
oplossing, vorm persepsie en die Rorschach PTI as voorspellers 
identifiseer was  in 'n beste substel regressie analise.  
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Die bevindinge van hierdie studie suggereer dat neurokognitiewe, 
gedagte versteuringe en perseptuele inkortinge oor beide toestand 
en trek eienskappe beskik, en dat pasiёnte verbeter het met 
behandeling op 'n lae dosis eerste generasie antipsigotikum, en dat 
residuele neurokognitiewe en perseptuele inkortinge na behandeling 
aanduidend kan wees van onderliggende serebrale patologie. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Stellenbosch University  https://scholar.sun.ac.za
7 
 
CONTENTS 
Chapter 1:  Introduction                             8      
Chapter 2:  Neuropathogenesis of schizophrenia                              23 
Chapter 3:  Neurocognitive deficits in schizophrenia                         74 
Chapter 4:  Thought disorder in schizophrenia                                143 
Chapter 5:  Purpose of this study                                                    193 
Chapter 6:  Study design                                                                 196 
Chapter 7:  Results: Demographic data                                           223 
Chapter 8:  Results: Symptom severity, neurocognitive                  231 
                                 impairment and severity of thought disorder  
   at baseline                                                                      
Chapter 9:  Results: Treatment response and outcome                  252 
Chapter 10:  Discussion                                                                     294 
Chapter 11:  Conclusion                                                                    338 
Appendix A  Table 1: Summary table for demographic  
   variabels       342 
   Table 2: LSD means at each time point for  
   MCCB, PTI and PANSS scores    343 
Index of acronyms and abbreviations                                                       344 
Stellenbosch University  https://scholar.sun.ac.za
8 
 
CHAPTER 1: 
 
INTRODUCTION  
 
Schizophrenia is a heterogeneous disease characterised by its 
diverse symptom manifestations reflecting multiple etiological 
pathways (Tandon et al., 2009; Baxter & Little, 1998). Its clinical 
features are distinguished by the clustering of positive, negative, 
disorganized, cognitive, mood and motor symptoms (Tandon et al., 
2009; Sadock & Sadock, 2007) with varying degrees of severity 
across patients and over the course of the illness.  
 
The lifetime prevalence of schizophrenia is about 1% of the general 
population. The illness onset usually is evident during adolescence or 
early adulthood, and typically it follows a chronic course marked by 
frequent relapses, incomplete remissions, functional impairment, 
social and occupational disability, frequent co-morbid substance use, 
and high mortality rates (Tandon et al., 2009; Sadock & Sadock, 
2007). In South Africa the epidemiology and clinical features of 
schizophrenia are no different from the rest of the world with a 
prevalence of 0.81% and an unemployment rate of 50% amongst 
schizophrenia patients (US Census Bureau, 2004). The disease does 
not discriminate amongst gender, socio-economic status (SES) or 
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culture. However, Burns (2009) argues that the course and outcome 
of schizophrenia is poorer in developing countries. In South Africa, 
conditions of poverty, inequality, and violence are important socio-
economic stressors that may impact on the treatment and outcome of 
patients living with schizophrenia.  
 
Both thought disorder and neurocognitive deficits have been: 
 considered core features of schizophrenia (Keshavan et al., 
2008; Heinrichs, 2005; Metsȁnen et al., 2005),  
 shown to be relatively stable over time (Metsȁnen et al., 
2005; Kurtz, 2005), 
 associated with poorer outcomes and prognoses (Van Winkel 
et al., 2007; Bowie et al., 2008). 
 
Premorbid neurocognitive impairment and thought disorder have 
been found to be present prior to the onset of psychotic symptoms 
(Henry and Crawford, 2005; Metsȁnen et al., 2004; Woodberry et al., 
2008). Neurcognitive deficits and thought disorder have also been 
evidenced in the first-degree relatives of schizophrenia patients, 
indicating a 'trait' vulnerability or endophenotype (Erlenmeyer-Kimling 
et al., 2000; Saykin et al., 1994; Metsȁnen et al., 2005).   
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The correlation between thought disorder and neurocognitive deficits, 
the underlying mechanisms thereof and the association with positive, 
negative and disorganized symptoms in schizophrenia, remains 
unclear. Mild to moderate correlations have been found between 
neurocognitive impairments and negative and disorganized symptom 
clusters (O' Leary et al., 2000; Davidson et al., 2009). On the other 
hand positive symptoms have demonstrated no significant correlation 
with neurocognitive deficits in schizophrenia (Klingberg et al., 2006). 
Thought disorder has been correlated with: 
 basic attentional and information-processing deficits (Perry et 
al., 1999; Minȁssian et al., 2005),  
 executive and working memory impairments (Kerns and 
Berenbaum, 2002),  
 semantic-memory-lexical processing problems (Kerns & 
Berenbaum, 2002; Goldberg & Weinberger, 2000),  
 aberrant salience to environmental cues and internal 
representational states (Kapur, 2003).  
 
Whether thought disorder is secondary to underlying neurocognitive 
deficits remains to be answered, but the close association and 
shared phenomenology between the two constructs seem to point to 
a common underlying neural pathway.   
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Although thought disorder has been regarded as a variant of 
generalized neurocognitive impairment commonly found in 
schizophrenia patients (Gold & Hurt, 1990), there seems to be a 
partial dissociation between the two constructs in terms of treatment 
response (Goldstein et al., 2002; Remberk et al., 2012). Modest and 
selective improvement in thought disorder and neurocognition have 
been documented after antipsychotic treatment in schizophrenia 
patients (Ruhrmann et al., 2007; Remberk et al., 2012; Goldstein et 
al., 2002). Despite the association between neurocognition and 
thought disorder and its response to antipsychotic treatment, putative 
studies investigating the neurocognitive mechanisms underlying 
improvement in thought disorder and positive psychotic symptoms 
are lacking (Goldstein et al., 2002). The current study offers the 
opportunity to assess improvement in neurocognition, thought 
disorder and symptomatology in response to antipsychotic treatment 
over time.  
 
One of the impediments in schizophrenia research has been the lack 
of appropriate measurement tools investigating multi-dimensional 
constructs like neurocognition and thought disorder. Prior to 2004, 
the assessment of neurocognition was flawed by the compendium of 
different neuropsychological instruments purporting to measure the 
same cognitive domains (Keefe et al., 2011; Goldberg et al., 2010). 
The National Institute of Mental Health "Measurement and Treatment 
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Research to Improve Cognition in Schizophrenia'' (MATRICS) 
initiative led to the development of the MATRICS Cognitive 
Consensus Battery (MCCB), which was endorsed by the National 
Institute of Mental Health (NIMH) as the standard measurement of 
cognition in all schizophrenia clinical trials (Green et al., 2004; 
Nuechterlein et al., 2008). The MCCB measures Speed of 
processing, Attention/Vigilance, Working memory, Verbal learning, 
Visual learning, Reasoning and problem solving, and Social 
cognition. It allows clinicians and researchers to administer various 
tests in a relatively short time (Holmen et al., 2010). Despite the 
growing interest in using the MCCB as the standard measure of 
neurocognition in schizophrenia, very little research has been done 
to date using the MCCB in first-episode psychosis (FEP), 
immediately highlighting the importance of the current study. This 
study will also expand on the clinical utility and validity of the MCCB 
in the South African context.   
  
The measurement of thought disorder has posed similar difficulties: 
in early research the assessment of thought disorder was based 
largely on the subjective judgements of clinicians in unstructured 
interview settings (Nuechterlein et al., 1986). Subsequently, many 
different methods have been developed to assess thought disorder in 
schizophrenia using inter alia proverbs, verbal comprehension and 
vocabulary tests, speech and language rating scales, and the 
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Rorschach Inkblot Method (RIM) (Andreassen, 1986; Holzman, 1986; 
Exner, 2003).  
 
The RIM offers a unique opportunity to measure thought disorder 
because it encourages the patient to discuss his thoughts in an open 
and honest fashion. It can detect the subtleties of thought disorder 
that structured questionnaires tend to overlook (Perry et al., 2003). 
To date, the preferred Rorschach index for assessing thought 
disorder in schizophrenia and related disorders is the Perceptual 
Thinking Index (PTI) (Exner, 2000a). This study is novel insofar as 
the PTI and the MCCB has never before been correlated to assess 
the relationship and temporal association between neurocognitive 
deficits and thought disorder over time in a cohort of patients with 
schizophrenia.  
 
Longitudinal studies in FEP are often limited due to the challenges 
associated with the attrition rate of patients. Statistical power is 
diminished due to the patient attrition rate and missing data at follow-
up visits (Bozikas & Andreou, 2011). The timing of baseline 
assessments is another important factor to take into consideration: 
some studies conduct baseline assessments on patients who have 
received no antipsychotic treatment, while other studies do baseline 
assessments once patients are stable on antipsychotic medication. 
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There are very few studies comparing neurocognitive deficits before 
and after antipsychotic treatment (Hill et al., 2008).   
 
Assessing neurocognitive deficits and thought disorder in FEP offers 
several advantages. It provides a realistic baseline measure of these 
core factors in schizophrenia patients and it minimizes the effects of 
variables such as average illness duration (Keefe et al., 2013), long-
term antipsychotic treatment (Gold, 2004), institutionalization (Rajji et 
al., 2013), and the effects of aging on the neurobiology of the disease 
(Goldberg et al., 2010). 
 
The current study provides a longitudinal assessment of a well-
defined cohort of FEP schizophrenia spectrum patients (DSM-IV TR 
diagnosis of schizophreniform, schizoaffective and schizophrenia) , 
all treated with the same first generation agent (FGA) according to a 
fixed protocol. It will expand on the existing body of knowledge 
pertaining to neurocognitive deficits and thought disorder in 
schizophrenia patients by tracking the response to antipsychotic 
treatment serially over a period of 12 months. The intercorrelations 
between improvements in neurocognition, thought disorder and 
symptomatology on the one hand, and the prediction of treatment 
outcome from baseline neurocognitive and thought disorder 
assessments on the other, will further our understanding of the 
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complex interaction between the neurocognitive, clinical and 
functional dimensions of schizophrenia spectrum disorders during 
FEP.  
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CHAPTER 2: 
 
NEUROPATHOGENESIS OF SCHIZOPHRENIA 
 
INTRODUCTION 
Schizophrenia is a multi-faceted disease entity reflecting diverse and 
varying degrees of symptomatology over the course of the illness, 
with multiple possible neurobiological pathways and epigenetic 
interactions. To date there is no laboratory test to aid the diagnosis of 
schizophrenia and no single biomarker or gene variation has been 
isolated that could give a plausible explanation for the complete 
pathogenesis of the disease over the course of its lifetime (Titone, 
2010). 
 
With the technological advances made over the past few decades in 
the fields of Neuroscience and Genetics we have come closer to an 
understanding of how the brain works, and to what may go wrong in 
the brain that then leads to the development of schizophrenia. 
Understanding the neurobiological aspects of the disease is an 
important precursor to furthering our insight and to gaging our 
knowledge of the neuropsychological findings in schizophrenia 
research. Neurocognitive testing measures aspects of brain 
functioning and could therefore expand on existing data supporting 
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structural and functional neurobiological changes or disrupted neural 
networks often found in the brains of schizophrenia patients 
(Borofsky et al., 2010).     
  
This chapter will deal with some of the major neuroscientific 
discoveries that shed more light on the neuropathogenesis of the 
disease and its neurobiomarkers.  
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BRAIN CHANGES IN SCHIZOPHRENIA 
Both functional and structural brain changes have been found in 
schizophrenia, but the research data is not consistent, or evident, in 
all patients. Furthermore, many studies have contradictory findings 
making it difficult to map brain abnormalities that are specific to 
schizophrenia. To complicate matters further, the overlap between 
functional and structural brain imaging is inconclusive and the 
concordance between neurocognitive testing and brain imaging is 
similarly poor. 
 
Imaging studies have consistently demonstrated global and regional 
structural brain abnormalities in people with schizophrenia (Haijma et al., 
2013). While the presence of abnormalities at, and prior to the onset of first 
psychotic symptoms (Pantelis et al.,2003) is consistent with a 
neurodevelopmental origin, longitudinal studies have established that 
progressive changes also occur (Olabi et al.,2011). These changes are 
most pronounced in the early years of illness, and occur only in a subset of 
patients (Andreasen et al.,2013). There is debate as to the causes of the 
progressive changes - while they may reflect illness progression 
(Lieberman et al., 2001), there is also evidence to suggest that they are 
related to antipsychotic treatment per se (Smieskova et al., 2009;Ho et al., 
2011;Andreasen et al., 2013),  or they may be non-specific and secondary 
to factors such as substance abuse, poor adherence to treatment or the 
effects of co-morbid conditions (Zipursky et al., 2013). 
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Brain volume, ventricle size, and CSF spaces 
Brain imaging studies have indicated that whole brain volume (WBV) 
in schizophrenia patients is smaller than in normal controls. In a 
meta-analysis Ward et al. (2000) found that WBV is smaller by 2%. 
Intracranial volume (ICV) is also smaller but shows a smaller 
reduction than WBV in schizophrenia patients. These differences 
have been more consistently evidenced in chronic schizophrenia. 
 
Reduced brain volume is found differentially more in gray matter, but 
white matter abnormalities have also been reported (Liddle & 
Pantelis, 2003). Reduced brain volume has been noted with illness 
onset, noteworthy being similar findings in neuroleptic naive FEP 
(Ren et al., 2013; Gur et al., 1999). A recent study of 100 neuroleptic 
naive FEP schizophrenia patients matched against healthy controls 
showed significant volume reduction in the gray matter of the patient 
group involving the thalamo-cortical networks (Ren et al., 2013). It is 
therefore probable that the brain volume changes observed in 
schizophrenia are related to the illness itself and are not an effect 
produced by antipsychotic medicine. On the other hand progressive 
loss of WBV has been found in longitudinal studies over a 4-year 
period in 50 FEP schizophrenia patients (Velakoulis et al., 2000b). 
Wood et al. (2001) found similar results in comparing FEP and 
chronic schizophrenia, against controls, over a 4-year period. 
Further, recent work suggests a possible role for antipsychotic 
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treatment in these progressive changes (Smieskova et a., 2009;Ho et 
al., 2011;Andreasen et al., 2013). 
 
One of the most consistent morphological findings of the brain in 
schizophrenia has been enlargement of the ventricles, in particular 
the lateral and third ventricle. These changes are not, however, 
specific to schizophrenia, but have been found in other psychiatric 
disorders such as depression (Elkis et al., 1995). Enlarged ventricles 
in schizophrenia have been associated with obstetric complications, 
and genetic factors are also evident in contributing to this 
predisposition (McNell et al., 2000; Sharma et al.,1998; Lawrie et al., 
2001). Ventricular and sulcal enlargement have been found to be 
progressive from illness onset and are associated with poorer 
outcome (Staal et al.,1999) and longer duration of untreated 
psychosis (DUP) (Madsen et al., 1999).  
 
In summary, significant brain volume reductions and ventricular 
enlargement have been found in patients with schizophrenia. These 
changes are noted at illness onset, appear to be progressive over 
time and have been associated with poorer outcome.  
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Frontal neocortex  
While the reported brain changes in schizophrenia are widespread, 
one area frequently found to show changes is the frontal lobe. The 
prefrontal cortex is functionally diverse and includes executive, social 
cognitive, affective and motor functions.  Abnormalities in this region 
would be consistent with the heterogeneity of the symptom 
expression of schizophrenia which include disruptions in these 
functions.  
 
Several studies have indicated selective loss of gray matter in the 
dorsolateral prefrontal cortex (DLPFC) and in the orbitofrontal cortex 
(OFC) of schizophrenia patients (Ren et al., 2013; Goldstein et al., 
1999; Szezko et al., 1999). These areas are associated with the 
executive and controlling / inhibitory functions of the brain.  
 
Frontal abnormalities are evident before illness onset, which point to 
neurodevelopmental abnormalities in brain maturation early in life. 
Abnormal synaptic pruning during adolescence has been linked to 
the onset of the illness (Keshavan et al., 2000; Vance et al., 2000) as 
it coincides with prodromal changes which often precede the 
psychotic break in FEP. The notion of 'neurodevelopmental' 
schizophrenia has regained scientific popularity and will be discussed 
more extensively elsewhere.  
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Staging of the illness suggests that frontal lobe changes precede 
those in the temporal lobe and the more general gray matter decline 
in schizophrenia. Rapoport et al. (1999) have studied the decline in 
frontal and temporal regions in childhood-onset schizophrenia and 
their association with negative symptoms and symptom severity. 
Frontal abnormalities are apparent in FEP and further progression 
has been demonstrated over time (Ren et al., 2013).   
 
Temporal neocortex 
Volumetric changes in the temporal lobes have been reported in 
schizophrenia, particularly reduced gray matter (Levitt et al., 2010; 
Cronenwett et al., 2010). An area of special interest is the posterior 
part of the superior temporal gyrus, including the planum temporale. 
The planum temporale is responsible for the processing of language 
(Shapleske et al., 1999) and volume reductions in this area as well 
as the parahippocampal gyrus and fusiform gyrus (Wright et al., 
2000; Paillere-Martinot et al., 2001) have been implicated in 
schizophrenia.   
Progressive tissue loss in the temporal lobes has been found in 
childhood-onset schizophrenia, although longitudinal studies in 
general do not support ongoing progressive deterioration (DeLisi et 
al., 1995). Significant volume reductions of the temporal cortex have 
been associated with neuroleptic naive FEP schizophrenia patients 
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(Lui et al., 2009; Meisenzahl et al., 2008), which confirms the 
involvement of the temporal lobes during illness onset. Furthermore, 
abnormalities in the sulcal and gyral patterns of the temporal lobes 
may indicate neurodevelopmental pathology (Kikinis et al., 1994).  
 
The superior temporal gyrus, a region in the temporal lobes that 
includes the planum temporale, has consistently been implicated in 
schizophrenia. In a review by Shenton et al. (2001) of FEP studies, 
100% gray matter reduction of the superior temporal gyrus is 
observed in schizophrenia. The superior temporal gyrus and planum 
temporale plays a role in auditory processing and source monitoring 
of internal mental activity.  
 
Parietal cortex  
Although the parietal lobes have not been a major focus of attention 
in schizophrenia, volumetric reductions and functional deficits have 
been reported in these areas (Goldstein et al., 1999; Gur & Gur, 
2010). Left-right asymmetry involving the angular gyrus has been 
found. The angular gyrus of the inferior parietal lobule has been 
implicated in the semantic-lexical network (Schlaepfer et al., 1994; 
Goldstein et al., 1999). Under-activity of the parietal lobe has been 
associated with psychomotor poverty symptoms and the severity of 
disorganization symptoms (Liddle et al., 1992; Kaplan et al., 1993).  
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Cingulate cortex  
Studies have indicated cingulate abnormalities (Ren et al., 2013) in 
chronic schizophrenia and childhood-onset schizophrenia using 
voxel-based morphometry (VBM), and lower N-acetylaspartate (NAA) 
bilaterally has been found in the anterior cingulate regions 
(Sigmundsson et al., 2001; Sowell et al., 2000). Yucel et al. (2002b) 
demonstrated abnormal cingulate gyrification in the left hemisphere, 
with reduced fissurization in patients with schizophrenia.  
 
Anterior cingulate activation has been found to be inappropriate to 
stimulus demands in patients with schizophrenia, with either 
excessive or underactive responsiveness involving selective attention 
and response selection Bertolino et al.(2000).   
 
Hippocampus and amygdala  
Significant reductions in hippocampal and amygdala volumes have 
been found in schizophrenia, which are apparent during FEP (Nelson 
et al., 1998; Hirayaso et al., 1998; Velakoulis et al., 1999). Nelson et 
al. (1998) reported more left-sided volume reductions, whilst 
Velakoulis et al. (1999) found bilateral hippocampal changes.  
Reduced hippocampal volume may be a trait marker as suggested 
from twin studies, and bilateral reductions are found in first-degree 
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relatives of patients with schizophrenia (Seidman et al., 1999). Other 
than the involvement of genetic factors in hippocampal volume, the 
role of environmental factors may also contribute to hippocampal 
decrease. Neurochemical (e.g., glutamate) or hormonal (e.g., 
cortisol) effects of environmental stress on hippocampal volume are 
well documented and might interact with genetic susceptibility in 
some cases. For example, Stefanis et al. (1999) and McNeil et al. 
(2000) have studied how perinatal birth complications may have 
caused patients with schizophrenia to have smaller hippocampi. 
 
The amygdala forms part of the limbic system, which plays a primary 
role in the processing of emotions. Reduced activation of the 
amygdala was found in patients with schizophrenia during induction 
of sad mood (Schneider et al., 1998), whilst Phillips et al. (1999) 
found overactivation of the amygdala during the patients’ processing 
of facial expressions of disgust. The latter was associated with 
misappropriation of disgust with fear, which is consistent with the 
clinical notion that schizophrenia patients find it difficult to interpret 
emotions accurately and respond appropriately to emotional cues.  
 
Subcortical structures  
Overactivation in the cortico-striatal-thalamic circuits, with 
connections to the midbrain, striatum, and basal ganglia, has been 
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reported in patients with schizophrenia (Liddle et al., 1992). Thalamic 
hyperactivity is observed during periods in which the patient displays 
positive symptoms of the disease (Silbersweig et al., 1995). It follows 
that psychotic symptoms entail excessive feedback via the cortico-
striatal-thalamic circuits. This is consistent with the putative  
mechanism of antipsychotic medication which is blockade of D2 
receptors in the striatum (Lawrie et al., 1999). The cerebellum is 
reciprocally connected to the association cortex via the midbrain and 
the thalamus. In schizophrenia reduced cerebellar activation is seen 
during performance of tasks that engage the association cortex, 
which is consistent with disruption of cortico-striatal-thalamic 
connections (Andreasen et al., 1996; Kiehl & Liddle 2001).  
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AETIOLOGICAL MODELS OF SCHIZOPHRENIA 
Aetiological models of schizophrenia have heuristic value in 
understanding the pathogenesis, development, and progression of 
the disease, but clear linear cause-effect interactions have eluded 
science so far. A few of the mainstream schizophrenia 'hypotheses', 
which are not mutually exclusive, are briefly outlined below  
  
Hypofrontality  
Prefrontal abnormalities are well described in schizophrenia with 
numerous studies indicating a decrease in prefrontal gray matter, 
hypometabolism / hypodopaminergia and impaired performance on 
cognitive tasks (Howes & Kapur, 2009). Aberrant prefrontal 
functioning in patients with schizophrenia is present at illness onset 
and is temporally associated with adolescence, the developmental 
period during which maturation of the frontal cortices are critical 
(Weinberger et al.,1988).  
 
The DLPFC region has been of particular interest in schizophrenia. 
Post-mortem studies have indicated a decrease of cortical thickness 
in the DLPFC of 3-12% of schizophrenia patients (Pakkenberg, 1993; 
Daviss & Lewis, 1995). The presence of structural abnormalities in 
schizophrenia has also been supported by MRI studies, which 
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revealed subtle reductions in gray matter volume of the DLPFC. The 
reduction in gray matter is not necessarily due to a loss in neuronal 
numbers. Studies have indicated that the DLPFC neuropil, the axon 
terminals and dendritic spines of the synapses, are reduced in 
patients with schizophrenia (Selemon & Goldman-Rakie, 1999). 
Furthermore, the observation by Keshavan et al. (2000) of decreased 
DLPFC phosphomonoesters and increased phosphodiesters in 
neuroleptic naive FEP, is indicative of a decrease in synaptic 
numbers. Reductions in DLPFC N-acetylaspartate (NAA) have been 
reported (Bertolino et al., 1996; Deicken et al., 1997) and these are 
markers of disturbed neuronal and / or axonal integrity.  
 
Thus, the reduction of DLPFC gray matter in schizophrenia appears 
to be explained by  smaller neurones, aberrant axonal terminals and 
dendritic spines, and reduced synaptic numbers. These lines of 
evidence point to a disturbance in synaptic connectivity of the 
DLPFC, which correlates with impaired activation on working 
memory (WM) tasks in other brain regions (Bertolino et al., 2000). 
 
The notion of a hypodopaminergic DLPFC is held to be central in the 
core pathology of schizophrenia and has been supported by many 
studies. Hypofrontality is, however, unable to account for the diverse 
changes observed in other brain regions associated with the illness. 
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The role of the subcortical dopamine projections from the 
mesencephalon and thalamic nuclei is also deemed important. 
Reductions in D1 receptor density have been found in the DLPFC of 
neuroleptic naive schizophrenia patients (Okubo et al., 1997) and 
reduced mediodorsal thalamic nucleus (MDN) volume has been 
found in post-mortem studies (Pakkenberg, 1990; Popken et al., 
2000; Young et al., 2000). Furthermore, Danos et al. (1998) found 
supportive evidence of thalamic neurone density reduction in 
schizophrenia patients. Reduced MDN projection neurones are also 
associated with reduced DLPFC dendritic spine density, which 
supports the role of the MDN-DLPFC connectedness in the causation 
of schizophrenia. 
 
Executive function deficits are regarded as core deficits in 
schizophrenia patients when assessed on WM, problem solving, set-
shifting, and delayed-response performances. These cognitive 
functions require an intact DLPFC circuitry with its connections to the 
MDN and thalamic inputs. With normal development, delayed-
response behaviour is increasingly mediated by the DLPFC with less 
reliance on the MDN to serve these functions (Alexander & Goldman, 
1978). Schizophrenia patients have reduced activation of the DLPFC 
on WM tasks (the ability to hold information ''on line'' to guide 
behaviour) (Weinberger et al., 1986; Goldman-Rakic, 1994) and on 
delayed response tasks (Park & Holzman, 1992). Weinberger et al. 
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(1988) found that schizophrenia patients show less activation of the 
DLPFC on the Wisconsin Card Sorting Task (WCST), a task that 
taps into cognitive set-shifting or flexibility. Executive function deficits 
are not the primary cause of schizophrenia,  but they are regarded as 
risk factors that interact with social and environmental demands 
(Hollis & Taylor, 1997). 
 
Dysconnectivity  
The symptom expression of schizophrenia is diverse, including for 
example disorders of  affect, movement, and cognition (Nuechterlein  
et al., 2004). This likely reflects involvement of  multiple neural 
pathways and diverse brain regions. Studies of fronto-temporal and 
fronto-thalamo-striatal dysconnectivity have supported the notion of 
disordered synaptic communication between remote brain regions 
rather than neuronal cell loss.    
 
Several post-mortem studies have indicated structural abnormalities 
in sites connected to the DLPFC, i.e., the parahippocampal gyrus 
(Brown et al., 1986), anterior cingulate, and superior temporal sulcus 
(Benes & Bird, 1987). Similarities between patients with 
schizophrenia and those with subcortical brain lesions have 
suggested that there may be a primary dysfunction of the fronto-
thalamo-striatal pathways in the presentation of schizophrenia. Some 
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have argued that frontal lobe deficits, typically seen in schizophrenia 
patients, are linked to the disruption of the subcortical circuits and 
their projections to the DLPFC (Barnes, 1988; Pantelis et al., 1989). 
Patients with subcortical lesions involving the basal ganglia and 
thalamus have symptoms resembling the negative symptoms, 
bradyphrenia, abnormal movements and cognitive deficits found in 
patients with schizophrenia (Barnes, 1988; Pantelis et al., 1989; 
Cummings, 1986). The involvement of the basal ganglia in patients 
with schizophrenia is evidenced by abnormal eye movements and 
movement disorders, which are connected to the DLPFC and OFC 
(Barnes, 1988; Holtzman, 1987). Furthermore, Groenewegen et al. 
(1991) argue that emotional and behavioural abnormalities in 
schizophrenia implicate the limbic system and anterior cingulate 
projections.  
 
Functional imaging studies predicting prefrontal rCBF using 
measures of hippocampal volume found that prefrontal activation on 
the WCST was related to hippocampal volume in schizophrenia 
patients (Weinberger et al.,1992). These results support the notion 
that prefrontal malfunction observed in schizophrenia is secondary to 
structural hippocampal abnormalities, with the latter typically 
occurring earlier in life (Benes, 1989).  Changes in DLPFC volumetric 
measures and corresponding changes in thalamic structures have 
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been observed, which support the involvement of the DLPFC-MDN 
circuitry in schizophrenia (Benes, 2004).  
 
Bertolino et al. (1996) have found an association between prefrontal 
cellular abnormalities and excessive dopamine levels in the striatum 
of patients with schizophrenia. The modulatory role of dopamine is 
hypothesised to be dissociated in schizophrenia with subcortical 
striatal D2/3 hyperdopaminergia and conversely D1 prefrontal 
hypodopaminergia (Howes & Kapur, 2009). Striatal 
hyperdopaminergia is associated with an aberrant attribution of 
salience to stimuli, which could explain the hallucinatory and 
delusional interpretation of stimuli (Kapur, 2003; Kapur et al., 2005). 
On the other hand, prefrontal hypodopaminergia is often associated 
with the negative symptoms and cognitive impairment seen in 
schizophrenia (Goldman-Rakic et al., 2004; Tamminga, 2006).  
 
Abnormalities in frontotemporal white matter tracts, which translate 
into regional brain connectivity and fibre pathways, have been 
observed by using advanced imaging techniques (diffusion tensor 
and magnetization transfer imaging) to observe the brain activity of 
patients with schizophrenia (Lim et al., 1999; Foong et al., 2001). 
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Measures of cognitive function have indicated a dissociation between 
regional brain networks in schizophrenia. Word generation tasks are 
associated with prefrontal activation and simultaneous suppression 
of activity in the STG of normal subjects. In schizophrenia prefrontal 
activation is normal on word generation, but increased activity is 
observed in the STG (Frith et al., 1995; Fletcher, et al., 1996).  WM 
tasks are usually associated with the activation of the DLPFC, but 
this is conversely observed to be decreased in subjects presenting 
with schizophenia. However, observation of subjects undertaking 
WM tasks, shows that endogenous NAA levels  correlated with 
activation of a widely distributed WM network involving the DLPFC, 
temporal, and inferior-parietal cortices (Bertolino et al., 2000). Josin 
& Liddle (2001) have been able to distinguish schizophrenia patients 
from normal subjects with 100% reliability using data gathered from 
observing the functional connectivity between the prefrontal cortex 
and other cerebral sites. Furthermore, frontotemporal dysconnectivity 
has been defined as a state marker of schizophrenia with remitted 
patients and high-risk relatives showing no abnormalities in 
frontotemporal connectivity (Bertolino et al., 2000). Thus, measures 
of cognitive function support the findings of structural and functional 
brain imaging that point towards the involvement of prefrontal-
temporal cortical dysconnectivity in patients with schizophrenia.  
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Further support for the model of dysconnectivity as a primary cause 
underlying the wide spectrum of symptomatology in schizophrenia, 
comes from studies of neurological conditions involving intracortical 
connections associated with psychosis. Of these neurological 
conditions the velocardiofacial syndrome (VCFS) and metachromatic 
leucodystrophy (MLD) have drawn interest. VCFS and MLD (a pure 
connectivity disorder), are both associated with late age illness onset 
similar to schizophrenia. MLD is a rare disorder of aryl sulphatase 
deficiency leading to the functional dysconnection of the cortical 
regions (Hyde et al., 1992), with illness onset between 13-30 years of 
age and symptoms closely resembling that of schizophrenia. 
Neuropathological abnormalities are observed in the white matter of 
MLD subjects, with prominent changes in prefrontal white matter 
evident at the time of illness onset (Hyde et al., 1992). This suggests 
that functional dysconnectivity of the prefrontal cortex is responsible 
for psychosis, analogues to what has been observed in 
schizophrenia.  
 
In summary, the late expression of psychosis in schizophrenia might 
reflect early developmental abnormalities, which alter intracortical 
connectivity during the critical period for prefrontal maturation. 
Prefrontal connectivity involves the temporal, subcortical, and limbic 
regions.  
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Neurodevelopment  
Since the inception of Kraepelin's concept of ''dementia praecox", 
early models of schizophrenia regarded the illness as following a 
slow and progressive course with degenerative brain changes 
leading to an end state of dementia. Kraepelin and Bleuler noted 
abnormal neurological and behavioural signs in the childhood 
histories of patients with schizophrenia. Bender (1947) described 
schizophrenia as a developmental encephalopathy and others have 
noted developmental abnormalities (Fish & Hagin, 1972). The notion 
of schizophrenia as a degenerative disease has been disputed by 
longitudinal studies indicating recovery, static neuropsychological 
impairment, absence of astrogliosis, and absence of 
neurodegeneration (Harding et al., 1992; Aylward et al., 1984; 
Weinberger, 1986). By the end of the 1980s research attention 
shifted and the notion of abnormal brain development in the 
pathogenesis of schizophrenia gained momentum. The evidence 
suggests subtle abnormalities of cortical development, particularly in 
the prefrontal cortex with its connectedness to other brain regions.  
 
Several lines of evidence point to a neurodevelopmental process, 
rather than neurodegeneration, in the progression of schizophrenia. 
Brain morphology in schizophrenia is characterised by increased 
neuronal density (smaller neurons), regional decrease in dendritic 
spine density, especially in subcortical white matter, temporal regions 
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and DLPFC, decreased intra-neuronal space and reduced brain 
volume (Piper et al., 2012; Glantz & Lewis, 2000). Furthermore, the 
absence of gliosis and of neuronal cell death, count against adult-
onset neuropathology (Piper et al., 2012).  
 
Differences of opinion exist in what the mechanism of 
neurodevelopmental process is for schizophrenia. Early formulations 
led to the notion of an early prenatal or perinatal developmental 
insult, which could be neurogenetic or environmental in origin. This 
''lesion'' remains dormant until brain maturational interactions 
(environmental stressors and/or cortical maturation) during puberty 
alter the cytoarchitecture of the regional brain networks prior to 
illness onset (Piper et al., 2012).   
 
Early developmental risk factors are obstetric complications 
(infection, micro-nutrient deficiency, birth complication, famine), 
minor neuromotor abnormalities, delayed attainment of 
developmental milestones, behavioural, personality, and intellectual 
abnormalities (Piper et al., 2012; Petronis, 2004). Musculoskeletal 
anomalies, postural abnormalities and associated reactions, and 
weakness in the left hand, have been observed in pre-schizophrenic 
children under the age of 2 (Walker, 1994). Cannon et al. (2002) also 
found language impairments among children who later were 
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diagnosed with schizophrenia. Lower IQ scores have been reported 
in children who later develop schizophrenia,  with  at least 1 SD 
below the mean in most cases (IQ 80-85 range) and a third having IQ 
scores below 70 (Jacobsen & Rapoport, 1998).  Of interest is that 
these premorbid IQ deficits have been more marked in males 
(Aylward, Walker & Bettes, 1984). 
 
The role of DNA sequence variation in gene expression is considered  
to be an epigenetic mediator in the neurodevelopment of 
schizophrenia. Anecdotal evidence from cases of VCFS, an 
inheritable genetic disorder that closely resembles the clinical 
features of adult schizophrenia, is worth mentioning (Eliez & 
Feinstein, 2004).  As many as 30% of children who have this 
microdeletion of chromosome 22 syndrome, develop schizophrenia 
as young adults. VCFS is marked by cardiac anomalies, clefting of 
the secondary palate, small stature, distinctive facial appearance, 
slender hands, and learning difficulties or mental retardation 
(Shprintzen et al., 1978). 
 
The existence of early neuromotor, muscoskeletal, physical, 
behavioural and neuropsychological anomalies in a proportion of pre-
schizophrenic children, support the notion of abnormal brain 
development during foetal or neonatal life. Epigenetic expression and 
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aberrant genetic control of brain development seem to be linked to 
birth complications and other environmental stressors (Bayer et al., 
(1999).  
 
The ''late'' neurodevelopmental model of schizophrenia was first 
described by Feinberg (1983, 1997). According to this model 
excessive synaptic / dendritic pruning during adolescence leads to 
neural dysconnectivity and psychotic symptoms. This process of 
abnormal neural maturation explains the long delay between 
perinatal neurological abnormalities and disease expression around 
the time of adolescence. This implies an additional pathological 
process and further structural brain changes and cognitive decline 
around the time of FEP, which characterizes schizophrenia as a 
progressive late onset neurodevelopmental disorder (Woods, 1998; 
McGlashen & Hoffman, 2000). Other possible mechanisms for 
schizophrenia include abnormal myelination (Benes, 1989), neuronal 
sprouting (Stevens, 1992), or the adverse effects of stress (Piper et 
al., 2012; Bogerts, 1989) in producing neural disarray.  
 
A similar approach to protracted disease expression in 
neurodevelopmental schizophrenia indicates compensatory limbic 
reorganization in response to developmental insult (Grace & Moore, 
1998). The limbic system subsequently fails to subserve the 
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executive functions, with increasing environmental demands and 
stress placed on the prefrontal cortex, around the time of 
adolescence. Executive functions such as WM are dependent on DA 
innervation within the prefrontal cortex, which is reduced by as much 
as 33% in schizophrenia (Howes & Kapur, 2009; Akil et al., 1999).  
 
Moreover the hippocampus has been found to play a modulating role 
in the working of the hypothalamic-pituitary-adrenal axis (HPA) in 
response to stress-released glucocorticoids (Sapolsky et al., 1990). 
The importance of the hippocampus in neurodevelopmental 
schizophrenia has been underscored by studies indicating that 
prefrontal disruption may overload the hippocampus, which 
subsumes some of the WM functions while the prefrontal cortex is 
developing (Cullinan et al., 1995; Diamond, 1990). Available imaging 
data have supported this idea that some of the WM functions are 
mediated by the hippocampus in schizophrenia patients (Meyer-
Lindenberg et al., 2001; Weinberger et al., 1993) and increased 
hippocampal volume has been found prior to FEP (Pantelis et al., 
2003; Phillips et al., 2002). 
 
A second perspective, in the late neurodevelopmental model, 
postulates that cortical mal-development in utero interacts with 
normal developmental processes that occur much later in life 
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(Weinberger, 1986, 1987). In addition to synaptic maturation of the 
prefrontal cortex, inputs from subcortical projections also undergo 
dramatic changes during early adulthood. Studies have indicated that 
elaboration of postnatal dopamine input reaches its highest density in 
early adulthood (Lambe et al., 2000).  
 
The frontal lobes and their connectedness to temporal and 
subcortical regions are pivotal to highly evolved behaviours 
emanating from the demands of adulthood. Early developmental 
abnormalities may subtly alter intra-cortical connectivity, which may 
lead to further neural maturational abnormalities in the prefrontal 
cortex and its subcortical projections. This view is similar to the ''risk'' 
model, which proposes that early or late neurodevelopmental 
abnormalities act as risk factors that interact with exposure to other 
environmental risk or protective factors (Hollis & Taylor, 1997).  
 
Psychoactive substances also increase the risk of schizophrenia 
because of their effects on dopaminergic function (Yui et al., 2000). 
In this regard, it is worth mentioning the link between cannabis use 
and the onset of schizophrenia. Cannabis acts primarily on 
cannabinoid receptors that lead to an increase in striatal dopamine 
release (Cheer et al., 2004; Tanda & Pontieri, 1997). Thus, in 
essence the neurodevelopmental theory of schizophrenia postulates 
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that early disruption of brain development can alter the trajectory of 
brain maturation and changes the cytoarchitecture of different brain 
regions. Environmental risk factors interact with the epigenetic 
expression of the clinical features of the disease.  
 
Neurodegeneration  
The debate over whether the neurodevelopmental hypothesis 
represents a static encephalopathy or progressive 
neurodegeneration remains unresolved (Thompson & Levitt, 2010; 
Velakoulis et al., 2000). Limited neurodegeneration before, during, 
and after schizophrenia onset has been suggested in the temporal 
and frontal lobes, by available imaging data from studies indicating 
progressive volume reductions in the first 2-3 years following illness 
onset (Gur et al., 1998). Sequential volume reductions of the 
temporal lobes generally occur later on during the course of the 
illness with the frontal lobe and thalamic structures preceding 
temporal changes around the time of illness onset (Jacobson et al., 
1998). 
 
Post-mortem findings indicate an absence of gliosis or signs of 
neural apoptosis. These findings have been used as counter 
arguments against the notion of neurodegeneration in schizophrenia. 
However, a few studies have found increased periventricular and 
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subependymal gliosis, pyramidal and non-pyramidal neuronal loss in 
the anterior cingulate, nucleus accumbens, and mediodorsal 
thalamus (Benes et al., 1991; Young et al., 2000; Pakkenberg, 1990). 
Thus, although large-scale cortical neuronal loss is absent in 
schizophrenia, available research data reveal limited neuronal and / 
or glial reductions, especially in the subcortical areas.  
 
The role of apoptosis has been adapted in schizophrenia to include a 
process of excessive synaptic pruning or ''synaptic apoptosis''  during 
puberty (Mattson et al., 1998).  Abnormalities in pro- and anti-
apoptotic proteins, as well as DNA fragmentation profiles, have been 
found in post-mortem studies of schizophrenia brains suggesting 
neuropathological pathways similar to apoptosis evidenced in 
neurodegenerative disorders (Jarskog et al., 2000; Benes et al., 
2003).  
 
Consistent findings of brain abnormalities in schizophrenia have 
been enlargement of the lateral and third ventricles, and reductions in 
cortical gray matter volume. Recent studies indicate progressive 
lateral ventricular volume increase years after illness onset, which 
challenges a purely neurodevelopmental model of schizophrenia 
(Kempton et al., 2010; Pantelis et al., 2005). Furthermore, 
progressive volume reductions in fronto-temporal gray matter that 
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consists primarily of reductions in neuropil have been found in the 
brains of patients with childhood-onset schizophrenia, FEP, as well 
as in certain chronic and prodromal patients (Mathalon et al., 2001; 
Gur et al., 1998; Schlaepfer et al., 1994).  
 
Another important consideration in the 'static vs. progressive' debate 
is the duration of untreated psychosis (DUP). Longer DUP has been 
correlated with an increase in symptom severity, poorer treatment 
response, and less favourable outcome (Lieberman et al., 2001b). 
These findings have led to the idea that untreated psychosis is 
inherently neurotoxic, causing further progression of underlying 
neuropathologies (Loebel et al., 1992; Wyatt, 1991).  
 
Longitudinal studies have shown that neurocognitive impairments 
remain relatively stable after illness onset but that deterioration may 
occur before, during, and after, illness onset (Rund, 1998; Hoff et al., 
1999; Cannon et al., 2002). A subset of patients, with primarily 
negative symptoms or 'deficit syndrome', has been found to show 
progressive cognitive deterioration and diffuse cognitive impairment 
throughout the course of the illness (Mittleman & Buchsbaum, 2007). 
These presentations are often found in chronically institutionalized, 
geriatric patients (Friedman et al., 2002). It is, therefore, unclear 
whether this subset of patients has ''true'' neuropathic atrophy or 
Stellenbosch University  https://scholar.sun.ac.za
51 
 
whether it is a culmination of the effects of institutionalism, anti-
psychotic treatment, and/or interaction with other comorbid 
neuropathologies. Indeed, it has been argued that all of the so-called 
progressive changes in schizophrenia could be explained on the 
basis of secondary factors such as substance abuse and medication 
effects (Zipursky., Reilly &  Murray2012). 
 
Therefore, it seems that more recent brain imaging studies indicate 
longer-term brain changes after illness onset. However, the findings 
are not conclusive.  
 
Asymmetry   
The notion of hemispherical imbalances in schizophrenia patients 
has been controversial and the available literature is marked by 
divergent and often contradictory results. However, studies indicating 
asymmetries in brain structure and functioning in schizophrenia are 
worth mentioning in the context of intra-cortical connectedness and 
integration of regional neural networks.  
 
Flor-Henry (1969) was the first to implicate left hemisphere 
imbalances in schizophrenia patients and thereafter numerous 
studies have followed a similar trend (Gur, 1978; Posner et al., 
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1988). The role of weak right hemispheric pathways in the 
neuropathology of schizophrenia has also received widespread 
attention, with studies looking at the integration of the right prefrontal 
cortex, temporal cortex, and primary sensory cortex (Nuechterlein, 
1985; Grove et al., 1991).   
 
Early neuromotor delays and anomalies implicating left-sided 
weakness of the body and associated reactions of the left hand (such 
as posturing and neglect) have been suggested by retrospective 
studies of early childhood histories of schizophrenia patients (Meehl, 
1989; Meehl, 1990; Mirsky & Duncan, 1986; Johnstone et al., 1990). 
These signs of neuromotor delays during early development might be 
closer to the neurobiological substrate of the illness by implicating 
contra-lateral right-sided impairment. Harrison (1997) has even found 
that reduction in normal brain asymmetry is evident prenatally.  
 
Functional imaging data from Positron Emission Tomography (PET) 
studies have indicated that normal subjects produce prefrontal 
activation and differential right hemisphere activation on Continuous 
Performance Tests (CPT) (Nuechterlein et al., 2004). Schizophrenia 
patients, however, show less prefrontal activation and less activation 
of the right temporo-parietal areas compared to normal subjects. 
Cohen et al. (1987) stated that the role of the right temporal cortex in 
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the processing of visual vigilance on the CPT, could provide an 
explanation for the differential right hemisphere metabolic inactivation 
found in schizophrenia patients. Shallice (1988), on the other hand, 
has offered an alternative explanation for the role of right hemisphere 
abnormalities on vigilance tasks, by stating that the prefrontal cortex 
fails to organise strategies and activate brain regions for the 
processing of specific types of information.  
 
Older studies have indicated left-sided lesions with multifaceted 
hemi-neglect signs in schizophrenia: motor neglect as indicated by a 
tendency to turn to the left (Bracha et al., 1987; Pycock & Marsden, 
1978); right-sided sensory neglect (Manshreck & Ames, 1984); and 
impaired ability to shift attention to the right (Posner et al., 1988). 
Potkin et al. (1989) found that patients with schizophrenia have fewer 
eye fixations in right hemi-space. Manshreck & Ames (1984) 
demonstrated right hand impairments on tests of graphesthesia / 
stereognosis and increased leftward turning on a swivel chair (Lyon 
& Satz, 1991).  
 
Cutting (1985, 1990) made comparisons between patients with right-
sided brain lesions after cerebrovascular accidents / temporal lobe 
epilepsy and found analogous neuropsychological impairment and 
clinical features similar to schizophrenia. In another study by Parnas 
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et al. (1982) non-affective psychosis was found with right and left-
sided lesions in temporal lobe epilepsy patients, but classical 
''Bleulerian schizophrenia'' was predominately associated with right-
sided lesions. Another interesting finding stems from delusional 
misidentification or ''Capgras syndrome'' that is common in 
schizophrenia (Kimura, 1986) and that is associated with right 
hemisphere brain dysfunction (Feinberg & Shapiro, 1989). Capgras 
syndrome prevalence rates of 40% have been reported in 
schizophrenia (Kimura, 1986).  
 
The neurodevelopmental and dopamine hypotheses have received 
more emphasis in recent literature. This provides an inclusive 
framework incorporating genetic, environmental, epidemiologic, and 
neurocognitive research data (Piper et al., 2012; Howes & Kapur, 
2009; Kapur, 2003). Loss of normal brain asymmetry has also been 
linked to neurodevelopmental pathology in schizophrenia (Piper et 
al., 2012).    
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CHAPTER 3: 
 
NEUROCOGNITIVE DEFICITS IN SCHIZOPHRENIA 
 
HISTORICAL DEVELOPMENTS OF NEUROCOGNITION IN 
SCHIZOPHRENIA 
Before the advent of standardised neuropsychological testing and 
modern brain scanning technology, early conceptualizations of 
neurocognition in schizophrenia included attentional, reasoning, 
memory, and information processing deficits (Weiner, 1966).  
Original descriptions by Kraepelin (1919/1971) and Bleuler (1950) 
made reference to abnormalities in attention, associative and 
volitional processes.  
 
Traditional psychodynamic conceptualizations of cognitive functions 
in schizophrenia show remarkable empirical consistency with current 
neurocognitive findings in schizophrenia. Weiner (1966), building on 
the work of Rappaport et al. (1945/46), described abnormalities in 
schizophrenic thinking processes that included defective reasoning, 
concept formation, attention and general intelligence. 
 
Early notions of a ''generalized deficit'' indicated a pattern of diffuse 
neurocognitive decline in schizophrenia. Chapman and Chapman 
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(1973) found that patients with schizophrenia tend to do more poorly 
on a wide variety of cognitive tasks when compared to controls. 
Results of neurocognitve testing using the Halstead-Reitan battery 
on large normative samples have pointed towards a generalized 
deficit in schizophrenia (Blanchard & Neale, 1994; Braff et al., 1991).  
 
In contrast to the idea of diffuse neurocognitive deficits, other studies 
have indicated differential impairments, which may be associated 
with regionally specific neurocognitive deficits in schizophrenia. 
Circumscribed deficits in executive function (cognitive set-shifting 
and WM), attentional and memory impairment have been regionally 
connected to frontomedial-temporal lobe abnormalities in 
schizophrenia (Kolb & Whishaw, 1983; Shallice et al., 1991; Weickert 
et al., 2000). In comparison to other mental disorders, Goldberg et 
al., (1993a) found that patients with schizophrenia scored 
significantly lower than affective disorder groups on tests of attention, 
psychomotor speed, memory, abstraction and problem solving ability. 
Importantly, after controlling for general IQ between groups, the 
schizophrenia group performed significantly poorer on the WCST and 
tests of visual memory (Goldberg et al.,1993a). These findings are 
consistent with the hypothesis of executive, memory, and attentional 
deficits as key neurocognitive deficits in schizophrenia.  
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NEUROCOGNITIVE DEFICITS  
Different neuropsychological measurements, methodological 
differences, and the inherent symptom diversity found in the ''group 
of schizophrenias'' make direct comparison of neurocognitive testing 
very difficult across patient samples. Despite these methodological 
difficulties, available test results often converge on severe and 
differentially prominent neurocognitive deficits across the 
schizophrenia spectrum (Goldberg et al., 2003).  
 
Recent studies have indicated generalized neurocognitive deficits in 
schizophrenia (Lencz et al., 2006; Dickinson et al., 2008). 
Impairments are described in the domains of processing speed 
(Dickinson et al., 2007), verbal fluency (Henry & Crawford, 2005), 
attention (Fioravanti et al., 2005), verbal memory, learning (Saykin et 
al., 1994), visual-motor processing (Saykin et al., 1994), executive 
functions, and working memory (Lee & Park, 2005; Reichenberg & 
Harvey, 2007; Barch & Smith, 2008). However, attentional, memory, 
and executive functions have traditionally received more emphasis in 
schizophrenia research. This was in an attempt to circumscribe the 
core neurocognitive deficits underlying regionally disrupted neural 
systems in schizophrenia (Saykin et al., 1994; Lysaker et al., 2009).  
These neurocognitive functions are briefly discussed with reference 
to their significance in schizophrenia research.  
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Attentional deficits 
Attention is not a unitary construct and involves the ability to focus, to 
keep focus, to selectively attend, vigilance, and reaction time (Lezak, 
2004). The inability to ignore information irrelevant to the task, and 
the inability to shift attention according to environmental cues, 
characterized early conceptualizations of attentional deficits in 
schizophrenia (Shakow, 1950; Lang & Buss, 1965). Shallice (1988) 
referred to the ''supervisory'' attentional system, which is the 
executive function of attention: the ability to direct attention and to 
shift attention in a coordinated manner according to changing internal 
and external stimuli.   
 
The concepts of inappropriate attending or defective filtering of 
stimuli have received prominence again in recent literature indicating 
the role of dopamine to mediate the salience to environmental stimuli 
and internal representational states (Kapur, 2003; Howes & Kapur, 
2009). According to this model the hyperdopaminergic dysregulation 
of brain function leads to aberrant salience of experience: delusions 
and hallucinations are secondary reactions in the patient’s attempt to 
make sense of the intrusive rush of ideas and perceptions (Kapur, 
2003).  
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Brain structures that have been implicated in attentional paradigms 
involving selective attention and conflicting responses are the dorsal 
part of the anterior cingulate cortex and adjacent medial frontal 
cortex (MacDonald et al., 2000). Reduced activation of the anterior 
cingulate cortex has been shown in schizophrenia patients on the 
Stroop task, which entails shifting attention between conflicting 
responses and the ability to inhibit a proponent response at the 
expense of a less salient response (Carter et al., 1997).  
 
Research using neurocognitive testing also indicated deficits in 
vigilance, slowed reaction time, selective attention, and distractibility 
(Perlstein et al., 1998; Elvevag et al., 2000a; Fioravanti et al., 2005). 
Patients with schizophrenia also display deficits in maintaining 
vigilance on the Continuous Performance Test (CPT); the ability to 
ignore inappropriate cues and to respond to target stimuli (Mirsky, 
1988). Impairments in vigilance or sustained attention have been 
viewed as core vulnerability factors in schizophrenia, are not limited 
to periods of active psychosis, and are prominent in the first degree 
relatives of schizophrenia patients (Nuechterlein et al., 1994).  
 
Individuals with childhood-onset schizophrenia show similar 
attentional deficits to those with later onset schizophrenia (Asarnow 
et al., 1995). Children with schizophrenia do poorly on the span of 
apprehension task (Asarnow et al., 1991, 1995) and have reduced 
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performance on the CPT (Strandburg et al., 1994). "High-risk'' 
children, who are genetically susceptible to developing 
schizophrenia, have shown similar deficits in attention and 
information processing speed (Erlenmeyer-Kimling et al., 2000). This 
indicates that basic attentional deficits are potentially predisposing 
factors in schizophrenia spectrum disorders.  
  
Memory 
Impairment of episodic memory was one of the first neurocognitive 
deficits noted in schizophrenia studies (Hull, 1917). Early research 
findings indicated significantly poorer learning abilities when 
compared to healthy controls and neurotic groups. What has been 
found is an association between learning capacity and motivational / 
attentional factors, better performance by patients with paranoid 
schizophrenia when compared to other types, and a positive 
correlation between learning impairment with symptom severity and 
chronicity in schizophrenia (Shakow, 1950; Shakow, 1963). Early 
studies involving neurocognitive performance in schizophrenia 
should be interpreted with cautious scrutiny because of the different 
diagnostic classification systems and the lack of refined diagnostic 
tools and brain imaging technology before the 1980’s.  
 
Stellenbosch University  https://scholar.sun.ac.za
80 
 
Other studies have indicated that patients with schizophrenia do 
worse on story recall, paired associates, word lists, and visual 
designs when compared to healthy controls (Saykin et al., 1991). 
Furthermore, memory in schizophrenia has been associated with 
negative learning slopes (Paulsen et al., 1995), and impaired 
recognition on cueing (Gold et al., 1992).  Saykin et al. (1994) 
discriminated between FEP and healthy controls using verbal 
memory as primary variable and found it to be independent from 
anticholinergic medication or neurocognitive deficits involving 
attentional or executive domains. Memory impairment is not 
restricted to chronic or institutionalized patients with schizophrenia 
(McKenna et al., 1990). It has been found to be pronounced in 
comparison to other neurocognitive deficits found in schizophrenia 
(Braff et al., 1991; Saykin et al., 1991).  
 
Episodic memory deficits have been associated with an amnestic 
clinical presentation, which include impairments of recall, learning, 
recognition, and aspects of longer-term memory. Short-term and 
implicit memories were relatively spared (Achim & LePage, 2005; 
Ranganath et al., 2008).  
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Executive functions  
Neurocognitive deficits in planning, cognitive set-shifting, working 
memory, and response inhibition have been consistent findings in 
schizophrenia research and are central to the development and 
clinical manifestation of the illness. These findings correlate with 
numerous studies of brain morphology and function, indicating 
reduction in DLPFC gray matter and NAA concentrations in 
schizophrenia (Daviss & Lewis, 1995; Bertolino et al., 1996; Deicken 
et al., 1997) with corresponding prefrontal dopaminergic 
hypoactivation (Akil et al., 1999).   
 
In schizophrenia, an overall executive function deficit is implicated 
that is more severe than in patients with frontal lesions (Lee & Park, 
2005; Barch & Smith, 2008). Deficits have been demonstrated on the 
WCST with poor abstraction, set-shifting, and perseveration (Berman 
et al., 1986; Morice, 1990) even when controlling for IQ, in 
comparison to healthy controls (Weickert et al., 2000). Asarnow et 
al., (1994) have found similar executive function impairments in 
children with schizophrenia. Furthermore, executive deficits have 
been found on: 
 intradimensional / extradimensional set-shifting tasks (Pantelis 
et al., 1999),  
 planning ability as measured by the Tower of London (TOL) 
test (Pantelis et al., 1997),  
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 WM deficits or the ability to hold information ''on-line'' as seen 
on the letter-number-span (LNS) test (Lee and Park, 2005; 
Reichberg & Harvey, 2007),  
 digit span (Flemming et al., 1997; Aleman et al., 1999),  
 spatial memory span (Pantelis et al., 1997) and on  
 the delayed response alternation task (Gold et al., 1991).   
 
The hypofrontality hypothesis has been difficult to reconcile with the 
findings of several studies that have reported greater activation of the 
frontal cortex during WM tasks in schizophrenia when compared to 
healthy controls (Callicott et al., 2000; Manoach et al., 2000). 
Perlstein et al., (2001) postulated that the unexpected increase in 
activation on WM tasks could be attributed to the role of the DLPFC 
in the processing load. Decreased frontal activation has been found 
only when the processing load / task complexity was high and, 
therefore, excessive activation was associated with low-load baseline 
tasks. The role of the DLPFC is to resolve competing responses 
(MacDonald et al., 2000), but it is unable to meet the demands in 
high processing tasks that compete with the self-generated mental 
activity associated with positive symptoms.  
 
The prefrontal cortex is implicated in the initiation of motor acts and 
verbal responses and the suppression or inhibition of unwanted 
responses or impulses (Lezak, 2004). In patients with schizophrenia 
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who have difficulty initiating activity the DLPFC is under-activated 
(Liddle, 1987). This results in the loss of inhibitory function or 
sensori-motor gating, as tested via prepulse inhibition (Perry et al., 
1999), and difficulty in suppressing inappropriate mental activity on 
the Stroop test (Baxter & Liddle, 1998).  
 
General intelligence   
The question of general intellectual decline over the course of 
schizophrenic disturbance versus premorbid intellectual performance 
has been debated by early research using standard intelligence 
scales like the Stanford-Binet and Wechsler-Bellevue tests. Trapp 
and James (1937) were the first to document findings from a 
longitudinal study administering the Stanford-Binet to 41 hospitalized 
patients, indicating a mean drop of 7.6 IQ points over time (4 months 
to 13 years). Other studies followed that supported the concept of 
progressive intellectual deterioration after illness onset (Rappaport & 
Webb, 1950; Schwartzman & Douglas, 1962). On the other hand 
however, there are also early studies opposing these findings and 
indicating improvement in IQ scores in a large percentage of 
hospitalized patients with schizophrenia and a positive correlation 
between clinical improvement and raised IQ scores during 
hospitalization (Rabin, 1944; Haywood & Moelis, 1963). Early 
research findings were thus inconclusive with regards to general 
intellectual decline or improvement over the course of the illness.     
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More recent studies have indicated a decline in the mean IQ of 
children and adolescents before illness onset (Fuller et al., 2002; 
Reichenberg et al., 2005), and lower premorbid IQ has been 
associated with increased risk to develop schizophrenia later in life 
(Zammit et al., 2004; Reichenberg et al., 2006). 
Furthermore, results from a National Institute of Mental Health 
(NIMH) study on child and adolescent schizophrenia, have indicated 
a decline in IQ from a mean of 87,7 (pre-psychotic) to a mean of 83,7 
points (post-psychotic) (Alaghband-Rad et al., 1995). Intellectual 
deterioration and decline in scholastic performance preceding a FEP 
have been described in patients with childhood onset schizophrenia 
(Fuller et al., 2002). Lower IQ has been related to the severity of the 
illness (Daneluzzo et al., 2002). Later onset schizophrenia has 
shown a similar decline in IQ in pre-psychotic individuals when 
compared to healthy controls (Aylward et al., 1984).  
 
Longitudinal studies of IQ after illness onset indicate that general 
intellectual deterioration in schizophrenia is not greater than the 
decline associated with normal aging (Kurtz, 2005). In a systematic 
review of studies with repeated IQ testing in patients with 
schizophrenia and healthy controls, a larger practice effect was found 
in the control group (mean IQ change of +2.08), which indicate that 
patients with schizophrenia benefit less from repeated IQ testing 
(Hedman et al., 2013). This finding may imply that, in schizophrenia, 
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learning is compromised due to a neurodevelopmental 
neurocognitive deficit.    
 
In summary, little supportive evidence exist for general intellectual 
deterioration over the life course of schizophrenia. However, several 
studies have demonstrated a notable decline in IQ during the pre-
psychotic / prodromal phase, with further decline in the early phase 
after illness onset (Heaton et al., 1994; Hyde et al., 1994; Mockler et 
al., 1997).   
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RELATION BETWEEN NEUROCOGNITIVE DEFICITS AND 
SYMPTOMS 
Early theories of schizophrenia attempted to explain the 
heterogeneity of schizophrenia symptoms as reflecting a single 
underlying neurocognitive deficit. These involved conceptualisations 
of 'cognitive dysmetria' (Andreasen et al., 1999), 'theory of mind' 
(Frith, 1992), WM deficits (Goldman-Rakic, 1994), information 
processing deficits (Braff, 1993) and semantic memory deficits 
(Cutting & Murphy, 1988).    
 
Cognitive dysmetria refers to a disruption of the patient’s ability to co-
ordinate mental activity. It results from functional and anatomical 
disconnectivity in brain regions, which are often expressed as 
flattened affect, disorganized thought, avolition, hallucinations, and 
delusions (Andreasen et al., 1996, 1998, 1999).   
 
Theory of mind postulates that patients with schizophrenia lack 
awareness of their own mental states as well as the mental states 
(emotions, goals, intentions) of other people (Frith, 1992). This lack 
on self-awareness often leads to the inability to generate willed 
actions (avolition, inappropriate behaviour), disordered self-
monitoring (delusions, hallucinations), and disordered monitoring of 
the intentions of others (ideas of reference, paranoid delusions) (Frith 
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1992). Schizophrenia patients also fail to follow conventional norms 
in guiding their speech (incoherence), which is seemingly due to their 
inability to be aware of the other person's inner experience and 
knowledge base (Rochester & Martin, 1979). 
 
Goldman-Rakie (1994) used WM deficits, with the associated 
disrupted prefrontal cortical function in schizophrenia, to explain a 
range of positive and negative symptoms. Thought disorder may be 
related to the inability to hold a concept in mind and positive 
symptoms may reflect the inability to keep track of internal or external 
stimuli against established memories (Fuller et al., 2003).  
 
Information processing and attentional deficits have been considered 
central to a wide spectrum of symptoms in schizophrenia (Braff, 
1993). The ''filtering'' of relevant from irrelevant stimuli, while 
inhibiting attention toward certain tasks, have been tested 
experimentally on a wide range of attentional and information 
processing paradigms (such as CPT, PPI, backward masking) 
indicating that patients with schizophrenia process information more 
slowly and less efficiently, especially when under high processing 
demands with multiple tasks and distractions (Fuller et al., 2003).  
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Semantic memory or ''real world knowledge'' abnormalities (Cutting & 
Murphy, 1988) with its overlap with  executive and temporal / 
episodic memory, has been regarded as central to the 
phenomenology of schizophrenia (Frith & Frith, 1992). The concept 
of 'over-inclusive thinking' (Cameron, 1947; Payne, 1973) involves a 
disorder of concept formation. This means disrupted knowledge 
about the world and its representation in semantic memory, which 
has been central in explaining disordered thinking in schizophrenia 
patients. Several other authors have focussed on failures in cognitive 
systems, which represent 'knowledge' in schizophrenia patients (Frith 
& Frith, 1992; McKenna, 1991; Hoffman, 1987). This is synonymous 
with the concept of semantic memory and has been implicated in the 
development of thought disorder, hallucinations, and delusions.  
 
Positive, negative, and disorganised symptoms  
Crow (1980) originally proposed that positive symptoms are caused 
by dopaminergic imbalances, and that structural cerebral 
abnormalities are responsible for the negative symptoms in 
schizophrenia patients. Liddle (1984, 1987a) separated symptoms 
into three syndromes based on correlations of characteristic 
symptoms in chronic schizophrenia: reality distortion (positive 
symptoms), psychomotor poverty (negative symptoms), and 
disorganization (Baxter & Liddle, 1998). Other factor analytic studies 
have supported the three syndromes proposed by Liddle (Liddle & 
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Barnes, 1990; Brown & White, 1992; Thompson & Meltzer, 1993). 
Each of the syndromes has been associated with a pattern of 
neurocognitive correlates and regional brain functioning.  
 
Negative symptoms (psychomotor poverty) involve an absence or 
decrease of brain functions and include blunted or restricted affect, 
abulia (loss of motivation), alogia (poverty of speech), avolition (lack 
of initiative), apathy (lack of interest), and reduced social drive (Crow, 
1980; Andreasen, 1982; Carpenter et al., 1988). More recently, 
authors have found it useful to make a distinction between primary 
negative symptoms or 'deficit' schizophrenia and secondary negative 
symptoms, which might be attributed to the effect of chronic 
hospitalization, neuroleptic treatment, and depression (Kirkpatrick et 
al., 2006).  
 
The pathogenesis of negative symptoms remains unclear. They are 
relatively treatment refractory over the course of the illness 
(Keshavan et al., 2008; Erhart et al., 2006; Stahl & Buckley, 2007). A 
few studies have linked negative symptoms to left DLPFC under-
activity (Howes & Kapur, 2009; Ebmeier et al., 1993). 
 
Positive symptoms (reality distortion) in schizophrenia imply a 
breakdown in reality testing and include delusions, hallucinations, 
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and other forms of reality distortion (Tandon et al., 2009). Keshavan 
et al. (2008) have linked positive symptoms to hyperactivity of the 
dopaminergic mesolimbic circuit, which often characterizes the 
formal onset of psychosis or FEP (Kapur, 2003). Furthermore 
positive symptoms have been associated with over-activity of the left 
medial temporal lobe and under-activity of the left lateral temporal 
lobe (Liddle et al., 1992a; Ebmeier et al., 1993).    
   
Symptoms of disorganization in schizophrenia include thought 
disorder, disorganized behaviour / speech and neologisms.  It entails 
derailment or looseness of association and poverty of thought 
content (negative thought disorder) (Tandon et al., 2009). In this 
regard, Andreasen (1979) has developed a comprehensive scale for 
the assessment of thought, language and communication disorders, 
which includes poverty of content, pressure of speech, distractible 
speech, tangentiality, derailment, stilted speech, echolalia, self-
reference, circumstantiality, loss of goal, perseveration, and thought 
blocking. Disorganization has been associated with decreased 
perfusion of the right ventral prefrontal cortex and insula, and 
increased perfusion in the right anterior cingulate (Liddle et al., 
1992a; Ebmeier et al., 1993). 
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Neurocognitive correlates of positive symptoms (reality 
distortion)  
Positive symptoms in schizophrenia have been regarded as excess, 
or neurological release, signs (Fuller et al., 2003; Strauss et al., 
1974), which occur when higher cortical functions are impaired, 
thereby resulting in disinhibition. Several studies have found no, or 
weak, correlations between positive symptoms and neurocognitive 
measures (Klingberg et al., 2006; Weickert & Goldberg, 2000; Bilder 
et al., 1985).  
 
The notion of positive symptoms being viewed as accessory release 
phenomena, or attempts to make sense of aberrant salience in 
schizophrenia, offers a viable explanation for the weak correlation 
between positive symptoms and underlying neurocognitive deficits 
(Keshavan et al., 2008; Kapur, 2003).  
 
However, the association between positive symptoms and 
neurocognitive deficits has been inconsistent. Some studies indicate 
fewer neurocognitive deficits (Bilder et al., 1985), poor figure ground 
perception (Goldberg et al., 2003), and a positive association with the 
WCST, Trail-making Test A (TMTA) and right hand graphesthesia 
errors (Cuesta & Peralta, 1995a; Bornstein et al., 1990). 
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A few attempts at explaining the phenomenology of hallucinations 
and delusions in schizophrenia are also worth mentioning. 
Experimental and anecdotal findings indicate that inner speech can 
co-exist with auditory hallucinations (David & Lucas, 1993; Haddock 
et al., 1995). Patients with hallucinations and delusions are prone to 
failures in source monitoring (Vinograov et al., 1997; Johns & 
McGuire, 1999). An association exists between auditory 
hallucinations and attenuation of left hemisphere / right ear 
involvement in schizophrenia (Green et al., 1994; Bruder et al., 1995; 
Levitan et al., 1999). Positive symptoms have been linked to less 
salient visual scanning strategies compared to patients with 
schizophrenia with primarily negative symptoms (Phillips & Davids, 
1994; Streit et al., 1997).  
 
Neurocognitive correlates of negative symptoms (Psychomotor 
poverty)  
Several studies have found significant correlations between negative 
symptoms and a range of neurocognitive impairments in 
schizophrenia. Deficits involving general intelligence, memory, 
attention, object naming, cognitive slowing, executive and sensory-
motor function have been found (Basso et al., 1998; Himelhoch et al., 
1996; O'Leary et al., 2000). These deficits correspond to fronto-
temporal abnormalities, which are associated with higher cognitive 
functions (Kaplan et al., 1993; Schroder et al., 1995) and are 
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generalized in nature (Addington et al., 1991; Schroder et al., 1995; 
O' Leary et al., 2000).  
 
Negative symptoms in schizophrenia represent, essentially, a 
disorder of volition (Foussias & Remington, 2008), which implies 
difficulty with initiating activity and goal directed behaviour. This is 
consistent with our understanding of frontal lobe function (Liddle & 
Morris, 1991). Neurocognitive findings support the hypofrontality 
hypothesis, with evidence of slowed mental processing and 
impairment on a word generation task (Baxter & Liddle, 1998; Liddle, 
1994). Negative symptoms have shown significant correlations with 
the WCST and Booklet Category Test (Goldberg & Weinberger, 
1995; Cuesta & Peralta, 1995b), which are measures of executive 
function that more specifically tap into cognitive flexibility or set-
shifting ability. However, research findings have not always been 
consistent. A few studies report no correlation between negative 
symptoms and executive impairments (Morrison-Stewart et al., 1992; 
Van der Does et al., 1993). 
 
Attentional impairments have frequently been associated with 
negative symptoms and schizophrenia in general (Nieuwenstein et 
al., 2001; Nuechterlein, 1991). They are regarded as genetic 
vulnerability markers (Foussias & Remington, 2008; Salvatore et al., 
2007). Modest correlations have been found between negative 
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symptoms and measures of attention (Bozikas et al., 2004; Cohen & 
Docherty, 2004) when tested on measures such as the CPT 
(Nieuwenstein et al., 2001; Strauss et al., 1993) and the span of 
apprehension test (Nuechterlein et al., 1986).  
 
On the other hand, there are studies that found no association 
between negative symptoms and attention (Cornblatt et al., 1997), or 
differences between auditory and visual CPT (Cohen & Docherty, 
2004).  Lysaker et al. (2009) offered an explanation by indicating two 
distinct groups of patients with negative symptoms: those with 
attentional impairment on the CPT and those without. Additionally, 
they also found that the group with attentional impairment had more 
severe levels of avolition (Cohen & Docherty, 2004).   
 
Cognitive slowing or bradyphrenia is a clinically distinctive feature of 
the negative symptoms of schizophrenia, and of subcortical dementia 
(Cummings, 1986), but neurocognitive testing has failed to 
demonstrate a typical 'subcortical dysfunction' in schizophrenia 
(Nelson et al., 1990). The same applies for memory retrieval deficits, 
which were not found in schizophrenia patients with predominantly 
negative symptoms (Pantelis & Nelson, 1994).    
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In summary, negative symptoms invariably relate to poor 
neurocognitive performance. This accounts for 18 % of the total 
neurocognitive impairment (Goldberg & Weinberger, 1995; Basso et 
al., 1998), reflecting generalized deficits (O'Leary et al., 2000). 
Negative symptoms are associated with frontal and soft neurological 
signs (Wong et al., 1997) and additional structural brain changes 
involving the fronto-temporal cortex (Schroder et al., 1995; Kaplan et 
al., 1993). 
 
Negative symptoms in schizophrenia appear to reflect an underlying 
cerebral dysfunction involving especially the frontal cortex with its 
concordant executive neurocognitive deficits. The debate as to 
whether negative symptoms reflect a generalized neurocognitive 
deficit and its trajectory over the course of the illness and response to 
treatment remains unresolved.  
 
Neurocognitive correlates of disorganized symptoms 
(disorganization) 
Disorganized symptoms have been correlated with poor 
neurocognitive performance involving decreased intelligence, 
attention-span, sensory-motor performance, memory, verbal 
processing abnormalities, inability to inhibit inappropriate responses, 
and poor concept formation in schizophrenia patients (Basso et al., 
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1998; O'Leary et al., 2000; Kerns & Berenbaum, 2002). Indeed, 
some studies indicate that the factor-analysis derived disorganised 
domain from PANSS correlates more strongly than the other 
domains with cognitive performance. This has prompted the 
suggestion that the disorganised factor be referred to as the cognitive 
factor (Good et al., 2004). However, several studies could not 
confirm a significant correlation between disorganization symptoms 
and neurocognitive impairments using the Positive and Negative 
Syndrome Scale (PANSS) (Klingberg et al., 2006). The PANSS does 
not include disorganization as a standard factor, although a 
correlation of .29 has been reported between PANSS disorganization 
and the CPT (Mass et al., 2000). Similar weak correlations were 
found between disorganization and neurocognitive testing. This 
ranged from .04 to .43 in neuroleptic-naive FEP patients (Good et al., 
2004).  
 
Neurocognitive impairments have been found in patients with 
negative and disorganization symptoms. However, research data 
indicated that their cerebral correlates were different. Disorganization 
primarily involved the parietal association cortex, primary frontal 
motor strips, anterior cingulate, and subcortical white matter (Liddle 
et al., 1992a; Kaplan et al., 1993; Schroder et al., 1995), whereas 
negative symptoms were mainly associated with frontotemporal 
abnormalities (Wong et al. 1997; Schroder et al 1995). 
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Although the reported correlation between neurocognitive deficits 
and disorganization have lately received more support in 
schizophrenia research, their underlying mechanism and association 
remains unclear.   
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COURSE OF NEUROCOGNITIVE DEFICITS IN SCHIZOPHRENIA    
Neurocognitive deficits are evident in the premorbid / prodromal 
phase of the illness (Henry & Crawford, 2005; Woodberry et al., 
2008). Progression is notable prior to, during, and shortly after illness 
onset (Tandon et al., 2009; Bilder et al., 2006; Hambrecht et al., 
2002).  
 
The relative persistence of neurocognitive impairments over the long-
term course of schizophrenia has been well documented across 
studies (Hoff et al., 2005b; Delisi et al., 1998; Jarskog et al., 2004). 
There is no significant age-related decline, except for a small group 
of chronic, elderly, institutionalised schizophrenia patients who 
continue to show progressive cognitive deterioration of the ''dementia 
praecox'' type (Hedman et al., 2013; Kurtz, 2005; Rajji et al., 2013). A 
literature review by Kurtz (2005) revealed two neurocognitive 
trajectories during the life course of patients with schizophrenia: 
those with relative stability of neurocognitive impairments are seen 
mainly in community outpatients, and those, observed mainly in 
elderly institutionalised patients over the age of 65, showing marked 
neurocognitive decline.  
 
A recent systematic review by Bozikas & Andreou (2010) indicated 
relative stability of neurocognitive deficits in schizophrenia patients 
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for periods of up to ten years following a FEP. However, other FEP 
studies have indicated improvement across different neurocognitive 
domains tested at index hospitalization after being stabilized on 
medication, and then again with follow-up after 5 years (Gold et al., 
1999). Yet other studies have documented a longitudinal decline on 
several neurocognitive measures in support of the 
neurodegeneration model of schizophrenia (Harvey et al., 1999a; 
Fucetola et al., 2000). However, despite recent studies indicating 
progressive brain changes after illness-onset (Kempton et al., 2010; 
Velakoulis et al., 2000b), these changes have not been consistently 
correlated with neurocognitive decline. The exception is verbal 
memory, which shows some evidence of further decline (Bozikas & 
Andreou, 2010; DeLisi et al., 1998).  
 
Thus, the course of neurocognitive deficits in schizophrenia seems to 
be in favour of a 'static encephalopathy' model. However, a host of 
possible confounding variables, heterogeneous patient samples, 
possible practice effects, and the use of different neurocognitive 
measurements, might lead to inconsistent research findings.   
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TREATMENT AND OUTCOME CORRELATES OF 
NEUROCOGNITIVE DEFICITS 
Modest improvements in neurocognitive function have been 
documented in response to antipsychotic treatment (Klingberg et al., 
2008; Szoke et al., 2008; Keefe & Harvey, 2001) with few differences 
between first generation agents (FGA) and newer second-generation 
antipsychotic agents (SGA) (Keefe et al., 2007; Tandon et al., 2008; 
Keefe & Harvey, 2001). The Clinical Antipsychotic Trials of 
Intervention Effectiveness (CATIE) and the European First Episode 
Schizophrenia Trial (EUFEST) similarly indicated modest 
improvement in cognition across groups, with little differentiation 
between FGAs and SGAs (Richard et al., 2007; Davidson et al., 
2009).  
 
The notion of SGAs as so-called 'cognitive enhancers' has been 
underscored by a few studies indicating the significant cognitive 
benefit of olanzapine when compared to risperidone and haloperidol 
(Purdon et al., 2000; Leucht et al., 1999). A lesser benefit was found 
when comparing risperidone to haloperidol (Green et al., 1997; Kern 
et al., 1999). The improving of negative symptoms has been 
considered another advantage of SGAs over typical antipsychotics 
(Lublin et al., 2005), but several studies have found that FGAs 
(haloperidol, flupentixol) were not inferior to SGAs in improving 
negative symptoms. Ruhrmann et al. (2007) found comparable 
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improvements between flupentixol and risperidone in patients with 
chronic schizophrenia regarding negative symptoms, depressed 
mood, and the cognitive factor of the PANSS.  
 
Only a small number of studies have compared FGAs other than 
haloperidol to SGAs (Gattaz et al., 2004; Jones et al., 2006; 
Lieberman et al., 2005). This leaves the relative effectiveness of 
SGAs compared to FGAs still open-ended.  
 
Neurocognitive impairment, amongst other factors, is a strong 
predictor of functional and vocational outcome in schizophrenia 
patients (van Winkel et al., 2007; Bowie et al., 2008), with the 
severity of cognitive deficits related to psychosocial rehabilitation, 
community reintegration, and work capacity (Green, 1996; Green & 
Nuechterlein, 2004; Jablensky, 2000). Correlations between global 
level of functioning and specific neurocognitive deficits have been 
documented (Goldberg et al., 1993): with executive and attentional 
impairments accounting for 20%, and memory accounting for 30% to 
40% of variance in functional outcome (Green, 1996).  
 
Premorbid social / neurocognitive impairments and negative 
symptoms have been associated with poor outcome, and are 
considered as 'trait' vulnerability factors in the development of 
Stellenbosch University  https://scholar.sun.ac.za
102 
 
schizophrenia (Hollis, 1999; Schmidt et al., 1995). Positive symptoms 
on the other hand show little covariance with functional outcome 
measures (Green et al., 2000).  
 
More recently, the inclusion of social cognition in the measurement of 
neurocognitive domains has been considered a core feature and a 
strong predictor of outcome (Van Hooren et al., 2008; Penn et al., 
2008; Sprong et al., 2007). More importantly, neurocognitive deficits 
have also been associated with treatment adherence (Keefe et al., 
2013) and increased risk for relapse in FEP (Chen et al., 2005). 
 
 
 
 
 
 
 
 
 
 
Stellenbosch University  https://scholar.sun.ac.za
103 
 
MEASUREMENT OF NEUROCOGNITION IN SCHIZOPHRENIA 
WITH THE MATRICS COGNITIVE CONSENSUS BATTERY 
The measurement of neurocognitive deficit has gained significant 
prominence over the last few decades in schizophrenia research due 
to its consideration as a core feature of the illness, its association 
with functional outcome, and its status as a key determinant of 
treatment response.  
 
Prior to 2004 the assessment of neurocognitive deficits in 
schizophrenia was impeded by the host of different neurocognitive 
measurements purporting to measure the same neurocognitive 
constructs, and the possible practice effects that are common with 
repeated measurements in longitudinal studies. This made 
comparison of neurocognitive results across patient samples very 
difficult. For this reason, as well as the possible potentiating effect of 
neuroleptic medication on neurocognition, the National Institute of 
Mental Health (NIMH) "Measurement and Treatment Research to 
Improve Cognition in Schizophrenia'' (MATRICS) initiative led to the 
development of the MATRICS Cognitive Consensus Battery (MCCB). 
The MCCB was subsequently endorsed by the NIMH as the standard 
measurement of cognition in all schizophrenia trails (Green et al., 
2004; Nuechterlein et al., 2008).  
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The MCCB was developed based on consensus ratings by 
experienced neuroscientists and neuropsychologists of traditional 
''gold standard'' neurocognitive tests selected for their proven test-
retest reliability, sensitivity for cognition specific to schizophrenia, 
limited practice effect and practicality / tolerability for use in clinical 
trials (Nuechterlein et al., 2008). The MCCB consists of 10 subtests 
grouped into 7 domain scores (Speed of Processing, Attention / 
Vigilance, Working Memory, Verbal Learning, Visual Learning, 
Reasoning and Problem Solving, and Social Cognition). A global 
composite score is worked out by the MCCB computer scoring 
program and transformed into a global neurocognitive T-score 
(Nuechterlein et al., 2008).  
 
Since its inception the MCCB has increasingly been used in 
schizophrenia research. A meta-analysis conducted on 118 clinical 
trials until 20 April 2011 indicated that 53.8% used the MCCB alone 
or in combination with other neurocognitive tests (Keefe et al., 2011). 
Baseline MCCB composite T-scores for patient groups have been 
found to range between 20.8(8.5) and 27.8(8.6) indicating a general 
neurocognitive deficit (Keefe et al., 2011). The MCCB 
standardization study found slightly higher T-scores in stabilized 
patients with schizophrenia, ranging from 33.4 to 39.4, with Speed of 
processing and Social Cognition discriminating the best between 
patient and healthy control groups (Kern et al., 2011). Holmen et al. 
(2010) found a generalized neurocognitive deficit in early-onset 
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schizophrenia, with the patient group scoring 0.8 to 1.8 Standard 
Deviations (SDs) below the healthy control group on the MCCB. 
They found no significant differences between medicated and non-
medicated patients at index, and the Social Cognition subtest was 
questioned due to its lack of discriminant validity (Holmen et al., 
2010).  
 
In another multi-site study, comparing risperidone to lurasidone in 
stabilized schizophrenia outpatients, screening and baseline 
measurements indicated MCCB composite T-scores of 24.7(12.1) 
and 26.7(12.4) respectively, which were 2.5 SDs below healthy 
controls (Keefe et al., 2011). A small practice effect (z=0.18) was 
documented for the composite T-score in this study.  
 
Despite the growing interest in using the MCCB as the standard 
neurocognitive measurement in schizophrenia research, to date very 
few studies have been conducted using the MCCB in FEP before 
and after commencing treatment (Hill et al., 2008). The present study 
will expand on existing knowledge using the MCCB in FEP by 
documenting neurocognitive deficits at baseline, month 6, and month 
12 in response to antipsychotic treatment.  
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CHAPTER 4: 
 
THOUGHT DISORDER IN SCHIZOPHRENIA  
 
INTRODUCTION 
Thought disorder has traditionally been considered the signature or 
hallmark feature of schizophrenia, which is essentially characterized 
by illogical thinking, incoherence, loss of goal directed speech, 
deviant verbalizations and looseness of associative thinking 
(Andreasen, 1979). It includes both 'positive thought disorder' 
marked by derailment (looseness of association), over inclusiveness 
and neologisms, and 'negative thought disorder' that is marked by 
poverty of content and impoverished speech (Andreasen, 1986).  
 
Early concepts of thought disorder considered looseness of 
association to be a fundamental characteristic of schizophrenia 
(Bleuler, 1950; Kraepelin, 1919). Others emphasized the role of over 
inclusiveness (Cameron, 1944), drive-dominated primary process 
thinking (Fenichel, 1945), and key cognitive features involving faulty 
reasoning, concept formation, and reality testing (Chapman & 
Chapman, 1973). There is now a growing consensus that thought 
disorder is a multi-dimensional concept with varying degrees of 
severity that occurs in schizophrenic and non-schizophrenic 
psychotic conditions (Levy et al., 2010).  
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Thought disorder can be classified according to disorders of thought 
content (abnormal ideas, for example, delusions) and disorders of 
form of thought (observed from expressive language that reflects 
disordered thinking, for example, derailment, tangentiality and 
circumstantiality) (Sadock & Sadock, 2007). The term ‘’thought 
disorder’’ in this study refer to a disturbance in thinking that affects 
language and communication (thought processes). Thought disorder 
is not pathognomonic to schizophrenia; it occurs in other psychiatric 
conditions such as mania and in the autism spectrum disorders 
(Andreasen & Grove, 1986; Solomon et al., 2008), in healthy people 
during transient states of anxiety and stress (Johnston & Holzman, 
1979), and in patients with neurological impairments (Jefferson & 
Scott, 2004). It is common amongst the first-degree relatives of 
patients with schizophrenia (Bearden et al., 2011; Levy et al., 2010) 
and in individuals with schizotypal personality traits (Kiang, 2010). 
These findings indicate that the milder forms of thought disorder 
present in relatives of patients with schizophrenia have a genetic 
basis, with thought disorder being the manifestation of a genetic 
vulnerability trait factor.  
 
The persistence of thought disorder in schizophrenia has been 
shown to be relatively stable over time (Docherty et al., 2003; 
Marengo & Harrow, 1997). Antipsychotic treatment is associated with 
moderate improvement in thought disorder (Remberk et al., 2012; 
Goldstein et al., 2002) leaving only residual signs evident after 
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treatment (Spohn & Strauss, 1989). The degree of thought disorder 
has been correlated to the severity of psychotic symptoms (Docherty 
et al., 2003), illness duration (Maeda et al., 2007), and functional and 
social outcome (Bowie & Harvey, 2008; Keefe et al., 1987). Thought 
disorder is considered to be both state and trait related, which 
covaries with improvement in symptoms. (Docherty et al., 2003).  
 
The relationship between thought disorder and neurocognitive 
deficits in schizophrenia remains unclear. There is growing evidence 
that thought disorder is not merely a function of psychosis (Marengo 
& Harrow, 1997) and that a partial dissociation exists between 
thought disorder and neurocognitive deficits (Gold & Hurt, 1990). 
Research on the association between thought disorder and 
neurocognition in schizophrenia has emphasized the salience of 
executive and semantic-lexical processing (Kerns & Berenbaum, 
2002). Research to date has yielded inconclusive results on the 
relative contribution of these functions to the development of thought 
disorder in schizophrenia.  
 
In this chapter the association between neurocognitive deficits and 
thought disorder in schizophrenia is explored, and its corresponding 
neural correlates examined. The use of the Rorschach test will also 
be discussed in terms of its utility and sensitivity to measure thought 
disorder in schizophrenia.   
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SIGNS OF THOUGHT DISORDER 
Thought disorder can be broadly  defined as a disturbance in thinking 
that affects language, communication, and thought content (Sadock 
& Sadock, 2007), however thought disorder in this study refers to a 
disturbance in thought process as manifested in language and 
speech abnormalities. 
The implicit view that language disturbances in schizophrenia are 
secondary to thought disturbance have been challenged in recent 
studies indicating that it is the language-semantical-lexical network 
per se that is impaired in schizophrenia (Radanovic et al., 2013). The 
association between thought and language exists but is not perfectly 
related empirically (Radanovic et al., 2013). However, most of the 
signs of thought disorder can be classified as communication 
disorders. This said, studies have indicated that deviant 
verbalizations like neologisms, word substitutions, and incoherence 
are associated with language production, but are found in only a 
minority of patients with schizophrenia (Berenbach & Barch, 1995). 
Furthermore, contrary to the notion of thought disorder being 
expressed as speech abnormalities, only a small association has 
been found between thought disorder and language production 
(Kerns & Berenbaum, 2002).  
 
In an attempt to operationalize the different variants of thought 
disorder, Andreasen (1986) developed The Scale for the Assessment 
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of Thought, Language, and Communication (TLC). The TLC has 
improved the reliable assessment of thought disorder across patient 
populations and has been widely researched. It consists of 18 
different types of thought disorder with the more severe forms listed 
under the first 11 types (Andreasen, 1986). A factor analytic study of 
the TLC identified 7 factors that explained 71% of the variance 
(Peralta et al., 1992). The 7 factors are: disorganization (derailment, 
loss of goal directedness, tangentiality, illogical thinking, 
circumstantiality and incoherence), negative (poverty of speech and 
content, perseveration), idiosyncratic (stilted speech, word 
approximations), semantic (neologisms, clanging), attentional 
(distractibility, blocking), referential (self-reference, echolalia), and 
verbosity (pressure of speech). The disorganization factor is 
considered the most important type of thought disorder, explaining 
almost 25% of the variance (Peralta et al., 1992).   
 
The types of thought disorder with reference to the TLC are briefly 
listed (Andreasen, 1986): 
1. Poverty of speech (over-concrete and restricted speech), 
2. Poverty of content (long replies but conveys little information, 
repetitive, stereotyped answers), 
3. Pressure of speech (rapid speech and difficult to interrupt), 
4. Distractible speech (changes the subject in response to 
external stimuli), 
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5. Tangentiality (answer questions with irrelevant information), 
6. Derailment (spontaneous speech in which ideas do not follow 
one another), 
7. Incoherence (incomprehensible speech, confusing 
connections between ideas), 
8. Illogicality (conclusions do not follow logically in speech), 
9. Clanging (speech in which sounds guide choice of words), 
10. Neologisms (new word formations), 
11. Word approximations (old words used in new way, new words 
developed following conventional word formation rules),  
12. Circumstantiality (speech which is very indirect and delayed in 
reaching its goal), 
13. Loss of goal (wanders off the topic and never returns to it), 
14. Perseveration (repetition of words or ideas), 
15. Echolalia (speech in which the patient echoes the words or 
phrases of the interviewer), 
16. Blocking (a period of silence interrupting a thread of speech 
before a thought has been completed), 
17. Stilted speech (excessively formal, pompous or distant quality 
of speech), 
18. Self-reference (patient repeatedly refers to himself under the 
subject of discussion), 
19. Phonemic paraphasia (mispronunciation of words because 
sounds or syllables have slipped out of sequence), and 
20. Semantic paraphasia (substitution of an inappropriate word).    
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THE RELATIONSHIP BETWEEN NEUROCOGNITION AND 
THOUGHT DISORDER IN SCHIZOPHRENIA 
The underlying mechanisms and relationships between 
neurocognitive impairments and thought disorder remain unclear 
(Kerns & Berenbaum, 2002; Kiefer et al., 2009). However, special 
interest has developed over the years in the association between 
thought disorder and semantic memory as well as executive 
neurocognitive impairments (Stirling et al., 2006). Thought disorder is 
not likely to be the cause of neurocognitive deficits (Saykin et al., 
1994), nor is it secondary to general neurocognitive impairment 
(Goldberg et al., 2003; Radanovic et al., 2013). However, the 
supportive neurocognitive functions of memory, attention, and 
execution may contribute to language impairments in schizophrenia 
(Radanovic et al., 2013).  
 
Most research investigating the association between thought disorder 
and executive function versus the semantic memory system tends to 
implicate the role of both in the production of speech abnormalities. 
However, experimental findings have been inconsistent (Stirling et 
al., 2006; Barrera et al., 2005). This may in part be attributed to 
differences in patient samples, variable measurements of thought 
disorder, and different neurocognitive tests purporting to measure 
aspects of executive or semantic processing.  
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Executive difficulties in maintaining a stream of thought (working 
memory), planning speech and inhibiting irrelevant speech, may 
underlie the speech and language oddities associated with thought 
disorder (Kerns & Berenbaum, 2002; Barrera et al., 2005). Barrera et 
al. (2009) distinguished between patients with and without thought 
disorder as well as healthy controls, based on the poorest 
performance on four executive tests being found in the group with 
thought disorder. The executive tests included: The Hayling 
Sentence Completion test (Burgess & Shallice, 1997), The Brixton 
test (Burgess & Shallice, 1997), The Modified Six Elements (Wilson 
et al., 1996), and The Cognitive Estimates test (Shallice & Evans, 
1978). A more recent study (Qwashi et al., 2009) failed to 
demonstrate an association between thought disorder and executive 
function using the WCST. Stirling et al. (2006) found a positive 
correlation between patients with more thought disorder and 
performance on the following executive tests: Stroop test (1935), 
Trail-making test (Reitan, 1958), Design fluency (Jones-Gotman & 
Milner, 1977), Tower of London test (Shallice, 1982), and 
Phonological fluency (Spreen & Benton, 1969).  
 
The executive neurocognitive underpinnings of thought disorder 
involve working memory per se, but research indicates the strong 
possibility that an additional inhibition deficit contributes to thought 
disorder (Roesch-Ely et al., 2010). This is especially the case when 
the task load is high. Previous studies indicated a high degree of 
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association between inhibition and thought disorder (Liddle & Morris, 
1991), but other studies could not find an association with non-verbal 
inhibitory tasks using a prepulse inhibition paradigm (Perry & Braff, 
1994) and computer-based tasks of interference (Baxter & Liddle, 
1998). Thus, excessive interference associated with thought disorder 
might arise from the inability to suppress verbal responses, but not in 
suppressing motor responses. 
 
Other neurocognitive models with empirical support have 
emphasized the role of semantic-lexical processing abnormalities in 
the development of thought disorder. A meta-analysis conducted by 
Kerns & Berenbaum (2002) indicated an association between 
thought disorder and increased / decreased spreading activation, 
impaired semantic memory, and some studies indicating impaired 
language production.   
 
Maher (1983) was the first to describe how aberrant spreading 
activation may lead to irrelevant associations entering into the 
speech of patients with thought disorder (Soriano, 2008). The 
automatic spread of activation between two related concepts forms 
associative nodes in the semantic memory system or world 
knowledge about concepts (Kerns & Berenbaum, 2002; Kiang, 
2010). The amount of activation (measured by response time after 
exposure to the prime word) and the distance that the activation 
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spreads (activation of weaker related words) are related but 
independent from one another.  
 
Research findings on spreading activation and thought disorder have 
not been consistent. A few studies indicated an association between 
thought disorder and increased priming for related words 
(hyperpriming), while on the other hand, decreased semantic priming 
(hypopriming) has been found in other studies (Kerns & Berenbaum, 
2002; Soriano et al., 2008). A decrease or absence of semantic 
priming results in a breakdown of semantic memory, implying a loss 
of factual knowledge, which impairs the formation of conceptual 
meaning in thought disorder (Moss et al., 1995). Kiang et al. (2010) 
also found a higher degree of spreading activation of weaker or more 
remotely related concepts in people with schizotypal personality 
disorder. Thus, the under- or over-activation of unrelated concepts 
could lead to the intrusion of irrelevant associations in speech (Kiang 
& Kutas, 2005).   
 
Berenbaum & Barch (1995) only found a small number of patients 
with schizophrenia exhibiting neologisms, word approximation and 
incoherence, which may be associated with impairment in language 
production. Semantic-lexical impairment may involve retrieving 
deficits of lexical / syntactic information or with encoding of 
phonological information (Kerns & Berenbaum, 2002). Empirical 
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support for the disruption of the language-lexical system in patients 
with thought disorder stem mainly from greater impairment with 
semantic fluency compared to phonemic fluency (Phillips et al., 
2004). However, research findings have been contradictory in this 
regard. A more recent study by Soriano et al. (2008) found no 
difference between patient groups with thought disorder, without 
thought disorder, and healthy controls when controlling for retrieval 
deficits and processing speed on fluency tasks.  
 
Research to date on thought disorder has implicated the salience of 
frontal-executive functions and semantic-lexical processing 
underlying speech abnormalities. Whether the signs of thought 
disorder can be related to deficits in working memory versus 
inhibitory function, hyperpriming or hypopriming, or the result of a 
breakdown in the semantic-lexical network in speech production, 
remains unclear.  
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NEURAL CORRELATES OF THOUGHT DISORDER IN 
SCHIZOPHRENIA 
Several studies have implicated the frontotemporal and 
temperoparietal language areas in the production of thought disorder. 
More specifically, these consist of the left superior temporal gyrus 
(Radanovic et al., 2013), the left planum temporale (Shenton et al., 
2001), the orbitofrontal cortex (Nakamura et al., 2008), and the 
anterior cingulate gyrus (Horn et al., 2009).  
 
Other studies have associated thought disorder with decreased 
volume in the temporal lobes, in particular the region of the superior 
temporal gyrus and planum temporale (Shenton et al., 2001), 
excessive or underactive anterior cingulate activation (Liddle et al., 
1992; Kubicki et al., 2006), reduced grey matter volume in Broca's 
area (Douaud et al., 2007), and decreased activation of the angular 
gyrus (Liddle et al., 1992).  Horn et al. (2009), however, found 
increased activation of the left angular gyrus that is not consistent 
with the findings of Liddle et al. (1992), which showed decreased 
bilateral activation.  
A more recent study exemplified the mediating role of the OFC 
(monitoring, reward learning, response inhibition, motivation) and its 
association with the semantic-processing language related areas 
(Nakamura et al., 2008). A robust finding by Nakamura et al. (2008) 
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correlated severity of thought disorder with a specific pattern of OFC 
volume deficit, namely the left anterior middle orbital gyrus.  
 
Although several studies have found positive correlations between 
severity of thought disorder and changes in the left frontal and left 
temporoparietal language areas (Horn et al., 2009), other studies 
have indicated a deviance or even reversal of the normal left-
lateralization of neural activity during language production in 
schizophrenia patients (Borofsky et al., 2010). This abnormal 
lateralization during language processing has also been observed in 
genetically high-risk individuals (Li et al., 2007).  
 
To date, schizophrenia research using brain imaging to map the 
areas related to language processing and thought disorder in 
schizophrenia has been productive, but findings pertaining to 
hyper/hypoperfusion, increased/decreased volume, or left/right 
lateralization of language related brain areas have been inconclusive.  
 
However, the notion of disrupted neuro-circuitry underlying thought 
disorder and language production has received empirical support: 
which indicates a functional dysconnectivity between frontal, 
temporal and cingulate regions (Stirling et al., 2006). In support of 
this model, a study by Kubicki et al. (2006) has indicated how hyper-
Stellenbosch University  https://scholar.sun.ac.za
156 
 
activation of the superior temporal gyrus during semantic encoding 
could interact with an OFC failure or suppression of irrelevant 
associations leading to thought disorder. The mediating role of 
interneuronal gamma-aminobutyric acid inhibition has been 
described by Horn et al. (2009).  
 
The neural correlates of thought disorder in schizophrenia seem to 
be concordant with neurocognitive research findings linking 
frontal/executive function (working memory and inhibition) with 
semantic encoding (aberrant spreading activation) and impaired 
semantic memory (conceptual knowledge).  
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THE USE OF THE RORSCHACH INKBLOT METHOD TO 
MEASURE THOUGHT DISORDER IN SCHIZOPHRENIA 
 
Overview  
The Swiss psychologist, Hermann Rorschach, developed the 
Rorschach test. He wrote his first book ''Psychodiagnostik''  in 1921 
after experimenting with inkblots on 300  patients with a psychiatric 
disorder and 100 control subjects. From this he selected a set of ten 
inkblots for their diagnostic value (Rorschach, 1921). The Rorschach 
test was globally accepted as a method to study human personality 
in depth (Hertz, 1986).  
 
Since the death of Rorschach, the Rorschach Inkblot Method (RIM) 
has been further investigated, expanded on, and differentiated as a 
test of different modes of perception. Its relationship to personality 
and psychopathology was investigated by Samual Beck and Dr. 
Bruno Klopfer (Beck, 1937/45/52; Klopfer et al., 1956). Various 
systems of scoring, classification and interpretation of the RIM were 
developed. This led to its demise during the 1960's and 70's, 
because the test was criticized for its lack of reliability, inadequate 
norms and repeated failures in validating research. Many questioned 
its clinical utility (Hertz, 1986; Bersoff, 1973; Holt, 1970; Buros, 1970; 
Aronow & Reznikoff, 1973, Wade & Baker, 1972). However, with the 
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development of the Rorschach Comprehensive System (RCS) 
significant refinements were made. The more stringent 
administration, guidelines for standardization of coding, expansion of 
normative data and empirically based interpretation of the 
Rorschach, helped to re-establish it as a clinical tool (Exner, 1974). 
The RCS is today the most widely used system to code and interpret 
the test by clinicians globally (Mihura et al., 2012).   
 
Although Exner contributed significantly toward the scientific status of 
the test as a valid and reliable measure of personality and 
psychopathology (Exner, 1991/93/95), the debate about its validity, 
application across cultures, and reliability is ongoing (Mihura et al.,  
2012).  
 
The method   
The RIM uses the same set of 10 inkblot cards originally selected by 
Hermann Rorschach (1921/1942). Five inkblots are shades of black 
and grey, two are of black and red ink, and three are multi-coloured, 
all on a white background. Subjects look at each inkblot and say 
what it looks like or might be. More than one response may be given 
per inkblot and the examiner records all responses verbatim. The 
RCS requires at least one response per inkblot and a minimum of 14 
responses (R) for the entire protocol to meet adequate test-retest 
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reliability (Exner, 1988). The average number of responses per 
protocol is 22 (Exner, 2003). 
 
After the subject has responded to all the inkblots (free association 
phase) the examiner presents the cards again one at a time and the 
subject is asked to note where he sees what he originally saw and 
what in the card made it look like that (inquiry phase) (Exner, 2003). 
The examiner again records all responses verbatim for coding and 
analysis of the responses, using tabulation and a scoring sheet 
(Exner, 2003).  
Coding of responses is done with reference to: 
 the level of vagueness or synthesis of multiple images,  
 the location of the response ¹ (W, D, Dd, S),  
 the form quality (the degree to which the response is a good 
match for the actual inkblot),  
 the contents of the response (what the subject actually sees 
in the inkblot, e.g., human detail = Hd),  
 the determinants of the inkblot that contributed to the 
formulation of the response  ² (F, M, FM, m, C, CF, FC, Cn, 
C', C'F, FC', T, TF, FT, V, VF, FV, Y, YF, FY, FD, rF, Fr),  
 
_________________________________________________ 
ˡ   Location: W= whole response; D= common detail; Dd= infrequent detail S= use of white space 
response 
2   Determinants: F= pure form; M= human movement; FM= animal movement; m= inanimate 
movement; C= pure chromatic colour; CF= chromatic colour-form; FC= chromatic form-colour; 
Cn= chromatic colour naming; C'= pure achromatic colour; C'F= achromatic colour-form; FC'= 
achromatic form-colour; T= pure texture; TF= texture-form; FT= form-texture; V= pure vista; VF= 
vista-form; FV= form-vista; Y= pure diffuse shading; YF= undifferentiated shading-form; FY= 
undifferentiated form-shading; FD= form dimension; rF= reflection-form; Fr= form-reflection. 
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 the degree of mental organizing activity required in producing 
the response, and  
 any illogical, incongruous or incoherent aspects of responses 
(Exner, 2003).  
 
Using the scores for these categoriesˡ the examiner performs a 
series of calculations producing a structural summary, reflecting 
ratios, percentages and derivations. Six indices are derived from 
these various combinations of Rorschach scores: the Perceptual 
Thinking Index (PTI), Depression Index (DEPI), Coping Deficit Index 
(CDI), Suicide Constellation (SCON), Hypervigilance Index (HVI), 
and Obsessive Style Index (OBS) (Exner, 2003). 
 
The RCS places a lot of emphasis on the cognitive triad of 
information processing (information input), cognitive mediation (how 
information is transformed), and ideation (conceptualisation of 
information) (Exner, 2003).  
 
For this reason contemporary views of the RIM have conceptualized 
the Rorschach test as an external assessment of the person's 
behaviour (Mihura et al., 2012) that induces the respondent to use 
available cognitive, affective and representational resources to 
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formulate a response to an ambiguous task (Vigilone et al., 2003). In 
this sense, the Rorschach is used as ''a high-processing demand, 
abstract problem-solving test and is conceptualized as a perceptual 
and cognitive challenge'' (Perry et al., 2009). This expels the early 
notions and traditional classification of the Rorschach as a projective 
test (Bornstein, 2007; McGrath, 2008). Exner (1993) and others 
(Smith, 1992; Klepser et al., 1991) have also explicitly denied that the 
RIM is projective in nature. Meyer et al. (2011b) describes the 
Rorschach as a ''behavioural problem-solving task in which 
respondents must use reasoning and problem-solving skills''.  
 
Rorschach indices in schizophrenia research   
The search for signs of schizophrenic thinking has long been the 
subject of investigation using different rating scales, objective and 
projective tests, and various classifications of deviant verbalizations 
in psychiatric populations (Bellak, 1969; Weiner, 1966; Andreasen & 
Grove, 1986). The RIM has followed a similar trend in attempting to 
systematize and quantify the deviant responses or queer 
verbalizations found in Rorschach protocols and explaining the 
psychological processes leading to it (Rappaport et al., 1968). Prior 
to and after the development of the RCS, various Rorschach indices 
have been researched and refined in terms of incremental validity 
and sensitivity in detecting various forms of thought disorder and 
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signs of psychosis. They are briefly discussed as being the historical 
precursors of the Rorschach Perceptual Thinking Index.   
 
The delta index 
Watkins and Stauffacher (1952) developed the Delta Index in an 
attempt to quantify the clinical categories of thought disorder as 
evidenced by deviant verbalizations on patient Rorschach protocols. 
The Delta Index score is reflected as the sum of all weighted scores 
for 15 categories of deviant verbalisations, divided by the number of 
Rorschach responses. Minor deviant verbalizations, e.g., over-
elaborate symbolism, will receive a weight of (.25); moderate 
deviancies, e.g., confabulation, will receive a weight of (.50), and 
severe forms of deviant verbalisations, e.g., incoherence and absurd 
responses will receive a weight of (1.0) (Johnston & Holzman, 1979).  
 
The Delta Index has been found to significantly discriminate between 
groups (normal, neurotic and schizophrenic) with an overall inter-
rater reliability of .78 (Watkins & Stauffacher, 1952; Powers & 
Hamlin, 1955). A cut-off score of 10 on the Delta Index was 
recommended as a positive indication of schizophrenia, but the false 
positive rate for non-schizophrenia was found to be high (Powers & 
Hamlin, 1955). Further refinements to the Delta Index have been 
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made by other Rorschach researchers (Pope & Jensen, 1957; 
Kataguchi, 1959).  
 
The Thought Disorder Index  
The Thought Disorder Index (TDI) is a revision of the Delta Index and 
includes 20 categories of communication deviance evidenced on the 
Wechsler Adult Intelligence Scale (WAIS) and the Rorschach test 
(Johnston & Holzman, 1979; Solovay et al., 1986). The four level 
weightings (.25, .5, .75, and 1.0) of the Delta Index have been 
retained (Watkins & Stauffacher, 1952) and can be used to quantify 
the severity of disordered thinking and to identify the qualitative 
features of thought disorder (Makowski et al., 1997). The original 
research population consisted of 237 subjects, divided into 
chronically hospitalized schizophrenia patients, recently hospitalized 
psychiatric patients (schizophrenia, schizoaffective, bipolar), and 27 
normal controls (Johnston & Holzman, 1979).  
 
The TDI has been shown to be a valid test for the measurement of 
thought disorder in adults (Johnston & Holzman, 1979; Solovay et al., 
1987) and in children and adolescents (Arboleda & Holzman, 1985). 
Inter-rater reliability coefficients for the TDI have been in the .80 to 
.90 range (Johnston & Holzman, 1979; Coleman et al., 1993). A 
more recent study by Metsȁnen et al. (2005) differentiated intra-class 
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correlation coefficients (ICC): .94 for TDr (number of TD responses), 
.92 for .25 level, .92 for .50 level, .86 for .75 level, and .66 for 1.0 
level responses.   
 
Higher TDI scores have been associated with schizophrenia, 
psychotic depression and mania compared with nonpsychotic 
patients and healthy control subjects (Makowski et al., 1997). On the 
other hand, TDI scores do not discriminate between schizophrenia 
and mania and schizoaffective disorder (Shenton et al., 1987; 
Solovay et al., 1987). Studies have found the mean total TDI score 
for adult patients with schizophrenia to range between 16.8 and 34.6 
and a lower mean TDI for adolescent patients with schizophrenia of 
20.8. (Johnston & Holzman, 1979; Hurt et al., 1983). Overall, findings 
have consistently indicated that levels of thought disorder do not 
distinguish between psychotic patients, but qualitative differences 
have been found in the ways that patients with schizophrenia and 
those with mania organize their thoughts (Nuechterlein et al., 1986; 
Makowski et al., 1997). Furthermore, thought disorders are not 
restricted to psychiatric disorders but are also evident in healthy 
individuals in the form of minor cognitive slippages, especially during 
periods of fatigue or anxiety (Solovay et al., 1987). 
 
Thought disorder appears to be a trait marker in a subgroup of 
patients with schizophrenia and mania, but could be both a trait and 
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a state feature in psychotic patients (Metsȁnen et al., 2005). Severe 
forms of thought disorder as measured with the TDI in schizophrenia 
are responsive to neuroleptic treatment (Holzman, 1986; Spohn et 
al., 1986; Nuechterlein et al., 1986) with residual and less severe 
forms of thought disorder unmodified by treatment (Nuechterlein et 
al., 1986; Spohn et al., 1986). The residual thought pathology has 
been linked to a central nervous system deficit (Holzman, 1986).  
 
The TDI has been found to be a reliable index of various forms of 
thought disorder. This is observed in patients with chronic 
schizophrenia and in psychotic patients (Nuechterlein et al., 1986).  
 
The Ego Impairment Index  
The Ego Impairment Index (EII) is a composite measure of 
psychological impairment and thought disturbance, which was 
derived from factor analysis of the RCS (Perry & Viglione, 1991). The 
five EII Rorschach sub-component variables are distorted form 
quality (FQ-); Deviant Verbalizations and Incongruent Thinking 
(WSum6); Critical Contents score (depressed content e.g. blood, 
sex); Poor Human Form Perception (M-); and Good-to-Poor Human 
Experience variable (HEV) (measures positive versus negative 
aspects of human representation responses) (Viglione et al. 2003).   
 
Stellenbosch University  https://scholar.sun.ac.za
166 
 
In the original validation study, the total EII score predicted treatment 
outcome in patients with major depression, with the HEV variable 
emerging as the strongest predictor (Perry & Viglione, 1991). Studies 
using the EII extended to include those of patients with schizophrenia 
and psychotic disorders, since the EII appears to tap into the 
cognitive functioning of a broad range of thought disordered patients 
(Kleiger, 1999; Perry et al., 2003). The EII correlated with other 
known measures of psychotic processing such as the Eckblad-
Chapman Scale of Magical Ideation and scales 6 (r= .47), 8 (r= .41), 
and Ego strength (r= -.44) from the Minnesota Multiphasic 
Personality Index (MMPI) (Perry et al., 1992). The EII also 
differentiated between paranoid and non-paranoid patients with 
schizophrenia. The non-paranoid types achieved higher EII scores 
(Cohen's d= 1.37; r= .56) (Viglione et al., 2003). Perry et al. (1992) 
found a mean EII score of 1.6 for a heterogeneous sample of 
schizophrenia patients, which is substantially different from the 
original depressed sample (Perry & Viglione, 1991).  
 
However, in a study of 85 heterogeneous inpatient and outpatient 
psychiatric patients, the EII was found to discriminate between 
inpatients and outpatients but not between psychotic and non-
psychotic patients (Adrian & Kaser-Boyd, 1995). More recent 
research found increased EII scores in the schizophrenia spectrum 
disorders compared to normal controls and significant differences 
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between patients with schizophrenia and other schizophrenia 
spectrum disorders (Perry et al., 2003).  
 
Overall, research findings indicate that the EII is a robust and 
replicable instrument with adequate reliability and factorial validity 
(Viglione et al., 2003; Perry et al., 2003), and with temporal stability 
over the course of symptomatic treatment (Perry et al., 1995). Inter-
rater reliability was assessed to be high with ICCs of .93 to .98 found 
in the original EII study (Perry & Viglioni, 1991).  
 
The EII was further refined by replacing the HEV with the Human 
Representational variable (HRV), to create the EII-2 (Viglione et al., 
2003). The EII-2 is interchangeable with the EII with a correlation that 
approaches r =1.0 (Viglione et al., 2003). The HRV has been 
associated with healthy interpersonal relations, interpersonal 
perception, and psychological well-being (Viglione et al., 2003). The 
EII-2 has been found to be associated with schizophrenia spectrum 
disorders, poor response to treatment, thought disorder, cognitive 
dysfunction, and more prominent positive symptoms (Moore et al., 
2012; Viglione et al., 2003). Contrary to intuitive thinking, the EII-2 
was not related to social functioning or negative symptoms (Moore et 
al., 2012).   
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The psychometric properties of the EII-2 have demonstrated factorial 
validity and high inter-rater reliability with ICCs of .93 to .98 (Viglione 
et al., 2003). In conclusion, the use of the EII-2 is relevant to the 
study of schizophrenia as a measure of cognitive disorganization and 
perceptual disturbances (Perry et al., 1995; Moore et al., 2012). 
 
The Schizophrenia Index   
The Schizophrenia Index (SCZI) (Exner, 1978/1990) consists of 10 
Rorschach variables with 6 constellation criteria that assess 
inaccurate perception, thought disorder, inadequate controls, and 
interpersonal ineptitude. All of these are regarded as core features of 
schizophrenia (Exner, 1978).  
 
The TDI overlaps with the SCZI in the WSum6 score, but the SCZI 
adds a new element with the perceptual accuracy indices, i.e. (X-%), 
which are regarded as crucial in differentiating psychotic from non-
psychotic cognitive processes (Arboleda & Holzman, 1985). The 
specific clusters of Rorschach variables used to arrive at thought and 
perceptual disturbances included in the SCZI are a) Form Quality b) 
Poor Human Form Perception and c) Deviant Verbalizations and 
Incongruent Thinking (Exner, 1993).   
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The SCZI was developed using discriminant analyses on samples of 
schizophrenia patients, non-schizophrenia patients and non-patients, 
yielding a suggested cut-off of 4, indicating a likelihood of the 
presence of schizophrenia; and values of 5 or 6 regarded as more 
definitive (Exner, 1993). In Exner's psychiatric reference group 
(n=320) of schizophrenia patients, 82% have SCZI scores of 4 or 
more compared to 0.3% of the 700 non-patient adults (Exner, 1995).  
 
Studies have found that the SCZI discriminates between psychotic 
and non-psychotic patients (Jørgensen et al., 2000; Meyer, 1993). 
Empirically it relates to a diagnosis of psychotic disorder (Hilsenroth 
et al., 1998), and it has a high specificity in identifying first-episode 
schizophrenia (Ilonen et al., 1999).  
 
The SCZI has been found to be internally consistent and can be 
reliably scored (Ilonen et al., 1999). The psychometric findings have 
been replicated in child psychiatric patients with slightly lower internal 
consistency compared to adult patients (Hilsenroth et al., 1998). The 
SCZI score however needs to be interpreted with caution and not 
seen as an absolute. Research findings indicate that the correlations 
between SCZI scores and psychosis are significant in average-length 
protocols, but non-significant in high (R>29) and low (R<17) 
protocols (Meyer, 1993). Furthermore the SCZI has been associated 
with high false negative rates in identifying schizophrenia and high 
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false positives applied to the cut-off of 4, especially in manic patients 
(Ilonen et al., 1999; Exner, 2000a). The SCZI has also been found to 
lack adequate specificity in diagnosing childhood onset 
schizophrenia (Stokes et al., 2001).  
 
The SCZI is sensitive to the measurement of impaired reality testing 
and thought disorder, which are not specific to schizophrenia. The 
renaming of the SCZI as the ''Psychosis Index'' has been argued to 
be more relevant and a useful dimensional measurement of 
psychotic indicators of perceptual inaccuracy, disturbed thought 
processes and impaired reality testing (Hilsenroth et al., 1998).  
 
The Perceptual Thinking Index 
Previously the most widely used RCS instrument for the evaluation of 
psychosis was the SCZI (Exner, 1993; Hilsenroth et al., 1998). 
Further RCS revisions have led to the development of the Perceptual 
Thinking Index (PTI), a measure of perceptual oddities and cognitive 
slippage (Smith et al., 2001). To date, the PTI has replaced the SCZI 
as the preferred index for assessing thought disturbance in 
schizophrenia and related disorders (Exner, 2000a).  
 
The PTI comprises eight RCS variables arranged into 5 index scores: 
Good Form Perception (XA%), Good Form Perception to Whole and 
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Large Detail (WDA%), Poor Form Perception (X-%), Severe Deviant 
Verbalizations and Illogical Thinking (Sum2), Fabulised and 
Implausible Thinking (FAB2), and Sum of 6 Weighted special scores 
reflecting deviant verbalizations and restraint thinking (WSum6) 
(Exner, 2003).  
 
The PTI was developed to reduce false positives amongst adults and 
adolescent psychiatric populations and includes two new RCS 
variables:  XA% and WDA% (Exner, 2000b). To date, research using 
the PTI in schizophrenia is limited (Dao & Prevatt, 2006).  
 
As far as we are aware, the present study is the first to use the PTI 
longitudinally in a cohort of FEP patients receiving standardised 
antipsychotic treatment with assessments at baseline, month 6 and 
month 12.  
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CHAPTER 5: 
 
PURPOSE OF THIS STUDY 
 
INTRODUCTION 
This study formed part of a larger prospective study investigating the 
clinical, biological and functional outcome aspects in a cohort of FEP 
South African patients with a diagnosis of schizophreniform, 
schizoaffective or schizophrenia disorder, and their response to 
treatment with flupenthixol depot according to a fixed protocol over a 
period of 24 months.  
The overall aim of this study was to investigate the occurrence of, 
and associations between neurocognitive deficits, thought disorder 
and other symptomatology, and their changes over a 12-month 
treatment period in FEP.  
 
Null hypothesis: 
There exists no relationship between neurocognition, thought 
disorder and symptoms at baseline and longitudinally.     
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OBJECTIVES 
The primary objectives of this study were:  
1. To assess the degree of specific neurocognitive deficits 
(MCCB) and thought disorder (PTI) in a cohort of South 
African FEP patients at baseline, prior to treatment.  
2. To investigate the correlations between MCCB and PTI scores 
at baseline with demographic factors (age, sex, HLOE, 
ethnicity), DUP, substance abuse, and remission status. 
3. To investigate the correlations between MCCB and PTI scores 
with PANSS scores at baseline, month 6 and month 12 
respectively.. 
4. To assess changes in MCCB and PTI scores, as well as 
changes in PANSS factor scores, Social and Occupational 
functioning (SOFAS) and Quality of Life (WHOQOL), at 
baseline, month 6 and month 12 respectively. 
5. To investigate the correlations between the degree of change 
in MCCB and PTI scores with the degree of change in 
PANSS, SOFAS and WHQOL scores. 
The secondary objectives of the study were: 
1. To determine the value of baseline MCCB, PTI and PANSS 
scores with demographic factors in predicting treatment 
outcome after 12 months in terms of: 
 i.  Symptom severity (PANSS total).  
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 ii. Social and occupational functioning (SOFAS).  
 iii. Quality of life (WHOQOL).  
 iv. Remission status.  
    2. To determine the value of baseline PTI subscale scores in 
 predicting MCCB total scores at month 12.  
   3. To determine the value of improvement (difference between 
 baseline and month 6 scores) on the MCCB, PTI, and PANSS 
 in predicting treatment outcome after 12 months, in terms of:  
 i.  Symptom severity (PANSS total).  
 ii. Social and occupational functioning (SOFAS). 
 iii. Quality of life (WHOQOL). 
 iv. Remission status.   
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CHAPTER 6: 
 
STUDY DESIGN  
 
This was a prospective, non-comparative, longitudinal study of 
patients with FEP treated with a single long-acting FGA according to 
a fixed protocol, over a period of 12 months.  
 
PATIENTS 
A total of 47 patients were recruited over a period of 18 months. 
Thirteen patients were recruited from first admissions to Tygerberg 
and Stikland hospitals. A further 34 patients presenting at the 
community clinics, falling within the catchment area were recruited. 
The catchment area includes the metro and rural areas of the North 
Eastern part of Cape Town, the Winelands, and the Cape West 
Coast. Patients who presented with FEP at any of these service 
points were referred to the research unit for psychiatric assessment 
and enrolment into the study.  
 
Approval to conduct the study was obtained from the Human 
Research Ethics Committee of Stellenbosch University Faculty of 
Medicine and Health Sciences (N06/08/148). The study was 
conducted in accordance with the International Conference on 
Harmonization guidelines on good clinical practice (GCP) and was 
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registered at the South African National Clinical Trials Register 
(DOH-27-0710-1957) (International Conference on Harmonization, 
1996).   
URL: www.sanctr.gov.za/SAClinicalTrials/tabid/169/Default.aspx 
 .  
 Inclusion criteria  
a. Male or female in-or-outpatients. 
b. Aged between 16 and 45 years. 
c. A first-episode of schizophreniform disorder, schizophrenia, or 
schizoaffective disorder according to the Diagnostic and 
Statistical Manual of Mental Disorders Text Revision (DSM-IV-
TR) (American Psychiatric Association, 2000). 
d. Prior lifetime antipsychotic exposure of 4 weeks or less. 
e. Patients with an educational level of at least Grade 7.  
 
Exclusion criteria 
a. Patients who have been treated with a long-acting depot   
antipsychotic. 
b. Patients with a psychotic disorder other than schizophreniform, 
schizophrenia or schizoaffective disorder (bipolar mania, major 
depressive disorder with psychotic features, substance-induced 
psychotic disorder, psychotic disorder due to a general medical 
condition). 
Stellenbosch University  https://scholar.sun.ac.za
198 
 
c. Positive substance screen with a significant history of current and 
ongoing substance abuse. 
d. Significant physical illness (e.g., AIDS, neurodegenerative 
disease, tuberculosis) after physical examination at screening. 
e. Mental retardation. 
f. Patients who were not fluent in English or Afrikaans. The 
administration, coding and scoring of the RCS and MCCB is 
limited to the use of either English or Afrikaans. The patient thus 
requires an understanding of either instructional language during 
test administration. 
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DATA COLLECTION 
Patients were assessed with the Structured Clinical Interview for 
DSM-IV disorders (SCID-P) (First et al., 1994). The following 
information additional information was obtained:  
a. Demographic data included age, gender, ethnicity, first language, 
educational level, occupational history, marital status, and current 
living conditions.  
b. Psychiatric history including current complaints, history of current 
illness, duration of untreated psychosis, previous, and current 
treatment. 
c. Record of previous and current substance abuse. 
d. Family history of psychiatric and medical illnesses, and treatment 
received. 
e. Collateral history from the patient's family members regarding 
psychiatric and early developmental history (birth and 
developmental milestones). 
 
Routine drug screening was performed on all patients at baseline 
and thereafter at 3-month intervals for the duration of the study. 
During each of the follow-up visits, patients were asked about 
substance use since the previous visit.  
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Assessment instruments 
The following rating scales and measurements were administered at 
baseline, month 6 and month 12. Administration of the PANSS 
included a month 3 rating as well, as seen in the study plan (see 
Table 6.2): 
A. The Positive and Negative Syndrome Scale for Schizophrenia. 
The PANSS (Kay et al., 1987) was conducted by a trained 
psychiatrist. The PANSS consists of a 30-item clinician rating of 
the patient’s interpersonal behaviour, cognitive-verbal processes, 
thought content, physical behaviour, and responses to structured 
questioning, as well as collateral information obtained from the 
primary caregiver. It assesses three main domains: the positive 
subscale (P1-P7), the negative subscale (N1-N7), and a general 
psychopathology subscale (G1-G16). A forced five-factor model 
based on the equamax method was used for this study (Emsley, et 
al., 2003). The five factors are: negative, positive, disorganized (or 
cognitive), excited and anxiety/depression factors (see Table 6.1). 
Inter-rater reliability for the PANSS ratings was established by 
training clinicians to administer the PANSS and achieve an inter-
rater reliability of .70 or higher before enrolling patients into the 
study.  
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 PANSS item 
 
Factor loadings 
 
 
 
Negative 
(alpha=.89) 
 
 
 
 
N4:  social withdrawal 
N2:  emotional withdrawal 
N1:  blunted affect 
N6:  lack of spontaneity 
N3:  poor rapport 
G16: active social avoidance  
G7:  motor retardation 
G13: disturbance of volition 
 
% of variance 
.80 
.78 
.74 
.71 
.69 
.67 
.62 
.51 
 
15.4% 
 
 
Disorganized 
(alpha=.80) 
 
G11: poor attention 
N7:  stereotyped thinking 
P2:  conceptual                                    
       disorganization 
N5:  difficulty in abstract  
        thinking 
G15: preoccupation 
G10: disorientation 
G5:  mannerisms and    
        posturing 
 
% of variance 
.74 
.63 
 
.62 
 
.56 
.50 
.40 
 
.38 
 
11.4%  
 
 
Positive 
(alpha=.78) 
P1:  delusions 
G9:  unusual thought content 
P3:  hallucinatory behaviour 
P6:  suspiciousness 
P5:  grandiosity 
G12: lack of insight and  
        judgement 
 
% of variance 
.84 
.74 
.65 
.63 
.45 
 
.41 
 
10.8%  
 
 
Excited 
(alpha=.71) 
 
P7:  hostility 
G14: poor impulse control 
P4:  excitement 
G8:  uncooperativeness 
 
% of variance 
.80 
.69 
.63 
.57 
 
9.0% 
 
 
Anxiety/Depression 
(alpha=.66) 
 
 
G2:  anxiety 
G4:  tension 
G6:  depression 
G3:  guilt feelings 
G1:  somatic concern 
 
% of variance  
.81 
.67 
.59 
.56 
.43 
 
8.4%  
              (cumulative= 54.7%) 
Table 6.1: PANSS forced five factor model 
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B. The MATRICS Consensus Cognitive Battery (MCCB).  
Research psychologists administered the MCCB to measure 
specific neurocognitive deficits. The researcher (RO) supervised 
the administration and scoring of all MCCB protocols. The MCCB 
has been endorsed by the National Institute of Mental Health 
(NIMH) of the USA as the standard measurement of cognition in 
all treatment research of schizophrenia (Green et al., 2004).  
 
The MCCB battery consists of 10 individual subtests making up 7 
domain scores: 
1. Speed of Processing: Trail Making Test Part A (Spreen & 
Straus, 2006), Brief Assessment of Cognition in Schizophrenia 
(Keefe, 1999), and Category Fluency (public domain); 
2. Attention/Vigilance: Continuous Performance Test (Cornblatt, 
2006); 
3. Working Memory: Wechsler Memory Scale (Third edition)  
Spatial Span (Harcourt Assessment, 1997) and Letter-Number 
Span (Gold, 1997); 
4. Verbal Learning: Hopkins Verbal Learning Test - Revised 
(Brandt & Benedict, 2001); 
5. Visual Learning: Brief Visuospatial Memory Test (Brandt & 
Benedict, 1997); 
6. Reasoning - and Problem Solving Neuropsychological 
Assessment Battery-Mazes (Stern & White, 2003); and 
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7. Social Cognition: Mayer-Salovey-Caruso Emotional 
Intelligence Test (Mayer et al., 2005).  
 
The tests have been carefully selected from a list of established 
neuropsychological tests based on the psychometric properties of 
sensitivity, specificity, minimal practice effect, reproducibility and 
the practical convenience of the tests when measuring changes in 
neurocognitive abilities in schizophrenia trials. Nine of the tests are 
pencil-and-paper tests, while the Continuous Performance Test 
(CPT) is a computerized test. Randomized alternate forms were 
used on repeat testing for the subtests: Verbal Learning, Visual 
Learning, and Reasoning-and-Problem Solving (Nuechterlein & 
Green, 2006). 
 
The MCCB Computer Scoring Program was used to convert raw 
scores into T-scores for the 7 cognitive domains, and to derive an 
overall Composite T-score. Double data entry was adhered to, and 
age-and-gender corrected norms were selected on the computer 
program (Nuechterlein & Green, 2006). The MCCB 
standardization norm, which consists of 3000 non-psychiatric 
randomly selected United States citizens (Green et al., 2004), has 
been used as a reference norm for this study. The MCCB has 
good psychometric properties in terms of test-retest reliability and 
validity (Nuechterlein & Green, 2006). It has also been found to 
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have a strong correlation with functional outcome in schizophrenia 
research (Nuechterlein & Green, 2006). All test instructions were 
translated into Afrikaans to make provision for the majority of 
Afrikaans speaking patients in the study cohort.  
 
C. The Rorschach Comprehensive System (RCS).                         
The researcher (RO) administered the Rorschach according to the      
standardized RCS (Exner, 1993/2000a/2000b/2003). An 
independent, blinded rater (a registered clinical psychologist 
trained and experienced in the RCS) coded the Rorschach 
protocols. The independent rater coded all the Rorschach 
protocols and then entered the coded responses into the software 
program of the Rorschach Interpretation Assistance Program 
(RIAP5) (Exner, et al., 2008). The RIAP5 transformed the scores 
for each patient into a structural summary (ratios, percentages and 
derivations), and a constellation table with six summary index 
scores: Suicide Constellation, Depression Index, Hypervigilance 
Index, Obsessive Style Index, Coping Deficit Index, and 
Perceptual Thinking Index (Exner, 2003).  
 
For the purpose of this study, only the Perceptual Thinking Index 
(PTI) scores were entered into analysis as the primary measure of 
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thought and perceptual disorder. The PTI comprises of 5 
subcategory criterion rated scores:  
i) Good Form Perception (XA% <.70) and Good Form 
Perception to Whole and Large Detail (WDA% <.75) =1 
point. 
ii) Poor Form Perception (X- % >.29) =1 point. 
iii) Severe Deviant Verbalizations and Illogical Thinking 
(Sum2 >2) and Fabulised and Implausible Thinking 
(FAB2 >0) =1 point. 
iv) Number of responses (R <17) and Sum of 6 Weighted 
scores reflecting Deviant Verbalizations and Illogical 
Thinking (WSum6 >12) or (R >16) and (WSum6 >16) = 
1 point. 
v) Poor Human Form Perception (M- % >1) or Poor Form 
Perception (X- % >.40) = 1 point.  
 
The PTI Total score has a range from 0 to 5 with a suggested cut-
off of 3 or more, indicating the likelihood of psychosis (Dao & 
Prevatt, 2006).  
 
Research on the PTI has found that the number of responses (R) 
in a protocol is a strong moderator, accounting for almost 50% of 
the variance in test scores (Meyer, 1992a/1993). No significant 
bivariate correlation (two-tailed) was found (p<0.05) between PTI 
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and R, so there was no need to partial out the effect of R in the 
analyses of PTI total. To control for the possible effect of R on 
Sum2, FAB2, WSum6, and M- scores, and to make statistical 
comparison with WA%, WDA% and X-% possible, we averaged 
the totals for Sum2, FAB2, WSum6, and M- scores as a 
percentage of R for each patient. All the PTI Total and PTI sub-
category scores (percentages and averaged percentages for 
Sum2, FAB2, WSum6) were captured on a spreadsheet and 
entered into analyses. 
 
We calculated the Lambda (ratio of pure form responses to the 
frequency of all responses) for each patient, and in addition used 
F% (percentage of pure form responses in a protocol) as an 
equivalent for Lambda because of its suitability in parametric 
analyses (Meyer et al., 2001). A higher Lambda reflects a 
tendency to a guarded or defensive approach to the Rorschach 
task, which may mask some of the manifestations of psychotic 
thinking (Rosenbaum et al., 2012). We, however, did not exclude 
protocols with Lambda higher than .99 because of the large 
number of protocols with values exceeding this figure. Other 
studies have also found that inclusion of protocols with Lambda 
>.99 did not affect the results compared to analyses of the initial 
subset (Dao & Prevatt, 2006).  
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Inter-rater reliability of 13 variables critical for the PTI was done by 
making use of a second blind rater who coded and scored 20 
randomly selected Rorschach protocols. Intraclass correlation 
reliability analysis was conducted with intraclass correlation 
coefficients (ICC) ranging from .55 (WSum6), to .74 (F-) and .80 
(F+). Considering Cicchetti's (1994) guidelines, these coefficients 
would be considered fair to excellent (Cicchetti, 1994). 
 
The PTI can be regarded as a valid Rorschach composite score to 
detect psychosis (Mihura, et al., 2012; Viglione & Meyer, 2008). It 
measures different components of thought disorder, as manifested 
in the verbal responses given to the stimulus cards (use of 
peculiar language, neologisms, derailment, combining stimulus 
details in an illogical or implausible manner) and perceptual 
accuracy (how good the response matches the stimulus outline 
and perception of conventional responses).  
 
The Rorschach does not have alternate forms, but test-retest 
reliability values of .77 to .97 have been found (Grønnerød, 2003) 
and excellent inter-rater reliability (mean kappa of .88) exists for 
ten Rorschach response segments (Meyer, 1997a).    
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Normative data from a sample of 700 non-patient American adults 
(ages 18-70, measured during the 1970s and 1980s, 
representative of the United States demographic distribution 
including 19% of African American, Hispanic, and Asian American 
respondents) has been used as reference norm for this study 
(Exner, 1993/2000a/2000b/2003). 
 
 
D.Social and Occupational Functioning Assessment Scale  
The Social and Occupational Functioning Assessment Scale 
(SOFAS) was used as a secondary measure to provide a global 
rating of illness severity, improvement, and response to treatment. 
This is a clinician rated scale, requiring the clinician to compare 
the subject to the clinician's past experience with patients who 
have the same diagnosis (American Psychiatric Association, 
2000).  
 
The SOFAS is a clinician rating of social and occupational 
functioning independent of symptom severity, on a scale from 0 to 
100. The SOFAS score is represented on a continuum of 100 
(superior functioning in a wide range of activities), to 50 (serious 
impairment in social and occupational functioning) to 10 
(persistent inability to maintain minimal personal hygiene, unable 
to function independently) (American Psychiatric Association, 
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2000). Impairment can be due to mental and/or physical limitations 
and reflects current functioning at the time of assessment 
(Goldman et al., 1992).  
 
E. The World Health Organization Quality of Life  
The World Health Organization Quality of Life (WHOQOL-BREF) 
(World Health Organization, 1998) is a self-administered scale 
consisting of 26 items, which are rated by the patient from 0 (not at 
all satisfied) to 5 (completely satisfied). Items are summed to 
arrive at 4 domain scores: 
1) Physical health: activities of daily living, dependence 
on medicinal substances / medical aids, energy and 
fatigue, mobility, pain and discomfort, sleep and rest, 
work capacity; 
2) Psychological health: bodily image and appearance, 
negative feelings, positive feelings, self-esteem, 
spirituality/ religion/ personal beliefs, thinking, learning, 
memory and concentration, 
3) Social relationships: personal relationships, social 
support, and sexual activity and  
4) Environment: financial resources, freedom, physical 
safety and security, health and social care, home 
environment, opportunities for acquiring new 
information and skills, participation in and opportunities 
Stellenbosch University  https://scholar.sun.ac.za
210 
 
for recreation/ leisure activities, physical environment 
(World Health Organization, 1998).  
 
The four domain scores were converted to transformed scores of 
0-100 (Bergner et al., 1981) to make comparison with the 
comprehensive WHOQOL version possible. For regression 
analysis the four domain scores were averaged to arrive at an 
index score for WHOQOL as the dependent variable.   
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TREATMENT 
The patients were treated according to a specific algorithm, in order 
to standardise treatment as far as possible. Initially, there was a 
wash-out phase (of up to 7 days) during which all psychotropic 
medications were discontinued. Thereafter, treatment was initiated 
with oral flupenthixol, 1 to 4 mg/day for a 1 week prior to the first 
long-acting flupenthixol decanoate (FD) depot to rule out 
hypersensitivity to flupenthixol. The starting dose of FD was 10mg 
every second week, with dose increases allowed at 6-week intervals. 
Dose increases were determined according to clinical response and 
tolerability. Oral flupenthixol was given between visits, if the treating 
psychiatrist deemed it necessary due to acute exacerbations of 
symptoms. Patients who did not respond to FD by month 6 were 
offered clozapine. Concomitant medication for known physical 
illnesses (e.g. hypertension, hypothyroidism) were allowed and 
lorazepam was prescribed for additional sedation, if clinically so 
required. Extraparydamil side effects (EPSE) were treated with 
orphenadrine and/or biperidine and propranolol could be prescribed 
for akathisia. Antidepressant medication was permitted. No 
anticholinergic medication or lorazepam / propranolol were given 12 
hours before a neurocognitive assessment. Medications that were 
not permitted were: other antipsychotics, mood stabilizers, and 
psychostimulants.  
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STUDY PLAN 
The MCCB and RCS were administered in close proximity to one 
another (within the same week): at baseline, month 6 and month 12. 
The MCCB took an average 60 minutes to complete and the RCS 
about 90 minutes. If the patients were found to be too psychotic to 
complete the MCCB or RCS, these tests were postponed until the 
psychiatrist deemed the patient to have stabilized enough for formal 
testing to continue.  
Visit Baseline 
D-7 to D-0 
Wk 
2 
Wk 
4 
Wk 
6 
Mnth 
3 
Mnth 
6 
Mnth 
9 
Mnth 
12 
Consent 
 
X 
 
       
Demography 
 
X        
Physical 
exam 
X        
Psychiatric / 
Medical Hx  
+ SCID 
X        
DUP  
 
X        
PANSS 
 
X    X X  X 
SOFAS 
 
X     X  X 
WHOQOL-
BREF 
X     X  X 
MCCB 
 
X     X  X 
RCS 
 
X     X  X 
Adverse 
Events 
X X X X X X X X 
Concomitant 
treatment  
X X X X X X X X 
Oral 
treatment 
 
X 
and 
intermittentlyas 
required 
       
Depot 
treatment 
 X X X X X X X 
 
Table 6.2: Study plan as part of the larger study 
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DATA ANALYSES 
All data was recorded in case record format. A research assistant 
conducted data entry for the MCCB onto a spreadsheet. The 
researcher (RO) was responsible for the data management of the 
RCS and MCCB. Analyses of data was performed according to 
intention to treat and last observed cases carried forward method. 
 
Statistical analyses were conducted with the assistance of a 
biostatistician. Statistical analyses were performed with the Statistica 
version 12 (Statsoft) software (Statistica, 2013). A 5% significance 
level (p<.05) was used as the guideline for determining significant 
differences. The following analyses were performed: 
a. Spearman correlational analyses were conducted to 
explore significant relationships with regard to Age, HLOE 
and DUP on baseline measures of MCCB, PTI and 
PANSS. Differences in Gender, Ethnicity, drug screen, and 
Remission Status for the same baseline measures (MCCB, 
PTI, PANSS) were tested with one-way analyses of 
variance.  
b. To explore the relationships between MCCB and PTI 
scores at baseline and between MCCB/PTI scores with 
PANSS, SOFAS, and WHOQOL scores at baseline, 
Spearman correlational analyses were conducted.  
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c. To explore the relationships between degree of 
improvement in PANSS, MCCB and PTI scores from 
baseline to month 6, Spearman correlational analyses 
were conducted. 
d. To assess changes in neurocognitive deficits and thought 
disorder over time:  observed cases (OC) analyses at each 
time point, and mixed model repeated measures analyses 
of variance were conducted to examine mean changes in 
MCCB and PTI Total and subscale scores. In addition, 
changes in PANSS Total and factor scores, and changes 
in SOFAS and WHOQOL scores over time were assessed. 
e. To assess the value of neurocognitive deficits, degree of 
thought disorder and symptom severity at baseline in 
predicting outcome at month 12, multiple linear regression 
analysis with all the independent variables (including 
demographic variables, DUP, drug screen) was done with 
the PANSS Total, SOFAS and WHOQOL scores at month 
12 as the dependent variables. For Remission Status, a 
general discriminant analysis was conducted with the 
same independent variables. 
f. To assess the value of baseline measures of thought 
disorder in predicting outcome in MCCB Total score at 
month 12, multiple linear regression analysis with the PTI 
Total and PTI sub-category scores at baseline was 
conducted.  
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g. To assess the value of the degree of improvement from 
baseline to month 6 scores for the MCCB, PTI, and 
PANSS in predicting outcome at month 12, multiple linear 
regression analysis with all the independent variables 
(including demographic variables, DUP, drug screen any 
time) was done with the PANSS, SOFAS, and WHOQOL 
scores at month 12 as the dependent variables. For 
Remission Status, a general discriminant analysis was 
conducted with the same independent variables.  
  
 
 
 
 
 
 
 
 
 
 
 
Stellenbosch University  https://scholar.sun.ac.za
216 
 
ETHICAL CONSIDERATIONS 
Written informed consent was obtained from all patients, and/or their 
legal guardians. Ample opportunity was allowed to answer any 
questions before informed consent was signed. Patient anonymity 
was assured by non-disclosure of personal identifying detail. The 
patients were informed of the potential risks and benefits of the study 
and were assured that refusal to participate would not affect their 
current or future treatment in any way. Patients were also informed 
that treatment would be ongoing upon completion of the study and 
that they would be offered other clinical treatment should they decide 
to withdraw from the study. Patients were given the choice of 
completing all assessments in either English or Afrikaans and 
translation was offered when indicated.  
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CHAPTER 7: 
 
RESULTS: DEMOGRAPHIC DATA 
 
A total of 47 patients were recruited for this study. Of these, five were 
failed screens: two refused consent, one was under age, one was 
later diagnosed with a drug induced psychosis, and one was 
withdrawn early form the study due to insufficient response. Of the 
final sample (N=42) a total of 40 patients completed baseline MCCB 
and 30 patients received baseline PTI assessments (ten were 
excluded due to the low number of responses on Rorschach 
protocols (R<14) (Exner, 2003).   
 
Patient attrition  
A total of 26 patients completed the study, reflecting a patient attrition 
rate of 38% over a period of 12 months, with 11 (23%) lost to follow-
up, 5 (11%) refused further participation, 1 (2%) developed tardive 
dyskinesia, and 4 (9%) provided insufficient data.  
 
Age and gender  
Gender was disproportionally distributed with 8 (19%) females and 
34 (81%) males. The mean age of the sample was 24.91 years ±6.93 
depicted in figure 7.1.  
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Figure 7.1: Age distribution of patients 
 
There was a significant correlation between Age and overall 
neurocognitive ability at baseline (MCCB Cognitive Composite score: 
r=0.32; p=0.05), between Age and Attention/Vigilance at baseline 
(MCCB A/V score: r=0.33; p=0.04), and between Age and Working 
Memory at baseline (MCCB WM score: r=0.39; p=0.01). Age did not 
correlate significantly with thought disorder at baseline (PTI Total and 
sub-category scores) or with symptom severity (PANSS Total score) 
at baseline.  
 
One-way analysis of variance revealed no significant gender 
differences on measures of neurocognitive ability (p=0.66), thought 
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disorder (p=0.91) or symptom severity (p=0.18.) at baseline. These 
results must be interpreted with caution due to the small number of 
females in the sample.   
 
Education and ethnicity 
The patients had a mean educational level of 10.78 ±2.10 years of 
formal schooling depicted in figure 7.2.   
 
Educational level did not correlate significantly with any baseline 
measures of neurocognitive ability (MCCB Total and subscale 
scores), thought disorder (PTI Total and sub-category scores) or 
symptom severity (PANSS Total and factor scores).  
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 Figure 7.2: Educational level of patients 
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The patient's ethnic background reflected the demographic 
distribution of the catchment area with 67% mixedethnicity, 26% 
African and 7% Caucasian depicted in figure 7.3.   
 
 
Figure 7.3: Ethnic representation  
 
Educational level and ethnicity did not correlate significantly with any 
baseline measures of symptom severity or thought disorder.  
 
One way analysis of variance revealed significant differences 
between ethnic groups (F(2,37)=4.27, p=0.02) on baseline measures 
of neurocognitive ability with regard to Reasoning and Problem 
Solving (MCCB RPS scores: Caucasian (mean=44.66); mixed 
67%
26%
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0
Ethnic groups
mixed
african
caucasian
Stellenbosch University  https://scholar.sun.ac.za
227 
 
(mean=33.80); and african (mean=28.14)) (see figure 7.4). It may be 
that language differences have influenced the results.  
 
Ethnicity; LS Means
Current effect: F(2, 37)=4.2799, p=0.02 
Vertical bars denote 0.95 confidence intervals
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Figure 7.4: Ethnicity differences on baseline MCCB RPS scores  
_______________________________________________________ 
MCCB RPS: Matrics Consensus Cognitive Battery Reasoning and Problem 
Solving 
 
These results should be interpreted with caution due to the small 
number of Caucasian patients represented in the sample.  
 
A smaller but significant effect (F(2,37)=2.84, p=0.04) was found 
between ethnicity and baseline neurocognitive measures of Verbal 
Stellenbosch University  https://scholar.sun.ac.za
228 
 
Learning (MCCB Vrbl Lrng scores: Caucasian (mean=43.66); mixed 
(mean=34.80); and african (mean=39.14).  
 
Duration of untreated psychosis 
The mean duration of untreated psychosis (DUP) was 237 days ±269 
with a minimum of 8 days and a maximum 1307 days.   
 
There was a significant correlation between DUP and baseline 
neurocognitive measures of Attention/Vigilance (MCCB A/V: r=0.33, 
p=0.04), Reasoning and Problem Solving (MCCB RPS: r=0.42, 
p=0.01) and Speed of Processing (MCCB SoP: r=0.32, p=0.04).  
 
DUP was not significantly correlated with baseline measures of 
thought disorder (PTI Total and sub-category scores) and symptom 
severity (PANSS Total and factor scores).  
 
Use of illegal drugs 
At baseline (urine drug screen) a total of 4 patients tested positive for 
use of illicit drugs: cannabis (N=3); methaqualone (N=0); and 
methamphetamine (N=1).  
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No significant differences were found between illicit drug users and 
non-users at baseline on measures of neurocognitive ability (MCCB 
Total and subscale scores), thought disorder (PTI Total and sub-
category scores) and symptom severity (PANSS Total and factor 
scores).  
 
These results should be interpreted with caution due to the small 
number of patients who were using illegal drugs at baseline.   
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CHAPTER 8: 
 
RESULTS: SYMPTOM SEVERITY, NEUROCOGNITIVE 
IMPAIRMENT AND SEVERITY OF THOUGHT AND PERCEPTUAL 
DISORDER AT BASELINE 
 
Symptom severity 
The PANSS Total mean score at baseline was 89.06±16.89 with 
PANSS factor mean scores shown in table 8.1.  
 N mean sd 
PANSS Total  42 89.06 16.89 
PANSS N  42 22.27 7.73 
PANSS D  42 21.37 7.52 
PANSS P  42 23.14 6.96 
PANSS E  42 7.39 3.91 
PANSS A/D  42 11.16 5.78 
 
Table 8.1: PANSS Total and factor mean scores  
_______________________________________________________ 
PANSS: Positive and Negative Syndrome Scale; PANSS N: PANSS 
Negative factor; PANSS D: PANSS Disorganized factor; PANSS P: PANSS  
Positive factor; PANSS E: Excited factor; PANSS A/D: PANSS 
Anxiety/Depression factor.  
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Neurocognitive impairment 
The MCCB Composite mean score at baseline was 15.48±15.84 with 
MCCB mean subscale scores depicted in table 8.2. 
 N mean Sd 
MCCB Composite 37 15.48 15.84 
MCCB AV  40 26.30 11.41 
MCCB SoP² 40 22.67 14.23 
MCCB Vis Lrng  40 32.50 15.35 
MCCB Vrbl Lrng 40 36.22 7.42 
MCCB WM  40 25.75 15.22 
MCCB RPS² 40 33.62 8.87 
MCCB SC  40 26.86 15.10 
 
Table 8.2: MCCB Composite and subscale mean T-scores  
_______________________________________________________ 
MCCB: Matrics Consensus Cognitive Score; MCCB AV: 
Attention/Vigilance; MCCB SoP: Speed of Processing; MCCB Vis Lrng: 
Visual Learning;MCCB  Vrbl Lrng: Verbal Learning; MCCB WM: Working 
Memory; MCCB RPS: Reasoning and Problem Solving;MCCB SC: Social 
Cognition 
 
The MCCB Composite score was more than 3 standard deviations 
below the reference group norm at baseline (Nuechterlein & Green, 
2006).  
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The following MCCB subscale scores were positively correlated with 
the MCCB Composite score: Attention/Vigilance (MCCB A/V), Speed 
of Processing (MCCB SoP) and Working Memory (MCCB WM) 
scores shown in figure 8.1.   
 
Figure 8.1: PCA biplot of baseline neurocognitive measures 
 
Reasoning and Problem Solving (MCCB RPS), Visual Learning 
(MCCB Vis Lrng) and Verbal Learning (MCCB Verb Lrng) had 
weaker correlations with the MCCB Composite scores, and Social 
Cognition (MCCB SC) scores showed the weakest correlation with 
MCCB Composite scores at  baseline.  
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A one way repeated measures analysis of variance (ANOVA) 
between MCCB subscale scores revealed significantly higher 
baseline scores on Reasoning and Problem Solving (MCCB RPS 
mean=33.62), Visual Learning (MCCB Vis Lrng mean=32.50) and 
Verbal Learning (MCCB Vrbl Lrng mean=36.22) shown in table 8.2 
and figure 8.2.  
 
Current effect: F(6,231)=11.19, p=0.00
Vertical bars denote 0.95 confidence intervals
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Figure 8.2: Baseline differences between MCCB subscale scores  
_______________________________________________________ 
MCCB: Matrics Consensus Cognitive Battery; MCCB AV: 
Attention/Vigilance; MCCB SoP: Speed of Processing; MCCB Vis Lrng: 
Visual Learning;MCCB  Vrbl Lrng: Verbal Learning; MCCB WM: Working 
Memory; MCCB RPS: Reasoning and Problem Solving;MCCB SC: Social 
Cognition. 
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Fisher's least squared differences (LSD) with p-values for MCCB 
subscale means at baseline are depicted in table 8.3.  
 
Cell  
No. 
LSD test; MCCB Subscale scores at baseline 
subscale 
 
{1} 
26.30 
 
{2} 
33.62 
 
{3} 
26.48 
 
{4} 
22.67 
 
{5} 
32.50 
 
{6} 
36.22 
 
{7} 
25.75 
 
1 
 
MCCB_AV 
 
0.00 0.93 0.08 0.00 0.00 0.79 
2 
 
MCCB_RPS 0.00 
 
0.00 0.00 0.59 0.21 0.00 
3 
 
MCCB_SC 0.93 0.00 
 
0.07 0.00 0.00 0.73 
4 
 
MCCB_SoP 0.08 0.00 0.07 
 
0.00 0.00 0.14 
5 
 
MCCB_Vis Lrng 0.00 0.59 0.00 0.00 
 
0.07 0.00 
6 
 
MCCB_Vrbl Lrng 0.00 0.21 0.00 0.00 0.07 
 
0.00 
7 
 
MCCB_WM 0.79 0.00 0.73 0.14 0.00 0.00 
 
 
 
Table 8.3: LSD p-values for MCCB subscale mean scores  
_______________________________________________________ 
MCCB: Matrics Consensus Cognitive Battery;  MCCB AV: 
Attention/Vigilance; MCCB SoP: Speed of Processing; MCCB Vis Lrng: 
Visual Learning;MCCB  Vrbl Lrng: Verbal Learning; MCCB WM: Working 
Memory; MCCB RPS: Reasoning and Problem Solving;MCCB SC: Social 
Cognition.  
 
Overall neurocognitive ability (MCCB Composite score) had 
significant inverse correlations with PANSS Total (p=0.05), PANSS 
Disorganization (p<0.01) and PANSS Negative factors (p=0.05) at 
baseline shown in table 8.4.     
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Variable 1 Variable 2 N Spearman 
value 
Spearman 
p-value 
MCCB Comp PANSS Total 37 -0.33 0.05 
MCCB Comp PANSS N 37 -0.32 0.05 
MCCB Comp PANSS D 37 -0.44** <0.01 
MCCB AV PANSS Total 40 -0.35* 0.03 
MCCB AV PANSS N 40 -0.39* 0.01 
MCCB AV PANSS D 40 -0.52** <0.01 
MCCB SoP PANSS D 40 -0.32 0.05 
MCCB WM PANSS Total 40 -0.31 0.05 
MCCB WM PANSS N 40 -0.42** <0.01 
MCCB WM PANSS D 40 -0.47** <0.01 
MCCB Vis Lrng PANSS Total 40 -0.32* 0.04 
MCCB Vis Lrng PANSS N 40 -0.32* 0.04 
MCCB Vis Lrng PANSS D 40 -0.40* 0.01 
MCCB Vrbl Lrng PANSS Total 40 -0.34* 0.03 
MCCB Vrbl Lrng PANSS D 40 -0.33* 0.04 
MCCB Vrbl Lrng PANSS A/D 40 -0.31 0.05 
MCCB RPS PANSS E 40 -0.32 0.05 
* p<0.05  ** p<0.01 
Table 8.4: Correlations between MCCB and PANSS scores 
_______________________________________________________ 
MCCB: Matrics Consensus Cognitive Battery; MCCB AV: 
Attention/Vigilance; MCCB SoP: Speed of Processing; MCCB Vis Lrng: 
Visual Learning;MCCB  Vrbl Lrng: Verbal Learning; MCCB WM: Working 
Memory; MCCB RPS: Reasoning and Problem Solving;MCCB SC: Social 
Cognition; PANSS N: PANSS Negative factor; PANSS D: PANSS 
Disorganized factor; PANSS P: PANSS  Positive factor; PANSS E: Excited 
factor; PANSS A/D: PANSS Anxiety/Depression factor.    
Stellenbosch University  https://scholar.sun.ac.za
237 
 
The strongest correlations (p<0.01) were found between MCCB 
(Composite; Attention/Vigilance; Working Memory) and PANSS 
Disorganization factor scores at baseline depicted in table 8.4.  
 
There were no significant correlations between baseline 
neurocognitive measures (MCCB Composite and subscale scores) 
and baseline scores on PANSS Positive, PANSS Excited or PANSS 
Anxiety/Depression factor scores.  
 
Neurocognitive measures that assess Learning (MCCB Vis Lrng, 
MCCB Vrbl Lrng, MCCB WM) and Attention/Vigilance (MCCB A/V) 
were highly correlated with PANSS Disorganization and PANSS 
Negative factors. Reasoning and Problem Solving (MCCB RPS) and 
Speed of Processing (MCCB SoP) had weaker and fewer 
correlations with PANSS factor scores shown in table 8.4.  
 
Social Cognition (MCCB SC) poorly correlated with symptom severity 
(PANSS Total) or PANSS factor scores at baseline.  
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Thought disorder 
The mean number of Rorschach responses (R) was 23.16±8.22, with 
a range of 14 to 45. No significant bivariate correlation was found 
between Rorschach PTI and R shown in figure 8.3. 
 
 Spearman r = 0.12 p=0.53
Include condition:  t ime="baseline"
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Figure 8.3 Correlation between PTI Total and R  
_______________________________________________________ 
PTI: Perceptual Thinking Index; R: number of Rorschach responses. 
 
At baseline the mean Lambda was 2.28±3.23 and the mean F% was 
54.58. 
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The PTI Total mean score at baseline was 2.16±1.48 with mean 
percentages for PTI sub-categories: X- % (mean=38.30), M- % 
(mean=2.52), XA% (mean=60.03), WDA% (mean=62.60), WSum6% 
(mean=59.77), Sum2% (mean=6.16), and FAB2% (mean=0.48) 
shown in table 8.5.   
 
 N Mean Sd 
PTI Total 30 2.16 1.48 
X- %  30 38.30 17.84 
M- %  30 2.52 4.18 
XA%   30 60.03 18.25 
WDA%   30 62.60 18.64 
WSum6%   30 59.77 47.62 
Sum2%   30 6.16 7.95 
FAB2%  30 0.48 1.61 
 
Table 8.5: PTI Total mean and subcategory mean percentages 
_______________________________________________________ 
PTI: Perceptual Thinking Index; X- : % poor form perception; M-: %  poor 
human form perception; XA: % good form perception; WDA:% good form 
perception to whole and large detail; WSum6: % deviant verbalizations and 
illogical thinking; Sum 2: % severe deviant verbalizations and illogical 
thinking; FAB2: % fabulised and implausible thinking.  
 
A mild degree of perceptual and thought disorder was evident at 
baseline (PTI Total mean=2.16, cut-off score>3) (Dao & Prevatt, 
2003).  
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Recalculated cut-off scores for PTI sub-categories (Exner, 2003) 
indicated significant impairment for baseline scores that assess 
perceptual accuracy (X- %, XA%, WDA%) shown in table 8.6.  
 
 N Mean cut-off scores 
PTI total  30 2.16 equal or > 3 
X- %  30 38.30* > 29  
M- %  30 2.52 > 4.3 
XA%   30 60.03* < 70 
WDA%   30 62.60* < 75  
WSum6%    30 59.77 >73.4 
Sum2%   30 6.16 > 8.6 
FAB2%   30 0.48*  > 0 
* significant impairment at baseline 
 
Table 8.6: Recalculated cut-off scores based on mean R  
_______________________________________________________ 
PTI: Perceptual Thinking Index; X- : % poor form perception; M-: %  poor 
human form perception; XA: % good form perception; WDA:% good form 
perception to whole and large detail; WSum6: % deviant verbalizations and 
illogical thinking; Sum 2: % severe deviant verbalizations and illogical 
thinking; FAB2: % fabulised and implausible thinking; R: number of 
Rorschach responses.  
 
PTI sub-categories assessing perceptual accuracy indices (X- %; 
XA% and WDA%) accounted the most for raised PTI total scores 
depicted in table 8.5 and table 8.6. 
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Fabulised and Implausible Thinking scores (FAB2%) were also 
slightly raised at baseline as shown in table 8.6.  
 
There were no significant correlations between baseline thought 
disorder (PTI Total score) and baseline scores of symptom severity 
(PANSS Total score).  
 
Perceptual accuracy indices (XA% and WDA%) had significant 
positive correlations with PANSS Positive factor scores and Poor 
Form Perception (X- %) had a significant inverse correlation with 
PANSS Positive factor scores at baseline depicted in table 8.7. 
 
 Variable 1 Variable 2 N Spearman 
value 
Spearman 
p-value 
PTI X- % PANSS P 30 -0.42* 0.02 
PTI XA% PANSS P 30 0.40* 0.03 
PTI WDA%  PANSS P 30 0.42* 0.02 
* p < 0.05    ** p < 0.01 
Table 8.7: Correlations between PTI and PANSS scores 
_______________________________________________________ 
PTI: Perceptual Thinking Index, X- : % poor form perception; M-: %  poor 
human form perception; XA: % good form perception; WDA:% good form 
perception to whole and large detail;PANSS: Positive and Negative 
Syndrome Scale; PANSS P: PANSS  Positive factor. 
 
Stellenbosch University  https://scholar.sun.ac.za
242 
 
Thought disorder (PTI Total and PTI sub-category scores) were not 
significantly correlated with  PANSS Disorganization, PANSS 
Negative, PANSS Excited and PANSS Anxiety/Depression factors at 
baseline.  
 
Thought disorder at baseline (PTI Total score) correlated inversely 
with overall neurocognitive ability (MCCB Composite, p<0.01), Speed 
of Processing (MCCB SoP, p<0.01), Visual Learning (MCCB Vis 
Lrng, p<0.01) and Working Memory (MCCB WM, p=0.02) at baseline 
as shown in table 8.8. 
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Variable 1 Variable 2 N Spearman 
value 
Spearman 
p-value 
PTI Total MCCB Comp 30 -0.54** <0.01 
PTI Total MCCB SC 30 -0.42* 0.03 
PTI Total MCCB SoP 30 -0.55** <0.01 
PTI Total MCCB Vis Lrng 30 -0.63** <0.01 
PTI Total MCCB WM 30 -0.42* 0.02 
PTI X- % MCCB Comp 30 -0.56** <0.01 
PTI X- % MCCB SoP 30 -0.57** <0.01 
PTI X- % MCCB Vis Lrng 30 -0.46* 0.01 
PTI X- % MCCB WM 30 -0.44* 0.02 
PTI XA% MCCB Comp 30 0.58** <0.01 
PTI XA% MCCB SoP 30 0.59** <0.01 
PTI XA% MCCB Vis Lrng 30 0.55** <0.01 
PTI XA% MCCB WM 30 0.48** <0.01 
PTI WDA% MCCB Comp 30 0.55** <0.01 
PTI WDA% MCCB SoP 30 0.55** <0.01 
PTI WDA% MCCB Vis Lrng 30 0.53** <0.01 
PTI WDA% MCCB Vrbl Lrng 30 0.37 0.05 
PTI WDA% MCCB WM 30 0.46* 0.01 
* p <0.05   ** p <0.01 
Table 8.8: Correlations between PTI and MCCB scores 
_______________________________________________________ 
PTI Total: Perceptual Thinking Index total score; X- : % poor form 
perception; M-: %  poor human form perception; XA: % good form 
perception; WDA:% good form perception to whole and large detail; MCCB 
Comp: Matrics Consensus Cognitive Battery Composite;MCCB SoP: 
Speed of Processing; MCCB Vis Lrng: Visual Learning;MCCB  Vrbl Lrng: 
Verbal Learning; MCCB WM: Working Memory; MCCB SC: Social 
Cognition 
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The significant inverse correlation between PTI Total and Social 
Cognition (MCCB SC, Spearman p= -0.42, p=0.03) at baseline is 
clinically inconsistent with the correlations between MCCB subscale 
and PTI Total scores at baseline, and should therefore be interpreted 
with caution as depicted in table 8.8.    
 
The perceptual accuracy indices (X-%, XA%, WDA%) had significant 
correlations with overall neurocognitive ability (MCCB Composite, 
p<0.01), Speed of Processing (MCCB SoP, p<0.01), Working 
Memory (MCCB WM, p=0.02, p<0.01, p=0.01) and Visual Learning 
(MCCB Vis Lrng, p=0.01, p<0.01) at  baseline (see table 8.8). 
 
PTI Total and PTI sub-category scores did not correlate significantly 
with Verbal Learning (MCCB Verb Lrng) at baseline except for a 
relatively weak correlation with Good Form Perception to Whole and 
Large Detail (WDA%, Spearman=0.37, p=0.05) (see table 8.8).  
 
Various indices of Deviant Verbalizations and Illogical Thinking 
(WSum6%, Sum2%, FAB2%) were not significantly correlated with 
baseline measures of neurocognitive ability.  
 
 
Stellenbosch University  https://scholar.sun.ac.za
245 
 
Social and occupational functioning 
The mean score of Social and Occupational Functioning (SOFAS) at 
baseline was 48.67±13.53, which indicates serious impairment 
(Goldman et al., 1992).  
 
Social and Occupational Functioning correlated positively at baseline 
with overall neurocognitive ability (MCCB Composite, p=0.04),  
Attention/Vigilance (MCCB A/V, p<0.01) and Visual Learning (MCCB 
Vis Lrng, p=0.04) as depicted in table 8.9.  
 
Variable 1 Variable 2 N Spearman 
value 
Spearman 
p-value 
SOFAS MCCB Comp 37 0.35* 0.04 
SOFAS MCCB AV 40 0.42** <0.01 
SOFAS MCCB Vis Lrng 40 0.32* 0.04 
* p <0.05   ** p <0.01 
Table 8.9: Correlations between SOFAS and MCCB scores 
_______________________________________________________ 
SOFAS: Social and Occupational Functioning Scale; MCCB Comp: Matrics 
Consensus Cognitive Battery Composite; MCCB Vis Lrng: Visual Learning; 
MCCB AV: Attention / Vigilance. 
 
The strongest correlation at baseline was found between 
Attention/Vigilance (MCCB A/V) and SOFAS.   
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Measures of Thought Disorder (PTI Total and PTI sub-categories) 
were not significantly correlated with SOFAS at baseline.  
  
Quality of life 
The mean transformed scores for Quality of Life at baseline ranged 
from 46.91 to 53.24 for the four domains as depicted in table 8.10.   
 
 N Mean sd 
WHOQOL Domain 1 
- Physical 
42 46.91 13.29 
WHOQOL Domain 2 
- Psychological 
42 53.24 17.30 
WHOQOL Domain 3 
- Social relations 
42 47.33 23.72 
WHOQOL Domain 4 
- Environment 
42 48.06 21.50 
 
Table 8.10: WHOQOL mean transformed domain scores 
_______________________________________________________ 
WHOQOL: World Health Organization Quality of Life Questionnaire 
 
Overall Quality of Life as reported by patients at baseline reflected a 
moderate degree of dissatisfaction with Physical, Psychological, 
Social and Environmental well-being (Bergner et al., 1981).  
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Question1 (rating of quality of life) had a mean of 3.24±1.00 and 
Question2 (rating of health satisfaction) had a mean of 3.33±1.26, 
which indicate a neutral response to these questions at baseline by 
most patients.  
 
Quality of Life (Environment) correlated significantly with overall 
neurocognitive ability (MCCB Comp, p=0.03) and Social Cognition 
(MCCB SC, p<0.01) at baseline (see table 8.11). Quality of Life 
(Physical) also correlated with Social Cognition (MCCB SC, p=0.04) 
at baseline. 
 
Variable 1 Variable 2 N Spearman 
value 
Spearman 
p-value 
QOL Domain 4 MCCB Comp 36 0.35* 0.03 
QOL Domain 4 MCCB SC 36 0.45** <0.01 
QOL Domain 1 MCCB SC 36 0.35* 0.04 
*  p<0.05   ** p<0.01 
 
Table 8.11: Correlations between QOL domain and MCCB    
_______________________________________________________ 
QOL Domain 1: Quality of Life Physical; QOL Domain 4: Quality of Life 
Environment; MCCB Comp: Matrics Consensus Cognitive Battery 
Composite score; MCCB SC: Social Cognition    
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All four QOL domains (Physical, Psychological, Social, Environment) 
had significant inverse correlations with thought disorder (PTI Total) 
at baseline depicted in table 8.12.  
Variable 1 Variable 2 N Spearman 
value 
Spearman 
p-value 
QOL Domain 1 PTl Total 30 -0.49** <0.01 
QOL Domain 2 PTI Total 30 -0.55** <0.01 
QOL Domain 3 PTI Total 30 -0.51** <0.01 
QOL Domain 4 PTI Total 30 -0.41* 0.03 
QOL Domain 1 X- % 30 -0.45* 0.01 
QOL Domain 2 X- % 30 -0.49** <0.01 
QOL Domain 4 X- % 30 -0.41* 0.02 
QOL Domain 1 XA% 30 0.44* 0.01 
QOL Domain 2 XA%  30 0.49** <0.01 
QOL Domain 4 XA%  30 0.36 0.05 
QOL Domain 1 WDA% 30 0.49** <0.01 
QOL Domain 2 WDA%  30 0.47** <0.01 
QOL Domain 4 WDA% 30 0.39* 0.03 
QOL Domain 3 FAB2% 30 -0.43* 0.02 
* p<0.05   ** p<0.01 
Table 8.12: Correlations between QOL domain and PTI scores 
_______________________________________________________ 
QOL Domain 1: Quality of Life Physical; QOL Domain 2: Quality of Life 
Psychological;  QOL Domain 3: Quality of Life Social; QOL Domain  4: 
Quality of Life Environment; PTI Total: Perceptual Thinking Index total 
score; X- : % poor form perception; XA: % good form perception; WDA:% 
good form perception to whole and large detail; FAB2: % fabulised and 
implausible thinking.  
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Poor Form Perception (X- %) had significant inverse correlations with 
Physical (QOL Domain 1, p=0.01), Psychological (QOL Domain 2, 
p<0.01) and Environment (QOL Domain 4, p=0.02) as depicted in 
table 8.12.  
 
The Perceptual Accuracy indices (XA%, WDA%) had significant 
positive correlations with Physical (QOL Domain 1), Psychological 
(QOL Domain 2), and Environment (QOL domain 4) at baseline as 
depicted in table 8.12. 
 
Various degrees of Deviant Verbalizations and Illogical Thinking 
(WSum2%, Sum2%, FAB2%) were not significantly correlated with 
QOL domains at baseline except for Fabulised and Implausible 
Thinking (FAB2%) which had an inverse correlation with Social (QOL 
Domain 3, p=0.02) shown in table 8.12.     
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CHAPTER 9: 
 
RESULTS: TREATMENT RESPONSE AND OUTCOME 
 
Decrease in symptom severity 
A mixed model repeated measures ANOVA revealed a significant 
decrease in symptom severity (PANSS Total mean) from 
89.06±16.89 at baseline to 44.17±11.52 at month 12 as depicted in 
figure 9.1.  
Current effect: F(4, 138)=104.92, p=0.00
Vertical bars denote 0.95 confidence intervals
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Figure 9.1: Change in PANSS Total mean scores over time 
____________________________________________________ 
PANSS Total: Positive and Negative Syndrome Scale total score 
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The degree of symptom severity reached levels of  minimal 
psychopathology at month 12 (mean PANSS Total= 44.17) (Kay, 
1987). 
 
Most of the change occurred within the first 3 months after treatment 
with 41.8% improvement within the first month, 79.5% within the first 
3 months and  91.0% after 6 months as shown in table 9.1.  
 
 
Effect 
Descriptive Statistics: PANSS Total scores 
 
Level of 
Factor 
 
N 
 
PANSS_Total_score 
Mean 
 
PANSS_Total_score 
Std.Dev. 
 
   
time 
 
baseline 42 89.06 16.89 
   
time 
 
week4 41 70.29 16.10 
   
time 
 
month 3 38 53.36 16.036 
   
time 
 
month 6 35 48.20 12.48 
   
time 
 
month 12 28 44.17 11.52 
   
 
Table 9.1: PANSS Total mean scores over time 
_______________________________________________________ 
PANSS Total: Positive and Negative Syndrome Scale total score 
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No significant change in symptoms occurred between month 3 and 
month 6, or between month 6 and month 12 as shown in table 9.2.  
Assessment  
Effect: Time 
 
LSD test; variable PANSS_Total_score 
 
1st 
Mean 
 
2nd 
Mean 
 
Mean 
Differ. 
 
 
P 
 
{1}-{2} 
 
baseline week4 18.84 
 
0.00 
 
{1}-{3} 
 
baseline month 3 35.27 
 
0.00 
 
{1}-{4} 
 
baseline month 6 40.14 
 
0.00 
 
{1}-{5} 
 
baseline month 12 43.65 
 
0.00 
 
{2}-{3} 
 
week4 month 3 16.43 
 
0.00 
 
{2}-{4} 
 
week4 month 6 21.30 
 
0.00 
 
{2}-{5} 
 
week4 month 12 24.81 
 
0.00 
 
{3}-{4} 
 
month 3 month 6 4.87 
 
0.05 
 
{3}-{5} 
 
month 3 month 12 8.38 
 
0.00 
 
{4}-{5} 
 
month 6 month 12 3.51 
 
0.20 
 
 
Table 9.2: LSD p-values for PANSS Total mean scores over time 
_______________________________________________________ 
PANSS Total: Positive and Negative Syndrome Scale total score 
 
Change in the PANSS factors scores (Positive, Negative, 
Disorganization, Excited, Anxiety/Depression) followed a similar 
trend with most improvement occurring within the first 3 months after 
treatment.   
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PANSS Positive factor scores improved significantly between 
baseline and month 12, with most improvement between baseline 
and month 3 as shown in figure 9.2. 
Current ef f ect: F(4, 188)=92.114, p=0.0000
Vertical bars denote 0.95 conf idence interv als
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Figure 9.2: Change in PANSS Positive factor scores over time 
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PANSS Negative factor scores improved significantly from baseline 
to month 12 with most improvement occurring within the first 3 
months after treatment as shown in figure 9.3.  
 
Current ef f ect: F(4, 188)=47.467, p=0.0000
Vertical bars denote 0.95 conf idence interv als
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Figure 9.3: Change in PANSS Negative factor scores over time 
 
Change in PANSS Negative factor scores were not significant 
between month 3 and month 6 (p=0.20).  
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PANSS Disorganization factor scores improved significantly from 
baseline to month 12 with most change occurring within the first 3 
months after treatment as shown in figure 9.4.   
Current ef f ect: F(4, 188)=70.631, p=0.0000
Vertical bars denote 0.95 conf idence interv als
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Figure 9.4: Change in PANSS Disorganization factor scores over 
time  
Change in PANSS Disorganization factor scores were not significant 
between month 3 and month 6 (p=0.14). 
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PANSS Anxiety / Depression factor scores improved signicantly from 
baseline to month 12 with most improvement occurring within the first 
3 months after treatment as shown in figure 9.5.  
Current ef f ect: F(4, 188)=34.318, p=0.0000
Vertical bars denote 0.95 conf idence interv als
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Figure 9.5: Change in PANSS Anxiety / Depression factor scores 
over time  
Change in PANSS Anxiety / Depression factor scores were not 
significant between month 3 and month 6 (p=0.1) and between 
month 6 and month 12 (p=0.1).  
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PANSS Excited factor scores improved significantly from baseline to 
month 12 with most improvement occurring within the first 4 weeks  
after treatment as shown in figure 9.6. 
Current ef f ect: F(4, 188)=29.206, p=0.0000
Vertical bars denote 0.95 conf idence interv als
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Figure 9.6: Change in PANSS Excited factor scores over time  
Change in PANSS Excited factor scores were not significant between  
month 1 and month 3 (p=0.06), between month 3 and month 6 
(p=0.11) and between month 6 and month 12 (p=0.33).  
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Predictors of various outcome measures: 
Best subsets regression with all the independent variables identified 
baseline scores for Social Cognition (MCCB SC), highest level of 
education (HLOE), Working Memory (MCCB WM), thought disorder 
(PTI total) and Attention/Vigilance (MCCB A/V) as predictors 
accounting for 40.5% of the variance (adjusted R²=0.40, 
F(5,14)=3.58, p<0.02) of symptom severity (PANSS Total) at month 
12 as shown in table 9.4.   
 
 
N=20 
Regression Summary for  PANSS_Total_score  
R²= .561 Adjusted R²= .405 F(5,14)=3.58,p<0.02 
b* 
  
B 
  
p-value 
 
# times in best 
20 models 
 
Intercept 
   
77.17 
  
0.00 
 
MCCB_AV 
 
-0.19 
 
-0.22 
  
0.33 8 
MCCB_SC 
 
0.42 
 
0.29 
  
0.04 20 
MCCB_WM 
 
-0.22 
 
-0.18 
  
0.30 13 
HLOE 
 
-0.54 
 
-2.93 
  
0.00 20 
PTI_Tot 
 
0.23 
 
1.59 
  
0.24 10 
* standard beta 
Table 9.4: Beta and p-values of baseline predictors of PANSS 
Total score at month 12 
_______________________________________________________ 
PANSS: Positive and Negative Syndrome Scale; MCCB WM: Working 
Memory; MCCB SC: Social Cognition; MCCB AV: Attention / Vigilance; 
HLOE: highest level of education; PTI Tot: Perceptual Thinking Index total 
score.  
 
Of the predictors only Social Cognition (MCCB SC) and HLOE were 
significant independently and the same two variables were also the 
Stellenbosch University  https://scholar.sun.ac.za
260 
 
only ones to appear in all 20 of the best models as depicted in figure 
9.7.  
Dependent variable: PANSS Total month 12
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Figure 9.7: Predictors of PANSS Total score at month 12 
_______________________________________________________ 
PANSS: Positive and Negative Syndrome Scale; MCCB SC: Social 
Cognition; HLOE: highest level of education, MCCB WM: Working Memory; 
PTI Tot: Perceptual Thinking Index total score; MCCB A/V: Attention / 
Vigilance; MCCB Vis Lrng: Visual Learning. 
 
However, while Social Cognition (MCCB SC) was a significant 
predictor (b=0.42, p=0.04) it was in a positive direction – i.e. better 
performance in the social cognition domain predicted more severe 
symptoms at month 12. This is counter-intuitive, and the role of 
Social Cognition as a predictor of symptom severity at month 12 
should be interpreted with caution.  
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When entering change from baseline to month 6 in total and 
subscale scores for PANSS, MCCB and PTI with the same 
independent variables and PANSS Total at month 12 as dependent 
variable, the predictive power in a best subsets regression increased 
(adjusted R² =0.73, F(4,13)=16.41, p<0.01) compared to baseline 
predictors only (adjusted R² =0.40, F(5,14)=3.58, p<0.05) as 
depicted in table 9.5.  
 
 
N=18 
Regression Summary for Dependent Variable: 
PANSS_Total (M12)  
R²= .834 Adjusted R²= .783 F(4,13)=16.41 p<0.01 
b* 
  
b 
   
p-value 
 
# times in best 
20 models 
 
Intercept 
   
69.36 
  
0.00 
 
HLOE 
 
-0.57 
 
-3.08 
  
0.00 15 
Sum2% 
(M6- baseline) 
 
-0.53 
 
-1.03 
  
0.00 15 
WDA% 
(M6- baseline) 
 
0.72 
 
0.53 
  
0.00 14 
PANSS_E 
(M6- baseline) 
 
-0.35 
 
-0.94 
  
0.01 2 
* standard beta 
Table 9.5: Beta and p-values for change predictors of PANSS                   
Total score at month 12    
_______________________________________________________ 
PANSS: Positive and Negative Syndrome Scale; PANSS E: Excited factor; 
HLOE: highest level of education; Sum2: % deviant verbalizations and 
illogical thinking; WDA: % good form responses to whole and large detail. 
 
The following change variables explained 78.3% of the variance in 
PANSS Total score at month 12: Highest level of education (HLOE), 
Severe Deviant Verbalizations and Illogical Thinking (Sum2%),  
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Good Form Perception to Whole and Large Detail (WDA%) and 
PANSS Excited factor (PANSS E) as shown in table 9.5.  All of these 
predictors were significant and also appeared in the best 20 models 
depicted in figure 9.8.  
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Figure 9.8: Change predictors of PANSS Total score at month 12 
_______________________________________________________ 
PANSS Total: Positive and Negative Syndrome Scale total score; Sum2: % 
severe deviant verbalizations and illogical thinking; WDA: % good form 
responses to whole and large detail; MCCB SC: Social Cognition; PANSS 
P: Positive factor; MCCB Vrbl Lrng: Verbal Learning.   
 
The degree of improvement (increase from baseline to month 6 
scores) in WDA had a positive influence (beta=0.72, p<0.01) on the 
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variance which is clinically inconsistent with the negative influence of 
improvement in Sum2 (beta= -0.53, p=<0.01).  
 
The predictive validity of degree of improvement in WDA from  
baseline to month 6 should therefore be interpreted with caution.   
 
Improvement in neurocognitive performance 
Overall neurocognitive ability (MCCB Composite score) improved 
significantly from a baseline mean of 15.48±15.84 to a mean of 
26.28±15.20 at month 12 as shown in figure 9.9.  
Current effect: F(2, 51)=18.87, p=.00
Vertical bars denote 0.95 confidence intervals
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Figure 9.9: Change in neurocognitive ability over time 
_______________________________________________________ 
MCCB Comp: Matrics Consensus Cognitive Battery composite score. 
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Most of the improvement in overall neurocognitive ability occurred 
early with 100% improvement observed during the first 6 months 
depicted in table 9.6. 
 
Effect 
Descriptive Statistics: MCCB Composite scores 
Level of 
Factor 
 
      N 
 
MCCB_Comp 
Mean 
 
MCCB_Comp 
Std.Dev. 
 
   
Total 
  
94 22.36 15.71 
   
time 
 
Baseline 37 15.48 15.84 
   
time 
 
month 6 32 27.25 13.30 
   
time 
 
month 12 25 26.28 15.20 
   
 
Table 9.6: MCCB Composite mean T-scores over time 
_______________________________________________________ 
MCCB Composite: Matrics Consensus Cognitive Battery composite score. 
 
A degree of impairment in overall neurocognitive ability was evident 
at month 12 (MCCB Composite T score, mean=26.29) which is 2-3 
standard deviations (<1st percentile) below the reference norm 
(Nuechterlein & Green, 2006).  
 
For the MCCB subscales most improvement occurred within the first 
6 months: Attention/Vigilance (MCCB A/V=85.5%), Speed of 
Processing (MCCB SoP=100%), Working Memory (MCCB 
WM=100%), Verbal Learning (MCCB Vrbl Lrng=100%), Visual 
Learning (MCCB Vis Lrng=100%), Reasoning-and Problem Solving 
(MCCB RPS=100%), and Social Cognition (MCCB SC=86.6%) as 
shown in table 9.7.  
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 Descriptive Statistics: MCCB Subscale scores 
Effect 
Time 
N AV 
 
Mean 
SoP 
 
Mean 
Vrbl 
Lrng  
Mean 
 
Vis 
Lrng 
Mean 
WM 
 
Mean 
RPS 
 
Mean 
SC 
 
Mean 
Total 97 32.03 
 
27.87 38.58 36.39 32.23 37.34 29.72 
baseline 40 26.30 
 
22.67 36.22 32.50 25.75 33.62 26.86 
month 6 32 35.50 
 
31.75 41.43 39.81 37.03 40.21 31.28 
month 12 25 36.76 
 
31.24 38.72 38.24 36.48 39.60 31.96 
 
Table 9.7: MCCB Subscale mean T-scores over time 
_______________________________________________________ 
MCCB AV: Attention / Vigilance; MCCB SoP: Speed of Processing; MCCB 
Vrbl Lrng: Verbal Learning; MCCB Vis Lrng: Visual Learning; MCCB WM: 
Working Memory; MCCB RPS: Reasoning and Problem Solving; MCCB 
SC: Social Cognition. 
 
The mean differences between baseline and month 6 scores were 
significant at a 95% confidence interval for all domains except for 
Social Cognition (MCCB SC) which did not show significant 
improvement from baseline to month 6, but did so at month 12 as 
shown in figure 9.10.  
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Current ef f ect: F(2, 51)=3.67, p=.032
Vertical bars denote 0.95 conf idence interv als
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Figure 9.10: Change in Social Cognition scores over time 
The degree of change in neurocognitive performance (MCCB 
Composite and subscale scores) and symptoms (PANSS Total and 
factor scores) revealed the following significant inverse correlations: 
improvement in MCCB Composite and subscales measuring  
Learning (MCCB Visual Learning, MCCB Verbal Learning, MCCB 
Working Memory) correlated significantly with improvement in 
PANSS Negative and Disorganization factors  depicted in table 9.8.  
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Variable 1 Variable 2 N Spearman 
value 
Spearman 
p-value 
MCCB Comp  
(M6 - baseline) 
PANSS D 
(M6 - baseline) 
30 -0.41* 0.03 
MCCB Vis Lrng 
(M6 - baseline) 
PANSS D 
(M6 - baseline) 
30 -0.44* 0.01 
MCCB Vis Lrng 
(M6 - baseline) 
PANSS N 
(M6 - baseline) 
30 -0.48** <0.01 
MCCB Vrbl Lrng 
(M6 - baseline)  
PANSS N 
(M6 - baseline) 
30 -0.51** <0.01 
MCCB WM 
(M6 - baseline) 
PANSS N 
(M6 - baseline) 
30 -0.44* 0.01 
*  p < 0.05   ** p < 0.01 
Table9.8: Correlations between MCCB and PANSS change                 
scores 
_______________________________________________________ 
MCCB Comp: Matrics Consensus Cognitive Battery composite score; 
MCCB Vis Lrng: Visual Learning; MCCB Vrb Lrng: Verbal Learning; MCCB 
WM: Working Memory; PANSS D: Disorganization factor; PANSS N: 
Negative factor.  
 
A best subsets regression with MCCB Composite score at month 12 
as the dependent variable and baseline PTI Total and sub-category 
scores as independent variables had a relative weak predictive 
power with 21% of the variance explained by PTI variables as shown 
in table 9.9.  
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N=21 
Regression Summary for Dependent Variable: MCCB_Comp M12  
R²= .329 Adjusted R²= .211 F(3,17)=2.78, p<0.07 
b* 
  
B 
   
p-value 
 
# times in best 20 
models 
 
Intercept 
   
-10.36 
  
0.45 
 
FAB2% 
 
-0.32 
 
-2.67 
  
0.21 10 
WDA% 
 
0.62 
 
0.54 
  
0.01 8 
WSum6% 
 
0.30 
 
0.10 
  
0.24 9 
* standard beta 
Table 9.9: PTI predictors of MCCB Composite score at month 12 
_______________________________________________________ 
FAB2: % fabulised and implausible thinking; WDA: % good form responses 
to whole and large detail; WSum6: % deviant verbalizations and illogical 
thinking; MCCB Comp: Matrics Consensus Cognitive Battery composite 
score. 
 
Of the PTI predictor variables only Good Form Perception to Whole 
and Large detail (WDA) was significant (p=0.01) as shown in table 
9.9.  
 
Improvement in perceptual and thought disorder 
Perceptual and thought disorder index scores (PTI Total) decreased 
significantly from a baseline mean of 2.16±1.48 to 1.65±1.44 at 
month 6 and 1.31±1.49 at month 12 shown in figure 9.11.  
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Current ef f ect: F(2, 45)=4.30, p=.01
Vertical bars denote 0.95 conf idence interv als
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Figure 9.11: Change in PTI Total scores over time 
_______________________________________________________ 
PTI Total: Perceptual Thinking Index total score 
 
Most of the improvement in perceptual and thought disorder (PTI 
Total) occurred early with a 60% decrease at month 6 and a 40% 
decrease in perceptual and thought disorder at month 12 as depicted 
in table 9.10. 
 
Effect 
Descriptive Statistics: Thought disorder scores 
Level of 
Factor 
 
      N 
 
PTI_Tot 
Mean 
 
PTI_Tot 
Std.Dev. 
 
   
Total 
  
81 1.75 1.49 
   
time 
 
baseline 30 2.16 1.48 
   
time 
 
month 6 29 1.65 1.44 
   
time 
 
month 12 22 1.31 1.49 
   
 
Table 9.10: PTI total mean scores over time 
_______________________________________________________ 
PTI Total: Perceptual Thinking Index total score 
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The decrease in perceptual and thought disorder score was 
significant between baseline and month 6 (p=0.04) but not between 
month 6 and month 12 (p=0.38) as shown in table 9.11.  
 
Comparisons Cell {#1}-{#2} 
LSD test; variable PTI_Total  
Effect: time 
1st 
Mean 
 
2nd 
Mean 
 
Mean 
Differ. 
 
 
p 
   
{1}-{2} 
 
Baseline month 6 0.54 
 
0.04 
  
{1}-{3} 
 
Baseline month 12 0.78 
 
0.00 
  
{2}-{3} 
 
month 6 month 12 0.24 
 
0.38 
  
 
Table 9.11: LSD p-values for change in PTI total scores over                     
time 
_______________________________________________________ 
PTI Total: Perceptual Thinking Index total score 
 
The distribution of Lambda was skewed (see figure 9.12) and in 
order to calculate a mixed model repeated ANOVA, we used a 
statistically corrected Lambda mean which is more suitable for 
parametric analysis.  
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Figure 9.12: Distribution of Lambda scores at baseline  
 
Lambda increased significantly from baseline to month 6 whereafter 
it reached a plateau as depicted in figure 9.13.  
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Current ef f ect: F(2, 34)=4.97, p=.012
Vertical bars denote 0.95 conf idence interv als
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Figure 9.13: Change in Lambda scores over time  
 
Of the PTI sub-categories, improvement from baseline to month 6 
was most evident for Poor Human Form Perception (M-%=100%), 
Severe Deviant Verbalizations and Illogical Thinking (Sum2% 
=77.8%), and Fabulised and Implausible Thinking (FAB2% =100%) 
as depicted in table 9.12.  
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 Descriptive Statistics: PTI Sub-category scores 
Effect 
Time 
N X-  
% 
Mean 
XA 
% 
Mean 
WDA
% 
Mean 
M- 
% 
Mean 
WSum
6 % 
Mean 
Sum2
% 
Mean 
FAB2 
% 
Mean 
Total 81 
 
33.83 63.17 65.11 1.62 39.14 3.59 0.20 
baseline 30 
 
38.30 60.03 62.60 2.52 59.77 6.16 0.48 
month 6 29 
 
33.17 62.41 64.68 1.03 36.20 2.53 0.00 
month 12 22 
 
28.63 68.45 69.09 1.16 14.90 1.50 0.11 
 
Table 9.12: PTI Sub-category mean percentages over time 
_______________________________________________________ 
PTI: Perceptual Thinking Index; X- : % poor form perception; M-: %  poor 
human form perception; XA: % good form perception; WDA:% good form 
perception to whole and large detail; WSum6: % deviant verbalizations and 
illogical thinking; Sum 2: % severe deviant verbalizations and illogical 
thinking; FAB2: % fabulised and implausible thinking.  
 
Deviant Verbalizations and Illogical Thinking (WSum6%: LSD 
p<0.01), Severe Deviant Verbalizations and Illogical Thinking 
(Sum2%: LSD p<0.01) and Fabulised and Implausible Thinking 
(FAB2%: LSD p=0.04) showed significant improvement from 
baseline to month 6 at a 95% confidence interval (see table 9.12). 
 
Improvement in the Perceptual Accuracy indices occurred later with 
most improvement evident between month 6 and month 12 for XA% 
(71.8%) and WDA% (68%) as depicted in table 9.12. 
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Improvement between month 6 and month 12 was significant for 
Good Form Perception (XA%, LSD p=0.03, CI=0.95) as shown in  
figure 9.14.  
Current ef f ect: F(2, 45)=5.42, p=.00
Vertical bars denote 0.95 conf idence interv als
baseline month 6 month 12
time
50
55
60
65
70
75
80
P
T
I_
X
A
%
a
b
b
 
Figure 9.14: Change in Good Form Perception (XA%) over time  
_______________________________________________________ 
PTI XA: % good form responses 
 
At month 12 residual thought and perceptual impairment was evident 
with Good Form Perception (XA% mean=68.45, cut-off <70), Good 
Form Perception to Whole and Large Detail (WDA% mean=69.09, 
cut-off <75) and Fabulised and Implausible Thinking (FAB2% 
mean=0.11, cut-off >0) as depicted in table 9.12 (Exner, 2003).  
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No significant correlations were found between degree of 
improvement in thought disorder (difference between baseline and 
month 6 for PTI Total and sub-category scores) and improvement in 
symptoms (difference between baseline and month 6 for PANSS 
Total and factor scores).  
 
No significant correlations were found between improvement in 
thought disorder (difference between baseline and month 6 for PTI 
Total and sub-category scores) and improvement in neurocognitive 
performance (difference between baseline and month 6 for MCCB 
Total and subscale scores), except for significant correlations 
between improvement in Poor Human Form Perception (M- %) and 
improvement in Reasoning-and-Problem Solving (MCCB RPS), and 
improvement in Good Form Perception to Whole and Large Detail  
(WDA%) which was correlated to improvement in Working Memory 
(MCCB WM) as shown in table 9.13. 
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Variable 1 Variable 2 N Spearman 
value 
Spearman 
p-value 
M- %  
(M6 - baseline) 
MCCB RPS 
(M6 - baseline) 
24 0.50* 0.01 
WDA% 
(M6 - baseline) 
MCCB WM 
(M6 - baseline) 
24 0.54** <0.01 
*  p< 0.05   **  p< 0.01 
Table 9.13: Change correlations between PTI and MCCB scores 
_______________________________________________________ 
M-: % poor human form responses; WDA: % good form responses to whole 
and large detail; MCCB RPS: Reasoning and Problem Solving; MCCB WM: 
Working Memory 
 
The correlation between M- % and MCCB RPS should be interpreted 
with caution due to the small variance in mean M- % scores over 
time (see table 9.12).   
 
Improvement in Social and Occupational Functioning 
Social and Occupational Functioning (SOFAS) improved significantly 
from a baseline mean of 48.67±13.53 to a mean of 70.46±12.43 at 
month 12 as depicted in figure 9.15.  
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Current ef f ect: F(2, 61)=73.47, p=.00
Vertical bars denote 0.95 conf idence interv als
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Figure 9.15: Change in SOFAS scores over time 
_______________________________________________________ 
SOFAS: Social and Occupational Functioning Scale 
 
Most of the improvement (96%) in Social and Occupational 
Functioning occurred within 6 months after treatment as indicated in 
table 9.14. 
 
Effect 
Descriptive Statistics: SOFAS 
Level of 
Factor 
 
N 
 
CGI_SOFAS 
Mean 
 
CGI_SOFAS 
Std.Dev. 
 
   
Total 
  
109 60.99 16.54 
   
time 
 
baseline 46 48.67 13.53 
   
time 
 
month 6 35 69.60 12.18 
   
time 
 
month 12 28 70.46 12.43 
   
 
Table 9.14: SOFAS mean scores over time 
_______________________________________________________ 
SOFAS: Social and Occupational Functioning Scale 
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SOFAS scores at month 6 (mean=69.60) indicated considerably 
improved Occupational and Social Functioning although substantial 
impairments remained (Goldman et al., 1992).  
 
A best subsets regression with all the independent variables and 
SOFAS score at month 12 as the dependent variable explained 
56.5% of the variance with the following five predictors: Overall 
neurocognitive ability (MCCB Composite),  Reasoning and Problem 
Solving (MCCB RPS), highest level of education (HLOE), positive 
drug screen anytime, and thought  and perceptual disorder (PTI 
Total) as shown in table 9.15.  
 
N=20 
Regression Summary for Dependent Variable: SOFAS(M12)                  
R²= .679 Adjusted R²= .565 F(5,14)=5.93 p< .003 
b* 
  
B 
   
p-value 
 
# times in best 20 
models 
 
Intercept 
   
49.13 
  
0.00 
 
MCCB_Comp 
 
-0.91 
 
-0.89 
  
0.00 11 
MCCB_RPS 
 
0.64 
 
0.73 
  
0.01 15 
HLOE 
 
0.37 
 
2.21 
  
0.05 5 
Drug screen 
anytime 
 
0.37 
 
8.96 
  
0.04 3 
PTI_Tot 
 
-1.11 
 
-8.29 
  
0.00 20 
b* = standard beta  
 
Table 9.15: Predictors of SOFAS at month 12 
_______________________________________________________ 
MCCB Comp: Matrics Consensus Cognitive Battery composite score; 
MCCB RPS: Reasoning and Problem Solving; HLOE: highest level of 
education, PTI Tot: Perceptual Thinking Index total score. 
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The negative influence of MCCB Composite score (beta= -0.91) is 
clinically inconsistent with MCCB RPS (shown in table 9.15) and 
should therefore be interpreted with caution. The MCCB subscales 
have a multicolinear relationship and therefore should be in the same 
direction as the MCCB Composite score.  
 
Of the significant predictors only PTI Total, MCCB RPS and MCCB 
Composite appeared frequently in the best 20 models depicted in 
see figure 9.16. 
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Figure 9.16: Predictors of SOFAS scores at month 12 
_______________________________________________________ 
SOFAS: Social and Occupational Functioning Scale; PTI Tot: Perceptual 
Thinking Index total score; MCCB RPS: Reasoning and Problem 
Solving, MCCB Comp: Matrics Consensus Cognitive Battery 
composite score; MCCB AV: Attention/Vigilance; M- :% poor human 
form responses. 
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.   
When entering change scores (difference between baseline and 
month 6 scores) for PANSS Total and factor scores, MCCB 
Composite and subscale scores, and PTI Total and sub-category 
scores with all the independent variables in a best subsets 
regression, the predictive power increased (adjusted R²=0.82, 
F(5,12)=16.83, p<0.01) compared to baseline predictors only 
(adjusted R²=0.56, F(5,14)=5.93, p<0.01) (see table 9.16). 
 
N=18 
Regression Summary for Dependent Variable: SOFAS(M12)  
R²= .875 Adjusted R²= .823 F(5,12)=16.837 p<.01 
b* 
   
b 
  
p-value 
 
# times in best 20 
models 
 
Intercept 
    
13.52 
 
0.060 
 
MCCB_AV 
(M6-baseline) 
 
0.80 
  
1.06 
 
0.00 20 
MCCB_SoP 
(M6-baseline) 
 
-0.52 
  
-0.55 
 
0.00 7 
MCCB_WM 
(M6-baseline) 
 
0.41 
  
0.50 
 
0.00 11 
PANSS_E 
(M6-baseline) 
 
0.39 
  
1.16 
 
0.00 8 
PANSS_Total 
(M6-baseline) 
 
-1.12 
  
-1.21 
 
0.00 17 
 
Table 9.16: Change predictors of SOFAS score at month 12 
_______________________________________________________ 
SOFAS: Social and Occupational Functioning Scale; MCCB AV: 
Attention/Vigilance; MCCB SoP: Speed of Processing; MCCB WM: 
Working Memory; PANSS E: Excited factor; PANSS Total: Positive and 
Negative Syndrome Scale total score.  
 
Improvement in Attention/Vigilance (increase from baseline to month 
6 scores for MCCB A/V), improvement in Speed of Processing 
(increase from baseline to month 6 scores for MCCB SoP),  
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improvement in Working Memory (increase from baseline to month 6 
scores for MCCB WM), improvement in PANSS Excited (decrease 
from baseline to month 6 scores for PANSS E) and improvement in 
symptom severity (decrease from baseline to month 6 scores for 
PANSS Total) explained 82.3% of the variance of SOFAS scores at 
month 12 shown as depicted in table 9.16.  
 
The negative influence of MCCB SoP (b= -0.52) is clinically 
inconsistent with the positive influence of MCCB A/V and MCCB WM, 
therefore the predictive validity of MCCB SoP should be interpreted 
with caution in this regression analysis. The MCCB subscales have a 
multicolinear relationship and therefore should be in the same 
direction as the MCCB Composite score.  
 
All the significant predictors also appeared in a best 20 model as 
shown in figure 9.17.  
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Dependent variable: SOFAS month 12
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Figure 9.17: Change predictors of SOFAS at month 12 
_______________________________________________________ 
SOFAS: Social and Occupational Functioning Scale; MCCB AV: 
Attention/Vigilance; PANSS Total: Positive and Negative Syndrome Scale 
total score; MCCB WM: Working Memory; PANSS E: Excited factor'MCCB 
SoP: Speed of Processing; PANSS P: Positive factor 
 
Improvement in Quality of Life 
Quality of Life (WHOQOL) transformed scores improved in all four 
domains from baseline to month 12 as shown in table 9.17.  
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Effect 
Descriptive Statistics: WHOQOL 
Level of 
Factor 
N 
 
Physical 
 
Mean 
 
Psychological 
 
       Mean 
 
Social 
 
Mean 
 
 Environment 
 
      Mean 
 
 
Total 
  
108 49.33 54.13 52.24 54.00 
 
time 
 
Baseline 42 46.91 53.24 47.33 48.06 
 
time 
 
month 6 35 49.74 53.34 56.00 57.97 
 
time 
 
month 12 28 52.71 56.57 55.42 58.60 
 
 
Table 9.17: WHOQOL mean transformed scores over time 
_______________________________________________________ 
WHOQOL: World Health Organization Quality of Life. 
 
Most of the improvement occurred between baseline and month 6 
with regards to WHOQOL Social (LSD p=0.03) and WHOQOL 
Environment (LSD p<0.01) depicted in table 9.18.  
 
Comparisons  
LSD test; variables: Domain Social (a)  
Effect: time 
1st (a) 
Mean 
 
2nd (a) 
Mean 
 
Mean 
Differ. 
 
  
p 
  
{1}-{2} 
 
baseline month 6 -8.97 
  
0.03 
 
{1}-{3} 
 
baseline month 12 -5.82 
  
0.20 
 
{2}-{3} 
 
month 6 month 12 3.15 
  
0.50 
 
 
Comparisons  
Domain Environment (b)  
1st (b) 
Mean 
 
2nd (b) 
Mean 
 
 
Mean 
Differ. 
 
 
p 
  
{1}-{2} 
 
Baseline month 6 
 
-9.31 
 
0.00 
 
{1}-{3} 
 
Baseline month 12 
 
-9.45 
 
0.01 
 
{2}-{3} 
 
month 6 month 12 
 
-0.14 
 
0.97 
 
 
Table 9.18: LSD p-values for WHOQOL Social and Environment   
_______________________________________________________ 
WHOQOL: World Health Organization Quality of Life. 
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At month 12 the four mean transformed domain scores ranged from 
55.42 to 58.60 (shown in table 9.17), which falls at least one 
standard deviation below the mean for the reference group (Bergner 
et al., 1981).  
 
A best subsets regression with all the independent variables and 
averaged WHOQOL 4 domain scores at month 12 as the dependent 
variable, identified Verbal Learning (MCCB Verbal Learning:           
b= -0.72, p<0.01), HLOE (b=0.63, p<0.01), positive drug screen 
(b=0.74, p<0.01), Good Form Perception to Whole and Large Detail 
(WDA%: b=0.91, p<0.01) and Deviant Verbalizations and Illogical 
Thinking (WSum6%: b=0.37, p=0.02) as significant predictors 
accounting for 69.4% of the variance in WHOQOL at month 12 as 
depicted in table 9.19.  
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N=20 
Regression Summary for Dependent Variable: WHOQOL 
domain average (M12)  
R²= .775 Adjusted R²= .694 F(5,14)=9.65 p<.01 
b* 
   
b 
  
p-value 
 
# times in best 
20 models 
 
Intercept 
    
-20.43 
 
0.35 
 
MCCB_Vrbl Lrng 
 
-0.72 
  
-2.11 
 
0.00 19 
HLOE 
 
0.63 
  
6.58 
 
0.00 20 
Drug screen 
anytime 
 
0.74 
  
30.66 
 
0.00 18 
WDA% 
 
0.91 
  
1.02 
 
0.00 16 
WSum6% 
 
0.37 
  
0.16 
 
0.02 3 
b* = standard beta 
 
Table 9.19: Predictors of averaged WHOQOL scores at month12 
_______________________________________________________ 
WHOQOL: World Health Organization Quality of Life; MCCB Vrb Lrng: 
Verbal Learning; HLOE: highest level of education; WDA: % good form 
responses to whole and large detail; WSum6: % deviant verbalizations and 
illogical thinking.  
 
Of all the predictors (p<0.05) only highest level of education (HLOE, 
b=0.63) and Good Form Perception to Whole and Large Detail, 
WDA%, b=0.91) had an influence on the variance in the direction 
anticipated.  
 
The predictive power did not increase when entering change scores 
(difference between baseline and month 6 for: PANSS Total and 
factor scores, MCCB Composite and subscale scores, and PTI Total 
and sub-category scores) with all the independent variables in a best 
subsets regression (adjusted R²=.67, F(5,12)=8.20, p<0.01) 
compared to baseline measures only (adjusted R²=.69, F(5,14)=9.65, 
p<0.01) (depicted in table 9.20). 
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N=18 
Regression Summary for Dependent Variable: Domain average 
WHOQOL(M12)  
R²= .773 Adjusted R²= .679 F(5,12)=8.20 p<0.01 
b* 
   
b 
  
p-value 
 
# times in best 
20 models 
 
Intercept 
    
-52.42 
 
0.02 
 
Age 
 
0.44 
  
1.29 
 
0.01 6 
HLOE 
 
0.49 
  
4.99 
 
0.00 11 
MCCB_Vrbl 
Lrng 
(M6-baseline) 
 
0.51 
  
1.03 
 
0.00 16 
M-% 
(M6-baseline) 
 
0.89 
  
5.74 
 
0.00 14 
PANSS_D 
(M6-baseline) 
 
-0.34 
  
-2.13 
 
0.04 2 
*b= standard beta 
Table 9.20: Change predictors of WHOQOL scores at month 12 
_______________________________________________________ 
WHOQOL: World Health Organization Quality of Life; HLOE: highest level 
of education; MCCB Vrbl Lrng: Verbal Learning; M- :% poor human form 
responses; PANSS D: Disorganization factor. 
 
All the change predictors were significant (p<0.05) and revealed 
clinically congruent beta values: Age (b=0.44), HLOE (b=0.49), 
improvement in Verbal Learning (b=0.51), and improvement in M- % 
(b=0.89), except for PANSS D (b= -0.34) which is clinically 
unanticipated.  
 
The predictive validity of improvement in Poor Human Form 
Perception (M-%) should be interpreted with caution due to the small 
variance in mean differences over time (refer to Table 9.12, page 
272).   
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Of the significant predictors the following variables appeared more 
frequently in the best  20 models: improvement in MCCB Verbal 
Learning, improvement in M- %, and HLOE as depicted in figure 
9.18.
Dependent variable: WHOQOL average month 12
M
C
C
B
_
V
rb
l 
L
rn
g
(M
6
-D
7
)
P
T
I_
M
-%
(M
6
-D
7
)
P
A
N
S
S
_
T
o
ta
l_
s
c
o
re
(M
6
-D
7
)
H
L
O
E
M
C
C
B
_
A
V
(M
6
-D
7
)
M
C
C
B
_
S
o
P
(M
6
-D
7
)
A
g
e
P
A
N
S
S
_
P
_
T
o
t(
M
6
-D
7
)
M
C
C
B
_
S
C
(M
6
-D
7
)
P
T
I_
X
A
%
(M
6
-D
7
)
M
C
C
B
_
R
P
S
(M
6
-D
7
)
P
A
N
S
S
_
D
_
T
o
t(
M
6
-D
7
)
P
A
N
S
S
_
N
_
T
o
t(
M
6
-D
7
)
D
ru
g
 s
c
re
e
n
 a
n
y
ti
m
e
M
C
C
B
_
C
o
m
p
(M
6
-D
7
)
M
C
C
B
_
W
M
(M
6
-D
7
)
P
T
I_
S
u
m
2
%
(M
6
-D
7
)
P
T
I_
X
-%
(M
6
-D
7
)
P
A
N
S
S
_
A
/D
_
T
o
t(
M
6
-D
7
)
Independent variables
0
2
4
6
8
10
12
14
16
18
#
 t
im
e
s
 s
e
le
c
te
d
 f
ro
m
 2
0
 b
e
s
t 
m
o
d
e
ls
Figure 9.18: Change predictors of average WHOQOL scores at                      
month 12 
_______________________________________________________ 
WHOQOL: World Health Organization Quality of Life; MCCB Vrbl Lrng: 
Verbal Learning; M- :% poor human form responses; PANSS Total: 
Positive and Negative Syndrome scale total score; HLOE: highest level of 
eduction; MCCB: AV: Attention/Vigilance; MCCB SoP: Speed of Processing 
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Remission status 
A total of 47.6% of the patients achieved symptom remission when 
using the criteria of the Remission in Schizophrenia Working Group 
(Andreasen et al., 2005). 
 
A general discriminant analysis revealed that duration of untreated 
psychosis (DUP, Wilks F=5.40, p=0.02) and Fabulised and 
Implausible Thinking (FAB2%, Wilks F=5.96, p=0.02) predicted 
Remission Status at a 95% confidence interval level shown in table 
9.21.  
 
Effect 
Multivariate Tests of Significance: Remission Status 
        Test 
 
         Value 
 
F 
   
p 
 
Intercept 
 
Wilks 0.75 7.03 
  
0.01 
MCCB_Vrbl Lrng 
 
Wilks 0.93 1.44 
  
0.24 
Age 
 
Wilks 0.88 2.92 
  
0.10 
Gender 
 
Wilks 0.91 2.08 
  
0.16 
DUP days 
 
Wilks 0.80 5.40 
  
0.02 
FAB2% 
 
Wilks 0.78 5.96 
  
0.02 
 
Table 9.21: Predictors of Remission Status 
_______________________________________________________ 
MCCB Vrbl Lrng: Verbal Learning; DUP: duration of untreated psychosis; 
FAB2: % fabulised and implausible thinking.  
 
The two significant predictors (DUP and FAB2%) also appeared in 
the best 20 models as depicted in figure 9.19.  
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Discriminant Analy sis: Remission Status
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Figure 9.19: Predictors of Remission Status 
______________________________________________________  
DUP: duration of untreated psychosis; FAB2: % fabulised and implausible 
thinking; MCCB SC: Social Cognition; MCCB Vrbl Lrng: Verbal Learning; 
WSum6: % deviant verbalizations and illogical thinking.  
  
General discriminant analyses of Remission Status with change 
variables (difference between baseline and month 6 for PANSS Total 
and factor scores, MCCB Composite and subscale score, and PTI 
Total and sub-category scores) with all the independent variables 
strengthened the predictive power with the strongest predictor 
(improvement in PANSS Total: Wilks F=31.67, p<0.01) as depicted in  
table 9.22).   
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Effect: Change scores 
Multivariate Tests of Significance: Remission status 
Test 
 
Value 
  
F 
  
P 
 
Intercept 
 
Wilks 0.356 
 
32.46 
 
0.00 
Age 
 
Wilks 0.73 
 
6.53 
 
0.01 
MCCB_AV 
(M6-baseline) 
 
Wilks 0.74 
 
6.28 
 
0.02 
PANSS_E  
(M6-baseline) 
 
Wilks 0.62 
 
11.01 
 
0.00 
PANSS_Total 
(M6-baseline) 
 
Wilks 0.36 
 
31.67 
 
0.00 
 
Table 9.22: Change predictors of Remission Status 
_______________________________________________________ 
MCCB AV: Attention/Vigilance; PANSS E: Excited factor; PANSS Total: 
Positive and Negative Syndrome Scale total score.  
 
Improvement in PANSS Excited factor (Wilks F=11.01), improvement 
in MCCB A/V (Wilks F=6.26) and Age (WIlks F=6.53) were also 
significant predictors of Remission Status.   
 
Of the significant change predictors only MCCB A/V and PANSS 
Total appeared more frequently in the best 20 models (depicted in 
figure 9.20).   
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Discriminant Analysis: Remission Status
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Figure 9.20: Change predictors of Remission Status 
_______________________________________________________ 
PANSS Total: Positive and Negative Syndrome Scale total score; MCCB 
AV: Attention/Vigilance; WSum6: % deviant verbalizations and illogical 
thinking; MCCB RPS: Reasoning and Problem Solving; X- : % poor form 
responses. 
 
Remission Status appears to be correctly predicted by improvement 
in PANSS Total and Attention/Vigilance from baseline to month 6.  
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CHAPTER 10: 
 
DISCUSSION 
 
In this chapter the main findings pertaining to impairments in 
neurocognitive performance and thought and perceptual 
disturbances, their significance and course after treatment, their 
underlying associations, and their relationships to symptoms and 
outcome measures are discussed. 
 
GENERAL 
Patient demographics 
The gender distribution of the cohort was skewed with the majority  
(81%) represented by male patients. This is not unlike other first-
episode cohorts, and  is consistent with epidemiological studies that 
have found that the onset of schizophrenia for males is typically 
before the age of 25, whereas the onset for females usually peaks 
later, typically after age 35 (Hȁfner et al., 1998; Sadock & Sadock, 
2007). The mean age of this FEP cohort was 25 years with 25% lying 
between age 16 and 20 years. Although schizophrenia can have its 
onset at any age, the neurodevelopmental model postulates that the 
first psychotic ''break'', which marks the clinical onset of the disease, 
usually occurs in late puberty or early adulthood (Piper et al., 2012). 
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The age distribution of this FEP cohort supports the 
neurodevelopmental model of delayed disease onset during the 
critical period of brain maturation in adolescence/early adulthood. 
The mean age of the cohort is, however, not an accurate reflection of 
the age at the time of first psychotic episode. Considering the mean 
DUP of 237 days, the age at FEP will be slightly lower than the 
reported age distribution.   
 
There were no significant gender differences on baseline measures 
of symptom severity, neurocognitive impairment, and thought 
disorder. However, older patients tended to do better on composite 
neurocognitive scores, as well as on measures of Attention/Vigilance 
and Working Memory. This finding contradicts that of other studies 
reporting an inverse correlation between neurocognition as 
measured by the MCCB and age. A cross-sectional study by Rajji et 
al. (2013), with 235 stable schizophrenia patients and 333 healthy 
controls, found poorer performances on most of the MCCB subtests 
in patients and healthy controls who were of older age. The co-
norming of the MCCB on 300 U.S citizens (Nuechterlein & Green, 
2006) found similar aging effects on all 7 neurocognitive domains. 
However, it is important to note that these studies were conducted in 
older, chronic schizophrenia samples.   
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The positive correlation between age and neurocognitive ability in 
this FEP cohort may point to more impairment in younger patients 
with schizophrenia. Although this finding cannot be stated 
unequivocally, it mirrors previous studies of early-onset psychosis 
that have found significant impairments in social relations (Hollis, 
1995), language and motor development (Nicholson et al., 2000) and 
lower IQ (Reichenberg et al., 2005; Asarnow et al., 1994). Older age 
may also be associated with a higher educational level obtained by 
patients in this cohort, which generally has a curvilinear relation to IQ 
and measures of neurocognitive ability. However, educational level 
did not correlate with measures of neurocognitive ability or degree of 
symptoms in this study, therefore age may be considered an 
independent factor co-varying with neurocognitive ability.  
 
Significant ethnic differences were found on neurocognitive 
measures of Reasoning and Problem Solving; and Verbal Learning 
that favoured Caucasian patients in comparison to African and ethnic 
groups of mixed origin. The ethnic spread was representative of the 
catchment area with the majority of patients from mixed (67%), 
African (26%) and Caucasian (7%) origin. The significant differences 
found between ethnic groups on neurocognitive measures should be 
interpreted with caution due to the small number of Caucasian 
patients in this cohort. Also, socio-economic factors and educational 
inequalities are likely to have played a role here. The possible effect 
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of ethnicity on MCCB scores should be replicated with further studies 
on patient and non-patient samples in a South African context.  
 
There were no significant differences between ethnic groups on 
Rorschach measures of thought disorder. Critics of the Rorschach 
test have questioned its applicability to ethnic groups other than the 
original RCS United States normative sample (Wood & Lilienfield, 
1999) and its use in non-American countries (Weiner, 2001). 
However, the results from this study render support to literature 
favouring the cross-cultural use of the Rorschach without adjusting 
the RCS (Meyer & Archer, 2001; Viglione & Hilsenroth, 2001). In a 
study comparing 188 RCS variables between European Americans, 
African Americans, and non-European Americans, no evidence of 
cultural bias was found after controlling for relevant demographic 
factors (Meyer, 2002). 
 
Of all the relevant demographic variables, only educational level was 
identified as a strong predictor of treatment outcome at month 12. 
However, no significant correlations were found between educational 
level and baseline measures of neurocognition and symptoms. It can 
therefore be concluded that FEP patients had significant impairment 
at baseline regardless of educational level, but patients with a higher 
education had a better response to treatment.   
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Extrapolations between clinical variables and demographic factors to 
the broader schizophrenia population should however be scrutinized 
carefully because of the small sample size which may introduce 
selection bias if the demographic factors are not representative of the 
whole population.  
 
 Duration of untreated psychosis 
There was a significant correlation between DUP and neurocognitive 
measures (Attention/Vigilance, Reasoning and Problem Solving, 
Speed of Processing). DUP was also found to be a predictor of 
Remission Status. These findings would seem to underscore the 
neurotoxic concept of longer DUP leading to progression of 
underlying neuropathologies and poorer treatment response 
(Lieberman et al., 2001; Perkins et al., 2005). However, the results 
from this study did not fully support the association between longer 
DUP and more severe and persistent symptoms documented 
elsewhere (Loebel et al., 1992), as DUP was not significantly 
correlated with changes in PANSS scores.  
 
Use of ilicit drugs 
Substance use is a risk factor for FEP and has been associated with 
poorer outcome,  treatment non-adherence and higher rates of 
relapse (Tarricone et al., 2014). Its influence on the course of FEP 
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and neurocognition however remains unclear. The majority of studies 
reported better neurocognitive performances in cannabis using 
patients compared to non-users (Rabin et al., 2011; Ferraro et al., 
2013) and fewer brain abnormalities (Cunha et al., 2013) in FEP. 
Other studies have reported poorer neurocognitive performance 
(Mata et al., 2008) or no difference between cannabis using patients 
and non-using patients (Sevy et al., 2007).  
This study did not find any differences between substance using 
patients and non-users on neurocognitive measures or symptom 
severity. Substance use also did not predict outcome in terms of 
symptom severity or general functioning after 12 months of 
treatment. However, the low percentage of illegal substance using 
patients in our sample is much lower than what has been 
documented elsewhere (Barnes et al., 2006) which could explain the 
absence of significant group differences.  
 
At baseline, 9% of patients used illegal substances with the majority 
of patients using cannabis, followed by a smaller number using 
methamphetamine. Longitudinally the incidence of substance use 
increased to 19% over 12 months. Ongoing substance use was 
identified as one of the main contributors leading to the patient 
attrition rate (38%):  a third of the patients who were lost to the study 
could be directly or indirectly related to ongoing substance use. 
These results confirm the use of substances in FEP as an 
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independent risk factor, leading to inter alia treatment non-
adherence. Further studies investigating the relapse rate of patients 
who dropped out of the study due to ongoing substance use will add 
valuable data on the course of schizophrenia in defaulting substance-
abusing patients.  
 
Cannabis is the most commonly used drug among schizophrenia 
patients with a lifetime use reported to be as high as 64% (Barnes et 
al., 2006). The catchment area of the cohort is annexed within the 
geographical boundaries of the Western Cape. The South African 
Community Epidemiology Network on Drug Use (Dada et al., 2011) 
reported methamphetamine as the primary drug of abuse in 8407 
treatment admissions in the Western Cape, followed by cannabis as 
the second highest ranking drug being used. In patients under the 
age of 20 years, the prevalence of methamphetamine and cannabis 
was almost equal. The results of this study confirm the preference for 
cannabis use among FEP patients, but the reported prevalence rate 
might be an underrepresentation of real world substance use for the 
area. Also, it may be that the drug-screening assay was more 
sensitive to detecting cannabis than methamphetamine. 
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NEUROCOGNITION 
FEP patients scored 1-2 standard deviations below the U.S. 
community age/gender corrected norm (Nuechterlein & Green, 2006) 
on all the MCCB neurocognitive domains. The MCCB Composite 
mean T-score of 15.48±15,84 at baseline, which is a more robust 
measure of neurocognitive ability, was at least 3 standard deviations 
below the U.S.community population reference norm. These findings 
confirmed the presence of significant neurocognitive impairment in 
this cohort of FEP patients, which was generalized across 
neurocognitive domains.  
 
Numerous other studies have found similar general neurocognitive 
deficits in schizophrenia patients with scores falling 1-2 standard 
deviations below the population norm (Holmen et al., 2010; Rajji et 
al., 2013; Dickinson et al., 2008). In stable schizophrenia outpatients, 
Keefe et al. (2011) found a mean MCCB Composite T-score of 
26.7±12.4 and MCCB mean domain T-scores have been reported to 
range from 33.4 to 39.3 (Kern et al., 2011). In a study of FEP, which 
is comparable to this study, Vesterager et al. (2012) reported a 
MCCB Composite mean T-score of 42.8±5.5, which is considerably 
higher than the neurocognitive scores found in this FEP cohort. The 
sample studied by Vesterager et al. (2012) had relatively fewer 
symptoms at baseline with a reported PANSS mean total score of 
54.2±12.4. Furthermore, more than 89% of that sample had received 
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prior antipsychotic medication, which might explain why the patients 
achieved better neurocognitive performances at baseline and less 
severe symptoms as measured by the PANSS. A systematic review 
of 118 clinical trials found mean MCCB composite T-scores ranging 
from 20.8±8.5 to 31.0±12.6 (Keefe et al., 2013). The majority of these 
studies included patient samples of older stabilized schizophrenia 
patients.   
 
South African studies using the MCCB across patient and non-
patient samples are still lacking, thereby making comparison to this 
study difficult. The only other South African study that could be 
traced documented neurocognitive deficits in FEP of similar severity 
to this study, with MCCB domain T-scores ranging from 12.4 to 31.9 
(Schoeman, 2011).  
 
Numerous studies have documented differentially impaired 
neurocognitive deficits in schizophrenia patient samples with 
impairment accentuated in executive function, WM, verbal memory, 
visual memory, attention/vigilance, speed of processing and social 
cognition (Barch & Smith, 2008; Reichenberg & Harvey, 2007; Savla 
et al., 2012). In a systematic review of neurocognition in FEP 
patients, Aas et al. (2014) noted that differences exist between 
studies and within neurocognitive domains, also suggesting that 
neurocognitive impairment might be consolidated over the course of 
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the illness. In other FEP studies, verbal and visual memories have 
been found to be more impaired (Hovington et al., 2013; Benoit et al., 
2014). Impairment in speed of processing has been found to be a 
core feature of FEP (Townsend et al., 2001). Speed of processing 
and non-verbal WM deficits have also been identified as a risk factor 
for psychosis in an adolescent sample with psychotic symptoms 
(Kelleher et al., 2012). The results of this study confirm the presence 
of marked impairments in attention/vigilance, speed of processing 
and WM deficits in FEP patients. Impairments in these 
neurocognitive domains were significantly greater than those found in 
verbal memory, visual memory, and reasoning-and-problem solving 
at baseline. This study offers the advantage of assessing 
schizophrenia spectrum psychosis without the confounding variables 
associated with chronicity. Therefore, it can be assumed that the 
neurocognitive impairments found at baseline are a reflection of 
underlying cerebral pathology and not the effect of treatment or 
institutionalism. The differentially severe impairments found in the 
neurocognitive domains of attention/vigilance, WM and speed of 
processing suggest the involvement of the prefrontal cortex (Ren et 
al., 2013). These findings, coupled with age of illness onset 
documented elsewhere in this study, support the hypothesis of 
'hypofrontality' and the neurodevelopmental model of disease 
pathogenesis.   
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This study did not assess general IQ, thereby making it difficult to 
determine whether the poor neurocognitive performance in this FEP 
cohort was a reflection of low IQ. The question of IQ and its co-
variance with measures of neurocognitive ability has long been 
debated. Available literature has consistently indicated lower 
premorbid IQ and lower IQ after FEP schizophrenia when compared 
to healthy controls (Aas et al., 2014). Longitudinally, a decline in IQ 
has been found in FEP and chronic schizophrenia patients, but not 
more than from the expected effect of aging (Kurtz, 2005). Several 
studies have found that neurocognitive impairments are related to IQ 
but also independent from IQ in terms of the magnitude of 
impairment across neurocognitive domains (Holmen et al., 2010; 
Gray et al., 2013). Further support for differential neurocognitive 
impairment in schizophrenia patients, over and above IQ, is 
documented by Hedman et al. (2013). In this meta-analytic study, 
schizophrenia patients show a relative lack of gain from a 'learning or 
practice effect' with repeated IQ measures when compared to healthy 
controls. It can therefore be assumed that the mean IQ will be lower 
in this patient cohort when compared to healthy controls, and that the 
degree of neurocognitive impairment will remain significant after 
controlling for IQ.  
 
Social cognition has emerged as a key factor in schizophrenia 
research and has been found to be a strong predictor of functional 
outcome, and more specifically related to social outcome (Combs et 
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al., 2011; Vesterager et al., 2012). In a study of FEP schizophrenia 
patients, Bliksted et al. (2014) found that social cognition explained 
24% of the variance in real world functioning when entered with 
neurocognition, IQ, and clinical symptoms into principal component 
analysis. In our study, social cognition was measured by the Mayer-
Salovey-Caruso Emotional Intelligence Test (MSCEIT) (Mayer et al., 
2005). We found that social cognition, as measured by the MCCB, 
was not significantly related to clinical symptoms, other 
neurocognitive domains, or outcome in FEP patients. The validity of 
the measurement of social cognition in this cohort is questionable. 
Firstly, many patients had difficulty in following the test instructions 
and many test items were answered randomly. A similar difficulty has 
been encountered by Holmen et al. (2010), who used the MSCEIT 
with early-onset psychosis. Secondly, it is suggested that, in future, 
assessment tools should be used that limit the possible language 
and cultural barriers in the measurement of social cognition in a 
South African context. Also, other elements of social cognition such 
as perception of emotion, facial recognition and theory of mind, as 
co-primary MCCB measures, may render more promising findings in 
future FEP schizophrenia studies. 
 
This study treated patients with a long acting, low dose flupenthixol 
decanoate depot, thereby assuring treatment adherence. The low-
dosing strategy ensured minimal extrapyramidal symptoms and less 
cognitive interfering effects of concomitant anticholinergic 
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medication. Current data suggest improvement in neurocognition 
after antipsychotic dose reduction (Nielsen, 2011), which could 
explain significant neurocognitive gain in our FEP schizophrenia 
cohort. Improvement was significant across the neurocognitive 
domains with the exception of social cognition. Significant 
improvements in neurocognition after antipsychotic treatment has 
been documented elsewhere (Keefe et al., 2006), but the cognitive 
enhancing effects of typical and atypical antipsychotic medication 
remains controversial (Bozikas & Andreou, 2011). Most of the 
improvement occurred within the first 6 months after treatment, 
whereafter a plateau was reached. Longitudinally, neurocognition 
was relatively stable between month 6 and month 12 with scores 
falling 2-3 standard deviations below the US population reference 
norm (Nuechterlein & Green, 2006). This would be in line with the 
'static encephalopathy' view of schizophrenia and in support of 
numerous studies indicating stability of neurocognitive impairments 
after treatment in FEP schizophrenia (Bozikas & Andreou, 2011; 
Barder et al., 2013).  
 
Some of the improvement might be explained by a practice effect 
that is seen with repeat assessments of neurocognitive ability. In a 
systematic review of neurocognition in FEP, Bozikas & Andreou 
(2011) found that in most studies that included a healthy control 
group, improvement was of similar magnitude to improvement found 
in the patient group. Similarly, comparative effect sizes between FEP 
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patients (.35) and healthy controls (.33) have been found on 
neurocognitive testing after treatment with olanzapine and 
risperidone (Goldberg et al., 2007). A few studies have found that 
patients benefit less from a practice effect compared to healthy 
controls (Bozikas & Andreou, 2011). The MCCB has the advantage 
of alternate forms for verbal memory, visual memory and, reasoning-
and-problem solving, to minimize the practice effects associated with 
serial testing. The MCCB manual reports minimal practice effects 
across subtests with effect sizes ranging from .00 to .22 
(Nuechterlein & Green, 2006). A small practice effect (.18) on the 
MCCB composite score was also confirmed by Keefe et al. (2011) in 
a 29-site antipsychotic trial of stable schizophrenia patients.  
Goldberg et al. (2010) in their literature review found that practice 
effects occurred even when alternate forms were used. It is therefore 
likely that although significant changes in neurocognitive scores were 
found, improvement cannot be stated unequivocally, due to unknown 
variance that could be accounted for by a practice and/or placebo 
effect. Further FEP studies including a matched healthy group are 
paramount to determine the magnitude of change, over and above 
observed practice effects.   
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THOUGHT AND PERCEPTUAL DISTURBANCE  
A mild degree degree of perceptual and thought disorder was 
present in the patients at baseline with a mean PTI Total score of 
2.16(±1.48). This is slightly below the psychosis threshold score of 3 
or more, suggested by Dao & Prevatt (2006). Research using the PTI 
is scarce, despite its growing validity in the study of schizophrenia 
(Dao et al., 2008). Studies have been mostly conducted on stable 
schizophrenia patients with PTI total scores ranging from 1.0 
(Benedik et al., 2013), to 1.7 (Dao & Prevatt, 2006), 1.94 (Ilonen et 
al., 2010) and 2.95 (Dao et al., 2008). These studies vary across the 
schizophrenia spectrum, inpatient and outpatient status, and duration 
of illness, treatment regimes, patient demographics, and so on. Few 
studies have used the PTI longitudinally in FEP schizophrenia. The 
only other FEP study that could be traced that is comparable to our 
study, found a mean PTI total score of .82 at baseline (Rosenbaum 
et al., 2012). This low PTI total score found in a Danish FEP 
schizophrenia population (N=34) may arguably be a reflection of the 
effect of antipsychotic medication or raised Lambda scores (L=1.02; 
F%=50) during an acute psychotic state. A high Lambda, or 
'guardedness' in Rorschach responses, is commonly associated with 
psychosis, which may result in impoverished Rorschach protocols 
(Dao & Prevatt, 2006). However, in our study we found raised 
Lambda scores of greater magnitude at baseline than the Danish 
study (L=2.28; F%=54.5). The Danish study followed treatment with a 
low dose antipsychotic and baseline Rorschach assessments took 
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place within 2 weeks after treatment, similar to our study. A possible 
explanation for the failure of the Danish study to find significant 
elevations in Rorschach variables reflecting perceptual and thought 
disturbances, were the inclusion of protocols with less than 14 
responses. These might invalidate the results (Exner, 1993). 
Rorschach protocols with higher response frequency are generally 
known to result in more manifestations of perceptual and thought 
disturbances (Lilienfeld et al., 2000).  
 
The variables comprising the Rorschach PTI, measure two 
dimensions: perceptual accuracy (X-%, XA%, WDA%, M-%) and 
manifestations of thought disorder or illogical reasoning (Sum2, 
FAB2, WSum6) (Smith et al., 2001). In our study the perceptual 
accuracy scores contributed mostly to a raised PTI Total score when 
measured against the threshold for psychosis (Smith et al., 2001). 
Visual-perceptual deficits have been described elsewhere in 
schizophrenia research, with numerous studies indicating 
abnormalities in visual scanning and eye movements (Minassian et 
al., 2005), visual form recognition (Gabrovska et al., 2003), and 
figure-ground perception (Malaspina et al., 2004). Kimhy et al. (2007) 
found that good visual form perception as measured by the 
Rorschach (XA%) was decreased in the clinical high risk group for 
psychosis and the decrease in XA% was found to be relatively stable 
in the FEP schizophrenia group (duration of illness < 2 years). In a 
recent study by Ilonen et al. (2010) similar results were found in 
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adolescents at high risk for psychosis with a mean XA%(.71), 
WDA%(.74) and X-%(.28). This is slightly lower than the degree of 
perceptual inaccuracy we found at baseline, with a mean XA%(.60), 
WDA%(.62) and X-%(.38). Results from our study confirmed the 
elevation of poor form perception in FEP schizophrenia.  
 
The relative stability of thought disorder has been documented in 
previous research using a variety of rating scales and indices across 
schizophrenia samples (Docherty et al., 2003; Maeda et al., 2007). 
Antipsychotic treatment has been found to have an ameliorating 
effect on more severe forms of thought disorder during acute phases 
of the illness, with the presence of residual thought pathology evident 
after treatment (Marengo & Harrow, 1997; Spohn et al., 1986) and 
some improvement found in FEP patients (Goldstein et al., 2002). 
Research on the temporal development and stability of perceptual 
and thought disturbances in schizophrenia as measured by the 
Rorschach PTI is limited. In our study we found significant 
improvement in perceptual and thought disturbances over time with 
thought disorder (Sum2, FAB2, WSum6) improving relatively early 
(first 6 months) and perceptual accuracy improving later (between 
month 6 and month 12). By month 12, residual impairment in 
perceptual accuracy scores XA%(.68), WDA%(.69), X-%(.28) was 
evident but manifestations of thought disorder (Sum2, FAB2, 
WSum6) were within normal limits when compared to the published 
norms (Exner, 2003).  Our findings contradict the findings of a recent 
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FEP study that documented no improvement in Rorschach PTI 
variables after treatment (Rosenbaum et al., 2012), and another 
study which showed worse form perception (X-%) in schizophrenia 
inpatients on antipsychotic or antidepressant treatment (Ilonen et al., 
2010). 
 
Our findings support the findings by Kimhy et al. (2007) that 
perceptual inaccuracies in schizophrenia reflect a trait factor and 
thought disturbances are manifestations of disease expression. We 
found that indices of thought disorder as measured by the PTI 
improved early (between baseline and month 6) and reached normal 
limits by month 12, whilst perceptual inaccuracies improved later 
(between month 6 and month 12) with residual perceptual 
impairment evident by month 12.  
 
Future studies are needed to replicate our findings in larger FEP 
schizophrenia samples. Differential treatment effects on thought 
disorder should be investigated in  comparative clinical trials.  
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RELATIONSHIPS BETWEEN SYMPTOMS, NEUROCOGNITION 
AND DISTURBANCES IN THOUGHT AND PERCEPTION 
The neurocognitive correlates of schizophrenia symptoms and 
thought disorder per se have been studied extensively in 
schizophrenia research. To date, the temporal stability of 
neurocognitive, thought and perceptual disturbances have been 
widely documented, indicating both trait and state like features.  The 
underlying association between neurocognitive deficits, thought and 
perceptual disturbances, and clinical symptoms over the course of 
treatment after FEP schizophrenia, however, remains unclear.   
 
The majority of studies have found correlations with small to modest 
effect sizes between neurocognitive impairment and negative and 
disorganization symptoms, and little or no correlation with positive 
symptoms (O'Leary et al., 2000; Kerns & Berenbaum, 2002; 
Keshavan et al., 2008). Thought disorder has been correlated with 
executive, WM and semantic-lexical processing deficits (Kerns & 
Berenbaum, 2002; Roesch-Ely et al., 2010) but its relation to general 
neurocognitive deficits remains unclear. Furthermore the correlation 
between measures of thought disorder and PANSS derived scores is 
controversial (Stirling et al., 2006; Horn et al., 2009; Palaniyappan, 
2009). Research on Rorschach measures of thought disorder and 
the correlation with PANSS scores is scarce. Perry et al. (2009) 
found that perceptual inaccuracy (X-%) accounted for 35% of the 
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variance in positive symptoms as measured by the Scale for the 
Assessment of Positive Symptoms. The only other study we could 
trace documented improvement in PANSS symptoms after FEP, but 
no change in form perception (Rosenbaum et al., 2012).  
 
In our study we found significant inverse correlations (p<0.05) 
between the MCCB composite score and PANSS factor derived 
negative and disorganization symptoms. This finding supports 
current literature on the association between neurocognitive 
impairment and symptoms of schizophrenia. The association was 
evident across the neurocognitive domains of attention/vigilance, 
speed of processing, working memory, visual learning and verbal 
learning. This finding is similar to previous studies (Nielsen, 2011) 
using the MCCB with the exception of reasoning and problem 
solving, for which we found no significant correlation. We also found 
that perceptual accuracy (form perception) as measured by the 
Rorschach PTI was significantly correlated to overall neurocognition, 
speed of processing, visual learning and working memory (p<0.01), 
but perceptual accuracy did not share the correlation with negative 
and disorganization symptoms. The PTI subscales reflecting thought 
disturbances (WSum6, Sum2, FAB2) did not correlate with PANSS 
Disorganization factor scores, which is not suprising when 
scrutinizing the Disorganization factor items (G11, N7, P2, N5, G15, 
G10 and G5) which are considered to reflect more a cognitive factor 
(Good et al., 2004) and not formal thought disorder as much.  
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Perceptual accuracy was significantly correlated to PANSS factor 
derived positive symptoms (P1, G9, P3, P6, P5, P6, G12) with X-% 
(poor form perception) having an inverse correlation (Spearman= -
0.42, p=0.02) and XA% (good form perception) a positive correlation 
(Spearman= 0.40, p=0.02). This finding is clinically counter intuitive 
and extremely unexpected since accurate form perception on the 
Rorschach is seen as a measure of reality testing (Benedik et al., 
2013). It is generally expected that acutely psychotic patients will 
have poor reality testing and more severe positive symptoms 
(delusions and hallucinations). Our findings indicate that patients with 
poor reality testing (X-%) had less severe positive symptoms during 
FEP and that patients with good form perception  (XA% and WDA%) 
had more severe positve symptoms. Statistically it is possible that a 
third unknown variable had a shared variance, or that the PANSS 
positive factor reflects a heterogeneity of symptoms that potentially 
could contribute to differential correlations, which were not accounted 
for in our analysis. Of the PANSS positive factor derived items, only 
P1 (delusions) and P3 (hallucinations) can directly be translated into 
impaired reality testing. The other PANSS positive factor items reflect 
distortions in thought content (unusual, suspiciousness, grandiosity, 
lack of insight) and not so much distortions on a visual-perceptual 
level.  
 
Another possible explanation is offered by previous Rorschach 
research, which indicated that high Lambda (ratio of pure form 
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responses compared to all responses) is a defensive compensatory 
mechanism often found in psychosis. This may mask the severity of 
thought and perceptual disturbances (Dao & Prevatt, 2006). 
However, no studies could be traced that measured Lambda 
longitudinally after FEP. We found that Lambda was raised at 
baseline with a mean of 2.28(±3.23) but after 6 months Lambda 
increased significantly to a mean of 3.44±5.05. Between month 6 and 
month 12 Lambda remained relatively stable. These findings suggest 
that defensive compensation against psychosis is manifest early after 
FEP and that further consolidation of defensiveness takes place in 
temporal association with clinical improvement. Furthermore, 
although Lambda was increased, we found more perceptual and 
thought disturbances at baseline as measured by the Rorschach PTI. 
Our results therefore do not support the notion that raised Lambda in 
acute psychosis will obscure the essential features of psychosis.  
 
The results of our study support the findings of previous studies 
indicating a temporal association between perceptual accuracy (form 
perception) and neurocognitive impairment. Improvement in 
symptoms co-varied with improvement in neurocognition and thought 
and perceptual disturbance, with neurocognitive impairment and 
perceptual inaccuracy remaining relatively stable following treatment, 
which is independent from symptomatic improvement. This finding is 
consistent with previous studies indicating stability of neurocognitive 
impairment and perceptual inaccuracy (Ilonen et al., 2010; Barder et 
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al., 2013). Perceptual inaccuracy, as measured by poor form 
perception on the Rorschach PTI, appears to reflect an underlying 
neurocognitive impairment, more specifically executive deficits (WM 
and speed of processing) and impaired visual learning. The 
association between thought disorder, visual scanning deficits and 
executive impairments have also been documented elsewhere 
(Minassian et al., 2005; Stirling et al., 2010).  Our study investigated 
only visual perception as measured by the Rorschach PTI, but the 
multi-sensory model proposed by De Jong et al. (2013) deserves 
mentioning here in terms of its implication for future research. In this 
model schizophrenia is viewed as a severe form of disintegration 
between sensory input and neurocognitive processing. This opens 
the avenue for novel future studies.    
 
The significance of perceptual accuracy per se needs to be qualified 
in our study since the inter-rater reliability for WSum6 (thought 
disorder)  variables was fair (ICC=.55). This is in contrast to form 
perception which was good for F-(ICC=.74) to excellent for F+ 
(ICC=.80). This could affect the interpretation of results since the 
degree of thought disturbance, as measured by the Rorschach PTI, 
could be higher or lower than the documented findings in our study. 
Nevertheless, a clear trend was established with perceptual 
inaccuracy being relatively more stable than thought disturbances, 
regardless the degree thereof.   
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PREDICTORS OF OUTCOME 
It is generally accepted that neurocognitive impairment and thought 
disorder in schizophrenia are related to functional and social 
outcomes (Bowie & Harvey, 2008; Nielsen, 2011). In particular, 
neurocognitive deficits in social cognition (Savla et al., 2012; Combs 
et al., 2011), working memory and executive function (O'Connor et 
al., 2013; González-Ortega et al., 2013), speed of processing (Kern 
et al., 2011) and verbal memory (Bodnar et al., 2008) have been 
associated with these outcomes. Furthermore, the persistence of 
thought disorder after FEP (Bearden et al., 2011) and visual-
perceptual deficits (Kimhy et al., 2007) in schizophrenia patients 
have been found to be a robust predictor of poor outcomes.  
 
In our study we found that only HLOE (beta= -0.54, p<0.01) predicted 
PANSS total score at month 12, when entering baseline measures 
and demographic variables into regression analysis. Longitudinally 
we found that HLOE and improvement from baseline to month 6 in 
Sum2 (severe deviant verbalizations and illogical thinking), PANSS 
excited factor and WDA% (good form perception) explained 78.3% of 
the variance in PANSS total score at month 12. In terms of clinical 
outcome we therefore conclude that higher educational level, degree 
of improvement in thought disorder, form perception and excited 
symptoms, are associated with better symptomatic response. A 
higher level of educational attainment is generally associated with 
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higher IQ, which potentially may serve as a neuroprotective factor in 
facilitating better treatment response.  
 
In terms of functional and social outcomes we found that HLOE and 
change scores (improvement between baseline and month 6) for 
cognitive, perceptual and thought disorder measures were better 
predictors of outome. The amount of improvement in PANSS total 
and excited symptoms, working memory and attention/vigilance 
accounted for 82.3% of the variance in SOFAS at month 12.  
 
Regression coefficients remained the same for WHOQoL at month 
12, when entering the amount of improvement in symptoms, 
improvement in neurocognition and improvement in Rorschach PTI 
variables from baseline to month 6. This is probably due to the 
WHOQoL answers which reflect the patient's self assessment on 
aspects pertaining to physical, environmental, psychological and 
social health. We found little improvement over time on WHOQoL 
answers, which may be indicative of the broader societal constraints. 
The living conditions of the patients in the catchment area reflected 
the broader socio-economic landscape of South Africa, which is 
marked by conditions of inequality, poverty, unemployment, limited 
access to health services, etc. For this reason we believe the SOFAS 
to be a more robust measure of social and functional outcomes in 
schizophrenia. Future research could incorporate more appropriate 
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and sensitive outcome measures relevant to the South African 
context.     
 
We also investigated predictors of remission status as defined by the 
Remission in Schizophrenia Working Group (Andreasen et al., 2005). 
We found that DUP (F=5.40, p<0.05) and FAB2 (F=5.96, p<0.05) 
predicted remission status when entering baseline measures and 
demographic variables into regression analysis. The effect of 
predicting remission status was strengthened significantly when 
using 
 the amount of improvement in PANSS total score from 
baseline to month 6 (F=31.67, p<0.01),  
 improvement in excited symptoms from baseline to month 6 
(F=11.01, p<0.01),  
 improvement in attention/vigilance from baseline to month 6 
(F=6.28, p<0.05)  
 and age (F=6.53, p<0.05), as predictors.  
 
Overall, we found evidence that the amount of improvement in 
neurocognitive, thought and perceptual disorder between baseline 
and month 6, were related to social and functional outcomes in FEP 
schizophrenia. Baseline neurocognitive deficits, thought or 
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perceptual disturbances did not predict symptomatic improvement at 
month 12.   
 
Interestingly we found that the amount of improvement in symptoms 
from baseline to month 6, more specifically in PANSS total and 
excited symptoms, predicted outcomes in terms of social and 
occupational functioning as well as symptomatic improvement. Of 
note is the significance of excited symptoms per se (hostility, poor 
impulse control, excitement, uncooperativeness) and their relation to 
symptomatic and functional outcome. Similar associations have been 
documented elsewhere (Emsley et al., 2006; Jerrell & Hrisko, 2013), 
but research to date investigating excited symptoms is scarce. Future 
studies could investigate the underpinnings of excited symptoms in 
schizophrenia and their relation to various outcome measures.    
 
We furthermore found that improvement in neurocognition from 
baseline to month 6, in particular in attention/vigilance, was invariably 
related to social and occupational functioning and remission status. 
The same applied for WM and remission status. It is possible that 
attentional impairment is a function of increased excitability during 
the acute phase of FEP schizophrenia, hence the shared relation to 
outcome. Further studies are needed to investigate this relationship 
and its effect on treatment outcome correlates.  
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STRENGTHS AND LIMITATIONS 
Most studies assessing neurocognition and thought disorder in 
schizophrenia have used cross-sectional designs with stabilized and 
chronic patient samples. This study offered the advantage of 
 assessing FEP patients who were largely treatment naive at 
baseline,  
 tracking changes over a course of 12 months after treatment 
with a low-dose single antipsychotic depot, thereby  
 assuring treatment adherence and avoiding the confounding 
variables associated with chronicity and polypharmacy.  
The use of standardized assessment instruments is an added 
advantage when documenting findings that are comparable to other 
studies and can be replicated in future research.  
 
This is the first study to assess neurocognitive deficits and 
disturbances in thought and form perception longitudinally, in close 
temporal association, using the MCCB and Rorschach PTI in a FEP 
schizophrenia cohort. Assessing patients before treatment when they 
were floridly psychotic offered the opportunity to gage the salient 
neurocognitive, thought, perceptual and clinical features associated 
with acute  illness.  
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Although careful planning was executed to ensure scientific rigor, 
several limitations were inherently part of this study:  
1. The sample size was small (N=42), and was further diminished by 
a relatively high attrition rate. This reduced the statistical power 
and limited the statistical analyses of sub-units. This limitation 
was evident especially for identifying outcome predictors; very 
small numbers were encountered in some groups, e.g., number of 
females, non-remitters, etc.  
2. We did not include a healthy control group. However, the MCCB 
and RCS are adequately normed on large European and 
American samples, albeit normative data in South Africa is still 
lacking.  Furthermore, we do not know to what degree a practice 
effect could account for improvement in MCCB scores, over and 
above the minimal effect sizes documented in the MCCB 
standardization study. The inclusion of a control group would 
make analysis of a practice effect possible in comparable 
statistical units. 
3. The inclusion of patients who were actively using illegal 
substances may have acted as a confounder. Yet, we found 
substance use had no effect and the number of patients who 
were using substances was very small. 
4. The inclusion of a comparator group, either receiving a higher 
dose, or else oral flupenthixol, or a second generation 
antipsychotic  would have strengthened our findings.  
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5. The duration of our study was sufficient to document longitudinal 
changes in FEP schizophrenia, yet extending the study over a 2-
year period would have added support to our findings indicating 
relative stability of neurocognitive and perceptual disturbances. 
6. Although the cross-cultural applications of the MCCB and RCS 
have been researched and found to be valid across cultures, 
more research on these instruments are needed on South African 
samples, to determine the effect of possible cultural bias. 
7. We found that the MCCB was relatively insensitive to the 
measurement of social cognition in our cohort. The need exists to 
use more appropriate and culturally relevant instruments to 
assess aspects of social cognition. Similarly, the use of a self-
report measure to assess quality of life may not accurately reflect 
social and functional outcomes. 
8. The recruitment of patients from the spectrum of schizophrenia 
disorders encompasses a broad diagnostic entity that allows for 
important sub-group differences, which may have been missed in 
our study.  
9. The use of the Rorschach PTI as a measure of thought disorder 
is debateable given it’s low correlation with other measures of 
thought disorder, it’s modest interrater reliability coefficients (refer 
to page 206) and the incongruent fit between thought processes 
and spoken language.  
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Despite these limitations, we believe that the findings of this study 
are significant and clinically relevant. We hope that the dissemination 
of our results will prompt future research to further investigate the 
relationships between thought and perceptual disorder, 
neurocognition and symptom expression in schizophrenia.     
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CHAPTER 11: 
 
CONCLUSION 
 
Neurocognitive deficits and thought disorder have long been 
regarded as hallmark features in schizophrenia. Their relative 
stability has been widely accepted, but their response to treatment 
remains controversial. The development of more sensitive, 
standardized instruments such as the MCCB and Rorschach PTI 
have led to numerous studies in schizophrenia over the past two 
decades. The literature on schizophrenia has often been 
characterized by a division between neurocognitive science and 
''Rorschach science''. The protagonists of the latter have generally 
relied on Rorschach nomenclature and interpretation without regard 
for the neurocognitive underpinnings of Rorschach measurement. In 
this study we examined the relatedness between neurocognitive 
deficits and disturbances in thought and form perception, using the 
MCCB and Rorschach PTI as primary co-measures. A cohort of FEP 
schizophrenia patients offered us the ideal opportunity to tap into the 
salient features of neurocognitive and thought and perceptual 
disturbances: their significance in FEP, their association, and 
trajectory over the course of treatment, and their significance as 
predictors of outcome.  
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In our study we found a significant degree of neurocognitive 
impairment across domains, thought and perceptual disturbances, 
and the observation of concordant elevation in symptoms in 
schizophrenia patients during pre-treatment. Improvement in thought 
disorder and improvement across neurocognitive domains occurred 
during the first 6 months after treatment, with improvement in form 
perception occurring later from month 6 to month 12. Improvement in 
symptoms had a positive influence on neurocognitive, thought and 
perceptual disturbances, but by month 12 residual neurocognitive 
and perceptual disturbances were still evident when symptom levels 
were approaching normal limits. We concluded that poor form 
perception may reflect an underlying neurocognitive deficit, and that 
symptoms and neurocognitive and perceptual deficits, although 
closely related, are separate in terms of treatment response. We 
confirmed the relative stability of neurocognitive and thought and 
perceptual disturbances, the correlation between neurocognitive and 
negative / disorganization symptoms, and the correlation between 
form perception and positive symptoms. We have also identified 
HLOE, improvement in form perception, improvement in 
neurocognition and improvement in excited symptoms as stronger 
predictors of outcome measures.  
 
This study should hopefully stimulate further research into multimodal 
sensory-perceptual processes prior to, during and after onset of 
schizophrenia and its association with clinical, neurocognitive, 
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neurological and functional correlates. The use of the MCCB and 
Rorschach PTI were challenging in terms of it’s administrability and 
tolerability during the acute stage of schizophrenia when patients 
were floridly psychotic. In some cases testing had to be stopped or 
postponed until the patient has ‘settled’ enough to be testable. During 
acute psychosis patients characteristically are more excitable with 
higher scores on hostility, poor impulse control and 
uncooperativeness. This may have had a negative impact on the test 
situation, level of motivation, and test performance.   
 
With the advance of the Brain Research through Advancing 
Innovative Neurotechnologies (BRAIN) initiative (National Institutes 
of Health, 2013) we can hopefully move forward with the promise of 
more sensitive and accurate neurotechnologies that will assist us in 
deciphering some of the intricacies of brain function and disease 
expression in schizophrenia.  
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Appendix A 
 
Table 1 : Summary table for demographic variables 
 
_________________________________________________________________________________ 
   Mean  Range SD            P* MCCB     PTI        PANSS  
_________________________________________________________________________________ 
 
Age, years  24  16-45 6.9       0.05        0.29       0.13 
 
Gender          
  Male, n (%)  34 (81%)        0.71        0.91       0.18 
  Females, n (%)  8 (19%) 
Ethnicity, n (%)  
  Mixed   28 (67%)        0.51        0.82       0.41 
  African   11 (26%)  
  Caucasian  3 (7%)  
Education, years   10.7 7-15 2.1      0.16        0.95       0.24 
Diagnosis, n (%)   
  Schizophreniform  22 (53%) 
  Schizophrenia  19 (45%) 
  Schizoaffective   1 (2%) 
DUP, days  237 8-1307 269      0.1         0.35        0.24 
Substance use, n (%)  4 (9%)         0.73       0.68        0.11 
_________________________________________________________________________________ 
 P* = paired t-tests for continuous variables and Chi square tests for categorical variables 
   MCCB = MATRICS Cognitive Consensus Battery 
   PTI = Perceptual Thinking Index 
   PANSS = Positive and Negative Syndrome Scale  
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Table 2 : LSD means at each time point for MCCB, PTI and PANSS       
                scores  
_________________________________________________________________________________ 
Baseline      Month 6  Month 12  P*  P** 
_________________________________________________________________________________ 
 
MCCB Composite 15.5     27.3  26.3  <0.0001  0.7 
A/V   26.3     35.5  36.7  <0.0001  0.5 
SoP  22.7     31.8  31.2  <0.0001  0.9 
VerbLrng  36.2     41.4  38.7  <0.01  0.7 
VisLrng  32.5     39.8  38.2  <0.01  0.9 
WM  25.8     37.0  36.5  <0.0001    0.8 
RPS  33.6     40.2  39.6  <0.001  0.9 
SC  26.8     31.3  31.9  0.05  0.4 
 
PTI Total  2.2     1.7  1.3  <0.05  0.4 
Lambda  2.2     3.4  3.5  <0.01  0.9 
WSum6  59.8     36.2  14.9  <0.01  0.1 
FAB2  0.48     0.00  0.11  <0.05  0.6  
Sum2  6.2     2.5  1.5  <0.01  0.8 
M-   2.5     1.0  1.2  0.07  0.9 
XA  60.0     62.4  68.5  0.22  <0.05 
WDA  62.6     64.7  69.1  0.19  0.2 
 X-    38.3     33.2  28.6  0.06  0.1 
 
PANSS Total 89.1     48.2  44.2  <0.0001  0.2 
PANSS P  23.1     7.6  5.0  <0.0001  <0.05 
PANSS N  22.3     10.6  7.9  <0.0001  <0.05 
PANSS D  21.3     8.9  6.5  <0.0001  <0.05 
PANSS E  7.4     3.1  2.6  <0.0001  0.3 
PANSS A/D 11.2     4.9  3.8  <0.0001   0.1  
_________________________________________________________________________________  
P* = p values for differences between baseline and month 6 scores 
P** = p values for differences between month 6 and month 12 scores 
   MCCB = MATRICS Cognitive Consensus Battery  
     A/V = Attention / Vigilance  
     SoP = Speed of Processing  
     VerbLrng = Verbal Learning 
     Vis Lrng = Visual Learning  
     WM = Working Memory          
     RPS = Reasoning and Problem Solving 
     SC = Social Cognition 
   PTI = Perceptual Thinking Index 
     Lambda = ratio of pure form responses compared to all responses  
     WSum6 = sum of 6 weighted scores for Unusual Thinking and Illogical Combinations     
     FAB2 = Fabulized Thinking and Implausible Combinations        
     Sum2 = Deviant Verbalizations and Illogical Thinking  
     M-  = Poor Human Form perception 
     XA = Good Form perception 
     WDA = Good Form perception to Whole and Large Detail 
     X-  = Poor Form perception  
   
 PANSS = Positive and Negative Syndrome Scale 
     P = Positive factor 
     N = Negative factor 
     D = Disorganization factor 
     E = Excited factor 
     A/D = Anxiety / Depression factor 
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Acronyms 
 
AIDS   Acquired Immunodeficiency Syndrome 
BRAIN  Brain Research through Advancing Innovative   
  Neurotechnologies  
CATIE  Clinical Antipsychotic Trials of Intervention   
  Effectiveness  
CDI  Coping Deficit Index 
CPT  Continuous Performance Tests 
CSF  Cerebrospinal Fluid 
DA  Dopamine 
DEPI   Depression Index 
DLPFC Dorsolateral Prefrontal Cortex 
DUP  Duration of Untreated Psychosis 
EII   Ego Impairment Index  
EPSE  Extraparydamil side effects  
EUFEST  European First Episode Schizophrenia Trial  
FD   Flupenthixol Depot  
FEP  First Episode Psychosis 
FGA  First Generation Agent 
HIV  Human Immunodeficiency Virus 
HLOE  Highest Level of Education 
HPA  Hypothalamic-pituitary-adrenal axis  
HRV   Human Representational variable  
HVI  Hypervigilance Index 
ICC   Intraclass Correlation Coefficients  
ICV  Intracranial Volume 
LNS   Letter-number-span test 
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MATRICS Measurement and Treatment Research to Improve  
  Cognition in Schizophrenia 
MCCB MATRICS Consensus Cognitive Battery 
MDN  Mediodorsal thalamic nucleus  
MLD  Metachromatic leucodystrophy 
MMPI   Minnesota Multiphasic Personality Index  
NAA  N-acetylaspartate  
NIMH   National Institute of Mental Health of the USA 
OBS  Obsessive Style Index 
OC  Observed Cases  
OFC  Orbitofrontal Cortex 
PANSS  Positive and Negative Syndrome Scale  
PET  Positron Emission Tomography 
PPI  Prepulse inhibition 
PTI  Perceptual Thinking Index  
rCBF   regional Cerebral Blood Flow 
RCS  Rorschach Comprehensive System 
  Coding on the RCS  
1. Location: W= whole response; D= common 
detail; Dd= infrequent detail S= use of white 
space response. 
2. Determinants: F= pure form; M= human 
movement; FM= animal movement; m= 
inanimate movement; C= pure chromatic colour; 
CF= chromatic colour-form; FC= chromatic form-
colour; Cn= chromatic colour naming; C'= pure 
achromatic colour; C'F= achromatic colour-form; 
FC'= achromatic form-colour; T= pure texture; 
TF= texture-form; FT= form-texture; V=pure 
vista; VF= vista-form; FV= form-vista; Y= pure 
diffuse shading; YF= undifferentiated shading-
form; FY= undifferentiated form-shading; FD= 
form dimension; rF= reflection-form; Fr= form-
reflection. 
 RCS Indices 
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1. Perceptual Thinking Index (PTI), 
2. Depression Index (DEPI),  
3. Coping Deficit Index (CDI),  
4. Suicide Constellation (SCON),  
5. Hypervigilance Index (HVI), and  
6. Obsessive Style Index (OBS) 
 
RIAP5  Rorschach Interpretation Assistance Program  
RIM  Rorschach Inkblot Method 
SCID-P  Structured Clinical Interview for DSM-IV disorders 
SCON  Suicide Constellation 
SCZI   Schizophrenia Index  
SD  Standard Deviation 
SGA  Second-generation agents 
SOFAS Social and Occupational Functioning Scale 
STG  Superior temporal gyrus 
TDI  Thought Disorder Index 
TLC  The Scale for the Assessment of Thought, Language  
  and Communication 
TOL   Tower of London test 
TMTA  Trail-making Test A  
VBM  Voxel-based morphometry  
VCFS  Velocardiofacial syndrome  
WAIS  Wechsler Adult Intelligence Scale 
WBV  Whole Brain Volume 
WCST Wisconsin Card Sorting Test 
WHOQOL  World Health Organization Quality of Life  
WM  Working Memory 
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